{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 6191, "items": [{"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T00:55:37Z", "timestamp": 1575420937246}, "reference-count": 0, "publisher": "Georg Thieme Verlag KG", "issue": "01", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Semin Reprod Med"], "DOI": "10.1055/s-0033-1361822", "type": "journal-article", "created": {"date-parts": [[2014, 1, 3]], "date-time": "2014-01-03T23:30:46Z", "timestamp": 1388791846000}, "page": "043-049", "source": "Crossref", "is-referenced-by-count": 30, "title": ["Microbiota and Pelvic Inflammatory Disease"], "prefix": "10.1055", "volume": "32", "author": [{"given": "Harsha", "family": "Sharma", "sequence": "first", "affiliation": [{"name": "Department of Obstetrics and Gynecology, Mt Sinai School of Medicine Jamaica Program, Queens Hospital Center, Queens, New York"}]}, {"given": "Reshef", "family": "Tal", "sequence": "first", "affiliation": [{"name": "Department of Obstetrics and Gynecology, Maimonides Medical Center, Brooklyn, New York"}]}, {"given": "Natalie", "family": "Clark", "sequence": "first", "affiliation": [{"name": "Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan"}]}, {"given": "James", "family": "Segars", "sequence": "additional", "affiliation": []}], "member": "194", "published-online": {"date-parts": [[2014, 1, 3]]}, "container-title": ["Seminars in Reproductive Medicine"], "language": "en", "link": [{"URL": "http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0033-1361822.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 5, 23]], "date-time": "2017-05-23T04:49:54Z", "timestamp": 1495514994000}, "score": 36.322186, "issued": {"date-parts": [[2014, 1, 3]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2014, 1, 3]]}, "issue": "01"}, "URL": "http://dx.doi.org/10.1055/s-0033-1361822", "ISSN": ["1526-8004", "1526-4564"], "issn-type": [{"value": "1526-8004", "type": "print"}, {"value": "1526-4564", "type": "electronic"}], "subject": ["Obstetrics and Gynaecology", "Physiology (medical)", "Endocrinology, Diabetes and Metabolism", "Endocrinology", "Reproductive Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T09:44:42Z", "timestamp": 1574761482451}, "reference-count": 0, "publisher": "Informa UK Limited", "license": [{"URL": "http://creativecommons.org/licenses/by-nc/3.0/", "start": {"date-parts": [[2016, 1, 1]], "date-time": "2016-01-01T00:00:00Z", "timestamp": 1451606400000}, "delay-in-days": 0, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CEG"], "DOI": "10.2147/ceg.s51902", "type": "journal-article", "created": {"date-parts": [[2016, 1, 28]], "date-time": "2016-01-28T22:18:52Z", "timestamp": 1454019532000}, "page": "21", "source": "Crossref", "is-referenced-by-count": 18, "title": ["Fecal calprotectin in inflammatory bowel disease"], "prefix": "10.2147", "author": [{"given": "Roy", "family": "Sherwood", "sequence": "first", "affiliation": []}, {"given": "Natalie", "family": "Walsham", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2016, 1]]}, "container-title": ["Clinical and Experimental Gastroenterology"], "language": "en", "link": [{"URL": "https://www.dovepress.com/getfile.php?fileID=28826", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 10, 30]], "date-time": "2016-10-30T22:30:18Z", "timestamp": 1477866618000}, "score": 21.945637, "issued": {"date-parts": [[2016, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.2147/ceg.s51902", "ISSN": ["1178-7023"], "issn-type": [{"value": "1178-7023", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T12:45:23Z", "timestamp": 1574340323664}, "publisher-location": "Totowa, NJ", "reference-count": 262, "publisher": "Humana Press", "isbn-type": [{"value": "9781588295514", "type": "print"}, {"value": "9781597455336", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1007/978-1-59745-533-6_5", "type": "book-chapter", "created": {"date-parts": [[2007, 12, 25]], "date-time": "2007-12-25T18:07:13Z", "timestamp": 1198606033000}, "page": "69-112", "source": "Crossref", "is-referenced-by-count": 1, "title": ["C-Reactive Protein and Other Inflammatory Markers in Cardiovascular Disease"], "prefix": "10.1007", "author": [{"given": "Natalie", "family": "Khuseyinova", "sequence": "first", "affiliation": []}, {"given": "Wolfgang", "family": "Koenig", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "5_CR1", "doi-asserted-by": "publisher", "first-page": "499", "DOI": "10.1161/01.CIR.0000052939.59093.45", "volume": "107", "author": "TA Pearson", "year": "2003", "unstructured": "Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F; Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499\u2013511.", "journal-title": "Circulation"}, {"key": "5_CR2", "doi-asserted-by": "publisher", "first-page": "1387", "DOI": "10.1056/NEJMoa032804", "volume": "350", "author": "J Danesh", "year": "2004", "unstructured": "Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387\u20131397.", "journal-title": "N Engl J Med"}, {"key": "5_CR3", "doi-asserted-by": "publisher", "first-page": "561", "DOI": "10.1084/jem.52.4.561", "volume": "52", "author": "WS Tillett", "year": "1930", "unstructured": "Tillett WS, Francis TJ. Serological reactions in pneumonia with a nonprotein somatic fraction of pneumococcus. Exp Med 1930;52:561\u2013571.", "journal-title": "Exp Med"}, {"key": "5_CR4", "first-page": "426", "volume": "47", "author": "HK Meier-Ewert", "year": "2001", "unstructured": "Meier-Ewert HK, Ridker PM, Rifai N, Price M, Dinges DF, Mullington JM. Absence of diurnal variation of C-reactive protein concentrations in healthy subjects. Clin Chem 2001;47:426\u2013430.", "journal-title": "Clin Chem"}, {"key": "5_CR5", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.1161/01.CIR.79.1.101", "volume": "79", "author": "P Angleton", "year": "1989", "unstructured": "Angleton P, Chandler WL, Schmer G. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). Circulation 1989;79:101\u2013106.", "journal-title": "Circulation"}, {"key": "5_CR6", "first-page": "575", "volume": "48", "author": "M Fr\u00f6hlich", "year": "2002", "unstructured": "Fr\u00f6hlich M, Sund M, Thorand B, Hutchinson WL, Pepys MB, Koenig W. Lack of seasonal variation in C-reactive protein. Clin Chem 2002;48:575\u2013577.", "journal-title": "Clin Chem"}, {"key": "5_CR7", "doi-asserted-by": "crossref", "first-page": "2692", "DOI": "10.1161/01.ATV.17.11.2692", "volume": "17", "author": "M Frohlich", "year": "1997", "unstructured": "Frohlich M, Sund M, Russ S, Hoffmeister A, Fischer HG, Hombach V, Koenig W. Seasonal variations of rheological and hemostatic parameters, and acute phase reactants in young, healthy subjects. Arterioscler Thromb Vasc Biol 1997;17:2692\u20132697.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR8", "doi-asserted-by": "crossref", "first-page": "235", "DOI": "10.1172/JCI108932", "volume": "61", "author": "I Kushner", "year": "1978", "unstructured": "Kushner I, Broder ML, Karp D. Control of the acute phase response. Serum C-reactive protein kinetics after acute myocardial infarction. J Clin Invest 1978;61:235\u2013242.", "journal-title": "J Clin Invest"}, {"key": "5_CR9", "doi-asserted-by": "publisher", "first-page": "1930", "DOI": "10.1161/01.CIR.0000096055.62724.C5", "volume": "108", "author": "P Calabro", "year": "2003", "unstructured": "Calabro P, Willerson JT, Yeh ET. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 2003;108:1930.", "journal-title": "Circulation"}, {"key": "5_CR10", "doi-asserted-by": "publisher", "first-page": "1428", "DOI": "10.1161/01.CIR.0000092184.43176.91", "volume": "108", "author": "WJ Jabs", "year": "2003", "unstructured": "Jabs WJ, Theissing E, Nitschke M, Bechtel JF, Duchrow M, Mohamed S, Jahrbeck B, Sievers HH, Steinhoff J, Bartels C. Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue. Circulation 2003;108:1428\u20131431.", "journal-title": "Circulation"}, {"key": "5_CR11", "doi-asserted-by": "crossref", "first-page": "1039", "DOI": "10.1016/S0002-9440(10)64051-5", "volume": "158", "author": "K Yasojima", "year": "2001", "unstructured": "Yasojima K, Schwab C, McGeer EG, McGeer PL. Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol 2001;158:1039\u20131051.", "journal-title": "Am J Pathol"}, {"key": "5_CR12", "doi-asserted-by": "crossref", "first-page": "287", "DOI": "10.1016/S0002-9149(02)03156-9", "volume": "91", "author": "T Ishikawa", "year": "2003", "unstructured": "Ishikawa T, Hatakeyama K, Imamura T, Date H, Shibata Y, Hikichi Y, Asada Y, Eto T. Involvement of C-reactive protein obtained by directional coronary atherectomy in plaque instability and developing restenosis in patients with stable or unstable angina pectoris. Am J Cardiol 2003;91: 287\u2013292.", "journal-title": "Am J Cardiol"}, {"key": "5_CR13", "doi-asserted-by": "publisher", "first-page": "2019", "DOI": "10.1161/01.CIR.0000015507.29953.38", "volume": "105", "author": "AP Burke", "year": "2002", "unstructured": "Burke AP, Tracy RP, Kolodgie F, Malcom GT, Zieske A, Kutys R, Pestaner J, Smialek J, Virmani R. Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies. Circulation 2002;105:2019\u20132023.", "journal-title": "Circulation"}, {"key": "5_CR14", "doi-asserted-by": "publisher", "first-page": "1355", "DOI": "10.1161/01.CIR.0000158479.58589.0A", "volume": "111", "author": "W Maier", "year": "2005", "unstructured": "Maier W, Altwegg LA, Corti R, Gay S, Hersberger M, Maly FE, Sutsch G, Roffi M, Neidhart M, Eberli FR, Tanner FC, Gobbi S, von Eckardstein A, Luscher TF. Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein. Circulation 2005;111:1355\u20131361.", "journal-title": "Circulation"}, {"key": "5_CR15", "first-page": "4815", "volume": "156", "author": "Q Dong", "year": "1996", "unstructured": "Dong Q, Wright JR. Expression of C-reactive protein by alveolar macrophages. J Immunol 1996;156:4815\u20134820.", "journal-title": "J Immunol"}, {"key": "5_CR16", "doi-asserted-by": "publisher", "first-page": "80", "DOI": "10.1016/S0006-8993(00)02970-X", "volume": "887", "author": "K Yasojima", "year": "2000", "unstructured": "Yasojima K, Schwab C, McGeer EG, McGeer PL. Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer\u2019s disease. Brain Res 2000;887:80\u201389.", "journal-title": "Brain Res"}, {"key": "5_CR17", "doi-asserted-by": "publisher", "first-page": "152", "DOI": "10.1002/immu.200390018", "volume": "33", "author": "WJ Jabs", "year": "2003", "unstructured": "Jabs WJ, Logering BA, Gerke P, Kreft B, Wolber EM, Klinger MH, Fricke L, Steinhoff J. The kidney as a second site of human C-reactive protein formation in vivo. Eur J Immunol 2003;33: 152\u2013161.", "journal-title": "Eur J Immunol"}, {"key": "5_CR18", "doi-asserted-by": "publisher", "first-page": "1112", "DOI": "10.1016/j.jacc.2005.06.017", "volume": "46", "author": "P Calabro", "year": "2005", "unstructured": "Calabro P, Chang DW, Willerson JT, Yeh ET. Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation. J Am Coll Cardiol 2005;46:1112\u20131113.", "journal-title": "J Am Coll Cardiol"}, {"key": "5_CR19", "doi-asserted-by": "crossref", "first-page": "1194", "DOI": "10.1161/01.CIR.103.9.1194", "volume": "103", "author": "TP Zwaka", "year": "2001", "unstructured": "Zwaka TP, Hombach V, Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 2001;103:1194\u20131197.", "journal-title": "Circulation"}, {"key": "5_CR20", "doi-asserted-by": "publisher", "first-page": "235", "DOI": "10.1111/j.1749-6632.1982.tb22140.x", "volume": "389", "author": "JE. Volanakis", "year": "1982", "unstructured": "Volanakis JE. Complement activation by C-reactive protein complexes. Ann N Y Acad Sci 1982;389:235\u2013250.", "journal-title": "Ann N Y Acad Sci"}, {"key": "5_CR21", "doi-asserted-by": "publisher", "first-page": "585", "DOI": "10.1084/jem.190.4.585", "volume": "190", "author": "D Bharadwaj", "year": "1999", "unstructured": "Bharadwaj D, Stein MP, Volzer M, Mold C, Du Clos TW. The major receptor for C-reactive protein on leukocytes is FC\u03b3 receptor II. J Exp Med 1999;190:585\u2013590.", "journal-title": "J Exp Med"}, {"key": "5_CR22", "doi-asserted-by": "crossref", "first-page": "1386", "DOI": "10.1161/01.ATV.18.9.1386", "volume": "18", "author": "J Torzewski", "year": "1998", "unstructured": "Torzewski J, Torzewski M, Bowyer DE, Frohlich M, Koenig W, Waltenberger J, Fitzsimmons C, Hombach V. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol 1998;18:1386\u20131392.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR23", "doi-asserted-by": "publisher", "first-page": "1890", "DOI": "10.1161/01.CIR.0000015126.83143.B4", "volume": "105", "author": "S Verma", "year": "2002", "unstructured": "Verma S, Li SH, Badiwala MV, Weisel RD, Fedak PW, Li RK, Dhillon B, Mickle DA. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 2002;105:1890\u20131896.", "journal-title": "Circulation"}, {"key": "5_CR24", "doi-asserted-by": "publisher", "first-page": "361", "DOI": "10.1016/1043-4666(92)90079-7", "volume": "4", "author": "SP Ballou", "year": "1992", "unstructured": "Ballou SP, Lozanski G. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine 1992;4:361\u2013368.", "journal-title": "Cytokine"}, {"key": "5_CR25", "doi-asserted-by": "publisher", "first-page": "599", "DOI": "10.1084/jem.189.3.599", "volume": "189", "author": "SA Jones", "year": "1999", "unstructured": "Jones SA, Novick D, Horiuchi S, Yamamoto N, Szalai AJ, Fuller GM. C-reactive protein: a physiological activator of interleukin 6 receptor shedding. J Exp Med 1999;189:599\u2013604.", "journal-title": "J Exp Med"}, {"key": "5_CR26", "doi-asserted-by": "crossref", "first-page": "2094", "DOI": "10.1161/01.ATV.20.9.2094", "volume": "20", "author": "M Torzewski", "year": "2000", "unstructured": "Torzewski M, Rist C, Mortensen RF, Zwaka TP, Bienek M, Waltenberger J, Koenig W, Schmitz G, Hombach V, Torzewski J. C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol 2000;20:2094\u20132099.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR27", "doi-asserted-by": "crossref", "first-page": "2531", "DOI": "10.1161/01.CIR.103.21.2531", "volume": "103", "author": "V Pasceri", "year": "2001", "unstructured": "Pasceri V, Chang J, Willerson JT, Yeh ETH. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 2001;103:2531\u20132534.", "journal-title": "Circulation"}, {"key": "5_CR28", "doi-asserted-by": "crossref", "first-page": "2566", "DOI": "10.1161/01.CIR.0000131160.94926.6E", "volume": "109", "author": "KH Han", "year": "2004", "unstructured": "Han KH, Hong KH, Park JH, Ko J, Kang DH, Choi KJ, Hong MK, Park SW, Park SJ. C-reactive protein promotes monocyte chemoattractant protein-1\u2014mediated chemotaxis through upregulating CC chemokine receptor 2 expression in human monocytes. Circulation 2004;109: 2566\u20132571.", "journal-title": "Circulation"}, {"key": "5_CR29", "doi-asserted-by": "crossref", "first-page": "2165", "DOI": "10.1161/01.CIR.102.18.2165", "volume": "102", "author": "V Pasceri", "year": "2000", "unstructured": "Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000;102:2165\u20132168.", "journal-title": "Circulation"}, {"key": "5_CR30", "doi-asserted-by": "crossref", "first-page": "1785", "DOI": "10.1161/01.CIR.101.15.1785", "volume": "101", "author": "A Nakagomi", "year": "2000", "unstructured": "Nakagomi A, Freedman SB, Geczy CL. Interferon-gamma and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein: relationship with age, sex, and hormone replacement treatment. Circulation 2000;101:1785\u20131791.", "journal-title": "Circulation"}, {"key": "5_CR31", "first-page": "513", "volume": "82", "author": "J Cermak", "year": "1993", "unstructured": "Cermak J, Key NS, Bach RR, Balla J, Jacob HS, Vercellotti GM. CRP induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993;82:513\u2013520.", "journal-title": "Blood"}, {"key": "5_CR32", "doi-asserted-by": "publisher", "first-page": "975", "DOI": "10.1161/01.ATV.0000126681.16619.69", "volume": "24", "author": "E Paffen", "year": "2004", "unstructured": "Paffen E, Vos HL, Bertina RM. C-reactive protein does not directly induce tissue factor in human monocytes. Arterioscler Thromb Vasc Biol 2004;24:975\u2013981.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR33", "doi-asserted-by": "publisher", "first-page": "335", "DOI": "10.1097/00001721-200306000-00003", "volume": "14", "author": "AD Blann", "year": "2003", "unstructured": "Blann AD, Lip GY. Effects of CRP on the release of von Willebrand factor, E-selectin, thrombomodulin and intercellular adhesion molecule-1 from HUVEC. Blood Coagul Fibrinolysis 2003;14:335\u2013340.", "journal-title": "Blood Coagul Fibrinolysis"}, {"key": "5_CR34", "doi-asserted-by": "publisher", "first-page": "398", "DOI": "10.1161/01.CIR.0000052617.91920.FD", "volume": "107", "author": "S Devaraj", "year": "2003", "unstructured": "Devaraj S, Xu DY, Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation 2003;107:398\u2013404.", "journal-title": "Circulation"}, {"key": "5_CR35", "doi-asserted-by": "publisher", "first-page": "913", "DOI": "10.1161/01.CIR.0000029802.88087.5E", "volume": "106", "author": "S Verma", "year": "2002", "unstructured": "Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, Badiwala MV, Dhillon B, Weisel RD, Li RK, Mickle DA, Stewart DJ. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002;106:913\u2013919.", "journal-title": "Circulation"}, {"key": "5_CR36", "doi-asserted-by": "publisher", "first-page": "1439", "DOI": "10.1161/01.CIR.0000033116.22237.F9", "volume": "106", "author": "SK Venugopal", "year": "2002", "unstructured": "Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002;106:1439\u20131441.", "journal-title": "Circulation"}, {"key": "5_CR37", "doi-asserted-by": "publisher", "first-page": "1057", "DOI": "10.1016/j.bbrc.2004.01.004", "volume": "314", "author": "Y Nagoshi", "year": "2004", "unstructured": "Nagoshi Y, Kuwasako K, Cao YN, Kitamura K, Eto T. Effects of C-reactive protein on atherogenic mediators and adrenomedullin in human coronary artery endothelial and smooth muscle cells. Biochem Biophys Res Commun 2004;314:1057\u20131063.", "journal-title": "Biochem Biophys Res Commun"}, {"key": "5_CR38", "first-page": "e168", "volume": "24", "author": "CW Berg", "year": "2004", "unstructured": "van den Berg CW, Taylor KE, Lang D. C-reactive protein-induced in vitro vasorelaxation is an artefact caused by the presence of sodium azide in commercial preparations. Arterioscler Thromb Vasc Biol 2004;24:e168\u2013e171.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR39", "doi-asserted-by": "publisher", "first-page": "1225", "DOI": "10.1161/01.ATV.0000164623.41250.28", "volume": "25", "author": "KE Taylor", "year": "2005", "unstructured": "Taylor KE, Giddings JC, van den Berg CW. C-reactive protein-induced in vitro endothelial cell activation is an artefact caused by azide and lipopolysaccharide. Arterioscler Thromb Vasc Biol 2005;25:1225\u20131230.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR40", "doi-asserted-by": "crossref", "first-page": "e136", "DOI": "10.1161/01.ATV.0000175753.82842.cc", "volume": "25", "author": "SS Nerurkar", "year": "2005", "unstructured": "Nerurkar SS, McDevitt PJ, Scott GF, Johanson KO, Willette RN, Yue TL. Lipopolysaccharide (LPS) contamination plays the real role in C-reactive protein-induced IL-6 secretion from human endothelial cells in vitro. Arterioscler Thromb Vasc Biol 2005;25:e136.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR41", "doi-asserted-by": "publisher", "first-page": "2216", "DOI": "10.1161/01.ATV.0000183718.62409.ea", "volume": "25", "author": "U Singh", "year": "2005", "unstructured": "Singh U, Devaraj S, Jialal I. C-reactive protein decreases tissue plasminogen activator activity in human aortic endothelial cells: evidence that C-reactive protein is a procoagulant. Arterioscler Thromb Vasc Biol 2005;25:2216\u20132221.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR42", "doi-asserted-by": "publisher", "first-page": "714", "DOI": "10.1161/01.RES.0000163015.67711.AB", "volume": "96", "author": "RJ Bisoendial", "year": "2005", "unstructured": "Bisoendial RJ, Kastelein JJ, Levels JH, Zwaginga JJ, van den Bogaard B, Reitsma PH, Meijers JC, Hartman D, Levi M, Stroes ES. Activation of inflammation and coagulation after infusion of C-reactive protein in humans. Circ Res 2005;96:714\u2013716.", "journal-title": "Circ Res"}, {"key": "5_CR43", "doi-asserted-by": "publisher", "first-page": "e71", "DOI": "10.1161/01.RES.0000196746.75724.8b", "volume": "97", "author": "R Bisoendial", "year": "2005", "unstructured": "Bisoendial R, Kastelein J, Stroes E. In response to van den Berg et al: on the direct actions of CRP in humans. Circ Res 2005;97:e71.", "journal-title": "Circ Res"}, {"key": "5_CR44", "doi-asserted-by": "publisher", "first-page": "279", "DOI": "10.1385/IR:26:1-3:279", "volume": "26", "author": "AJ Szalai", "year": "2002", "unstructured": "Szalai AJ, McCrory MA. Varied biologic functions of C-reactive protein: lessons learned from transgenic mice. Immunol Res 2002;26:279\u2013287.", "journal-title": "Immunol Res"}, {"key": "5_CR45", "doi-asserted-by": "publisher", "first-page": "512", "DOI": "10.1161/01.CIR.0000085568.13915.1E", "volume": "108", "author": "HD Danenberg", "year": "2003", "unstructured": "Danenberg HD, Szalai AJ, Swaminathan RV, Peng L, Chen Z, Seifert P, Fay WP, Simon DI, Edelman ER. Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice. Circulation 2003;108:512\u2013515.", "journal-title": "Circulation"}, {"key": "5_CR46", "doi-asserted-by": "publisher", "first-page": "647", "DOI": "10.1161/01.CIR.0000114526.50618.24", "volume": "109", "author": "A Paul", "year": "2004", "unstructured": "Paul A, Ko KW, Li L, Yechoor V, McCrory MA, Szalai AJ, Chan L. C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Circulation 2004;109: 647\u2013655.", "journal-title": "Circulation"}, {"key": "5_CR47", "doi-asserted-by": "publisher", "first-page": "8309", "DOI": "10.1073/pnas.0503202102", "volume": "102", "author": "GM Hirschfield", "year": "2005", "unstructured": "Hirschfield GM, Gallimore JR, Kahan MC, Hutchinson WL, Sabin CA, Benson GM, Dhillon AP, Tennent GA, Pepys MB. Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice. Proc Natl Acad Sci USA 2005;102:8309\u20138314.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "5_CR48", "doi-asserted-by": "publisher", "first-page": "1635", "DOI": "10.1161/01.ATV.0000171992.36710.1e", "volume": "25", "author": "A de Trion", "year": "2005", "unstructured": "Trion A, de Maat MP, Jukema JW, van der Laarse A, Maas MC, Offerman EH, Havekes LM, Szalai AJ, Princen HM, Emeis JJ. No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice. Arterioscler Thromb Vasc Biol 2005;25:1635\u20131640.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR49", "doi-asserted-by": "crossref", "first-page": "1641", "DOI": "10.1161/01.ATV.0000171983.95612.90", "volume": "25", "author": "K Reifenberg", "year": "2005", "unstructured": "Reifenberg K, Lehr HA, Baskal D, Wiese E, Schaefer SC, Black S, Samols D, Torzewski M, Lackner KJ, Husmann M, Blettner M, Bhakdi S. Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer? Arterioscler Thromb Vasc Biol 2005;25: 1641\u20131646.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR50", "doi-asserted-by": "publisher", "first-page": "199", "DOI": "10.1136/bmj.321.7255.199", "volume": "321", "author": "J Danesh", "year": "2000", "unstructured": "Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MB. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000;321:199\u2013204.", "journal-title": "BMJ"}, {"issue": "2", "key": "5_CR51", "doi-asserted-by": "publisher", "first-page": "415", "DOI": "10.1016/j.atherosclerosis.2005.09.023", "volume": "187", "author": "SM Boekholdt", "year": "2006", "unstructured": "Boekholdt SM, Hack CE, Sandhu MS, Luben R, Bingham SA, Wareham NJ, Peters RJ, Jukema JW, Day NE, Kastelein JJ, Khaw KT. C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: The EPIC-Norfolk prospective population study 1993\u20132003. Atherosclerosis 2006;187(2):415\u2013422 [2005 Oct 27; Epub ahead of print].", "journal-title": "Atherosclerosis"}, {"key": "5_CR52", "doi-asserted-by": "publisher", "first-page": "25", "DOI": "10.1161/CIRCULATIONAHA.104.504159", "volume": "112", "author": "M Cushman", "year": "2005", "unstructured": "Cushman M, Arnold AM, Psaty BM, Manolio TA, Kuller LH, Burke GL, Polak JF, Tracy RP. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the Cardiovascular Health Study. Circulation 2005;112:25\u201331.", "journal-title": "Circulation"}, {"key": "5_CR53", "doi-asserted-by": "publisher", "first-page": "1349", "DOI": "10.1161/01.CIR.0000120707.98922.E3", "volume": "109", "author": "W Koenig", "year": "2004", "unstructured": "Koenig W, Lowel H, Baumert J, Meisinger C. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany. Circulation 2004;109:1349\u20131353.", "journal-title": "Circulation"}, {"key": "5_CR54", "doi-asserted-by": "publisher", "first-page": "2292", "DOI": "10.1161/01.CIR.0000100688.17280.E6", "volume": "108", "author": "PM Ridker", "year": "2003", "unstructured": "Ridker PM; JUPITER Study Group. Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial. Circulation 2003; 108:2292\u20132297.", "journal-title": "Circulation"}, {"key": "5_CR55", "doi-asserted-by": "publisher", "first-page": "7152", "DOI": "10.1073/pnas.77.12.7152", "volume": "77", "author": "J Weissenbach", "year": "1980", "unstructured": "Weissenbach J, Chernajovsky Y, Zeevi M, Shulman L, Soreq H, Nir U, Wallach D, Perricaudet M, Tiollais P, Revel M. Two interferon mRNAs in human fibroblasts: in vitro translation and Escherichia coli cloning studies. Proc Natl Acad Sci USA 1980;77:7152\u20137156.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "5_CR56", "doi-asserted-by": "publisher", "first-page": "1411", "DOI": "10.1002/eji.1830171004", "volume": "17", "author": "De Aarden LA", "year": "1987", "unstructured": "Aarden LA, De Groot ER, Schaap OL, Lansdorp PM. Production of hybridoma growth factor by human monocytes. Eur J Immunol 1987;17:1411\u20131416.", "journal-title": "Eur J Immunol"}, {"key": "5_CR57", "first-page": "144", "volume": "142", "author": "FR Jirik", "year": "1989", "unstructured": "Jirik FR, Podor TJ, Hirano T, Kishimoto T, Loskutoff DJ, Carson DA, Lotz M. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J Immunol 1989;142:144\u2013147.", "journal-title": "J Immunol"}, {"key": "5_CR58", "doi-asserted-by": "publisher", "first-page": "4196", "DOI": "10.1210/jc.82.12.4196", "volume": "82", "author": "V Mohamed-Ali", "year": "1997", "unstructured": "Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997;82:4196\u20134200.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "5_CR59", "doi-asserted-by": "crossref", "first-page": "621", "DOI": "10.1042/bj2650621", "volume": "265", "author": "PC Heinrich", "year": "1990", "unstructured": "Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J 1990;265:621\u2013636.", "journal-title": "Biochem J"}, {"key": "5_CR60", "doi-asserted-by": "publisher", "first-page": "443", "DOI": "10.1097/00001721-199010000-00013", "volume": "1", "author": "DL. Amrani", "year": "1990", "unstructured": "Amrani DL. Regulation of fibrinogen biosynthesis: glucocorticoid and interleukin-6 control. Blood Coagul Fibrinolysis 1990;1:443\u2013446.", "journal-title": "Blood Coagul Fibrinolysis"}, {"key": "5_CR61", "doi-asserted-by": "publisher", "first-page": "87", "DOI": "10.1016/1043-4666(94)90013-2", "volume": "6", "author": "Y Seino", "year": "1994", "unstructured": "Seino Y, Ikeda U, Ikeda M, Yamamoto K, Misawa Y, Hasegawa T, Kano S, Shimada K. Interleukin-6 gene transcripts are expressed in human atherosclerotic lesions. Cytokine 1994; 6:87\u201391.", "journal-title": "Cytokine"}, {"key": "5_CR62", "doi-asserted-by": "publisher", "first-page": "263", "DOI": "10.1016/S0021-9150(96)05968-0", "volume": "127", "author": "HG Rus", "year": "1996", "unstructured": "Rus HG, Vlaicu R, Niculescu F. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis 1996;127:263\u2013271.", "journal-title": "Atherosclerosis"}, {"key": "5_CR63", "doi-asserted-by": "crossref", "first-page": "1372", "DOI": "10.1161/01.CIR.101.12.1372", "volume": "101", "author": "B Schieffer", "year": "2000", "unstructured": "Schieffer B, Schieffer E, Hilfiker-Kleiner D, Hilfiker A, Kovanen PT, Kaartinen M, Nussberger J, Harringer W, Drexler H. Expression of angiotensin II and interleukin-6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation 2000;101:1372\u20131378.", "journal-title": "Circulation"}, {"key": "5_CR64", "doi-asserted-by": "publisher", "first-page": "3493", "DOI": "10.1161/01.CIR.0000148135.08582.97", "volume": "110", "author": "B Schieffer", "year": "2004", "unstructured": "Schieffer B, Selle T, Hilfiker A, Hilfiker-Kleiner D, Grote K, Tietge UJ, Trautwein C, Luchtefeld M, Schmittkamp C, Heeneman S, Daemen MJ, Drexler H. Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis. Circulation 2004;110:3493\u20133500.", "journal-title": "Circulation"}, {"key": "5_CR65", "first-page": "258", "volume": "91", "author": "P Biswas", "year": "1998", "unstructured": "Biswas P, Delfanti F, Bernasconi S, Mengozzi M, Cota M, Polentarutti N, Mantovani A, Lazzarin A, Sozzani S, Poli G. Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. Blood 1998;91:258\u2013265.", "journal-title": "Blood"}, {"key": "5_CR66", "doi-asserted-by": "publisher", "first-page": "584", "DOI": "10.1016/0006-291X(92)91234-H", "volume": "187", "author": "R Pigott", "year": "1992", "unstructured": "Pigott R, Dillon LP, Hemingway IH, Gearing AJ. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 1992;187:584\u2013589.", "journal-title": "Biochem Biophys Res Commun"}, {"key": "5_CR67", "doi-asserted-by": "crossref", "first-page": "2364", "DOI": "10.1161/01.ATV.19.10.2364", "volume": "19", "author": "SA Huber", "year": "1999", "unstructured": "Huber SA, Sakkinen P, Conze D, Hardin N, Tracy R. Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler Thromb Vasc Biol 1999;19:2364\u20132367.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR68", "doi-asserted-by": "publisher", "first-page": "3", "DOI": "10.1046/j.1365-2141.2001.03061.x", "volume": "115", "author": "R Kerr", "year": "2001", "unstructured": "Kerr R, Stirling D, Ludlam CA. Interleukin 6 and haemostasis. Br J Haematol 2001;115:3\u201312.", "journal-title": "Br J Haematol"}, {"key": "5_CR69", "doi-asserted-by": "crossref", "first-page": "2079", "DOI": "10.1161/01.CIR.99.16.2079", "volume": "99", "author": "LM Biasucci", "year": "1999", "unstructured": "Biasucci LM, Liuzzo G, Fantuzzi G, Caligiuri G, Rebuzzi AG, Ginnetti F, Dinarello CA, Maseri A. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation 1999;99:2079\u20132084.", "journal-title": "Circulation"}, {"key": "5_CR70", "doi-asserted-by": "publisher", "first-page": "2107", "DOI": "10.1001/jama.286.17.2107", "volume": "286", "author": "E Lindmark", "year": "2001", "unstructured": "Lindmark E, Diderholm E, Wallentin L, Siegbahn A. Relationship between interleukin-6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. JAMA 2001;286:2107\u20132113.", "journal-title": "JAMA"}, {"key": "5_CR71", "doi-asserted-by": "crossref", "first-page": "1767", "DOI": "10.1161/01.CIR.101.15.1767", "volume": "101", "author": "PM Ridker", "year": "2000", "unstructured": "Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000;101: 1767\u20131772.", "journal-title": "Circulation"}, {"key": "5_CR72", "doi-asserted-by": "publisher", "first-page": "836", "DOI": "10.1056/NEJM200003233421202", "volume": "342", "author": "PM Ridker", "year": "2000", "unstructured": "Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836\u2013843.", "journal-title": "N Engl J Med"}, {"key": "5_CR73", "doi-asserted-by": "publisher", "first-page": "980", "DOI": "10.1001/jama.288.8.980", "volume": "288", "author": "AD Pradhan", "year": "2002", "unstructured": "Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, Rifai N, Wallace RB, Jackson RD, Pettinger MB, Ridker PM. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women\u2019s Health Initiative observational study. JAMA 2002;288:980\u2013987.", "journal-title": "JAMA"}, {"key": "5_CR74", "doi-asserted-by": "publisher", "first-page": "506", "DOI": "10.1016/S0002-9343(99)00066-2", "volume": "106", "author": "TB Harris", "year": "1999", "unstructured": "Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH Jr, Heimovitz H, Cohen HJ, Wallace R. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999;106:506\u2013512.", "journal-title": "Am J Med"}, {"key": "5_CR75", "doi-asserted-by": "crossref", "first-page": "947", "DOI": "10.1161/01.CIR.103.7.947", "volume": "103", "author": "S Volpato", "year": "2001", "unstructured": "Volpato S, Guralnik JM, Ferrucci L, Balfour J, Chaves P, Fried LP, Harris TB. Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women\u2019s health and aging study. Circulation 2001;103:947\u2013953.", "journal-title": "Circulation"}, {"key": "5_CR76", "doi-asserted-by": "publisher", "first-page": "213", "DOI": "10.1189/jlb.0602313", "volume": "73", "author": "JA Gracie", "year": "2003", "unstructured": "Gracie JA, Robertson SE, McInnes IB. Interleukin-18. J Leukoc Biol 2003;73:213\u2013224.", "journal-title": "J Leukoc Biol"}, {"key": "5_CR77", "doi-asserted-by": "publisher", "first-page": "871", "DOI": "10.1530/eje.1.01897", "volume": "152", "author": "T Skurk", "year": "2005", "unstructured": "Skurk T, Kolb H, M\u00fcller-Scholze S, R\u00f6hrig K, Hauner H, Herder C. The proatherogenic cytokine interleukin-18 is secreted by human adipocytes. Eur J Endocrinol 2005;152:871\u2013876.", "journal-title": "Eur J Endocrinol"}, {"key": "5_CR78", "doi-asserted-by": "publisher", "first-page": "206", "DOI": "10.1126/science.275.5297.206", "volume": "275", "author": "Y Gu", "year": "1997", "unstructured": "Gu Y, Kuida K, Tsutsui H, Ku G, Hsiao K, Fleming MA, Hayashi N, Higashino K, Okamura H, Nakanishi K, Kurimoto M, Tanimoto T, Flavell RA, Sato V, Harding MW, Livingston DJ, Su MS. Activation of interferon-\u03b3 inducing factor mediated by interleukin-1\u03b2 converting enzyme. Science 1997;275:206\u2013209.", "journal-title": "Science"}, {"key": "5_CR79", "doi-asserted-by": "publisher", "first-page": "88", "DOI": "10.1038/378088a0", "volume": "378", "author": "H Okamura", "year": "1995", "unstructured": "Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K, Akita K, Namba M, Tanabe F, Konishi K, Fukuda S, Kurimoto M. Cloning of a new cytokine that induces IFN-\u03b3 production by T cells. Nature 1995;378:88\u201391.", "journal-title": "Nature"}, {"key": "5_CR80", "doi-asserted-by": "publisher", "first-page": "1647", "DOI": "10.1002/eji.1830260736", "volume": "26", "author": "MJ Micallef", "year": "1996", "unstructured": "Micallef MJ, Ohtsuki T, Kohno K, Tanabe F, Ushio S, Namba M, Tanimoto T, Torigoe K, Fujii M, Ikeda M, Fukuda S, Kurimoto M. Interferon-\u03b3-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-\u03b3 production. Eur J Immunol 1996;26:1647\u20131651.", "journal-title": "Eur J Immunol"}, {"key": "5_CR81", "doi-asserted-by": "publisher", "first-page": "245", "DOI": "10.1084/jem.20011022", "volume": "195", "author": "N Gerdes", "year": "2002", "unstructured": "Gerdes N, Sukhova GK, Libby P, Reynolds RS, Young JL, Schonbeck U. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med 2002;195:245\u2013257.", "journal-title": "J Exp Med"}, {"key": "5_CR82", "doi-asserted-by": "publisher", "first-page": "68", "DOI": "10.1007/s00210-002-0648-5", "volume": "367", "author": "M Nold", "year": "2003", "unstructured": "Nold M, Goede A, Eberhardt W, Pfeilschifter J, Muehl H. IL-18 initiates release of matrix metalloproteinase-9 from peripheral blood mononuclear cells without affecting tissue inhibitor of matrix metalloproteinases-1: suppression by TNF-\u03b1 blockage and modulation by IL-10. Naunyn Schmiedebergs Arch Pharmacol 2003;367:68\u201375.", "journal-title": "Naunyn Schmiedebergs Arch Pharmacol"}, {"key": "5_CR83", "doi-asserted-by": "publisher", "first-page": "156", "DOI": "10.1016/j.febslet.2004.05.039", "volume": "569", "author": "Y Ishida", "year": "2004", "unstructured": "Ishida Y, Migita K, Izumi Y, Nakao K, Ida H, Kawakami A, Abiru S, Ishibashi H, Eguchi K, Ishii N. The role of IL-18 in the modulation of matrix metalloproteinases and migration of human natural killer (NK) cells. FEBS Lett 2004;569:156\u2013160.", "journal-title": "FEBS Lett"}, {"key": "5_CR84", "doi-asserted-by": "publisher", "first-page": "1598", "DOI": "10.1161/hc3901.096721", "volume": "104", "author": "Z Mallat", "year": "2001", "unstructured": "Mallat Z, Corbaz A, Scoazec A, Besnard S, Leseche G, Chvatchko Y, Tedgui A. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 2001;104:1598\u20131603.", "journal-title": "Circulation"}, {"key": "5_CR85", "first-page": "E41", "volume": "89", "author": "Z Mallat", "year": "2001", "unstructured": "Mallat Z, Corbaz A, Scoazec A, Graber P, Alouani S, Esposito B, Humbert Y, Chvatchko Y, Tedgui A. Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ Res 2001;89:E41\u2013E45.", "journal-title": "Circ Res"}, {"key": "5_CR86", "doi-asserted-by": "publisher", "first-page": "234", "DOI": "10.1016/S0008-6363(03)00343-2", "volume": "59", "author": "R Elhage", "year": "2003", "unstructured": "Elhage R, Jawien J, Rudling M, Ljunggren HG, Takeda K, Akira S, Bayard F, Hansson GK. Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. Cardiovasc Res 2003;59:234\u2013240.", "journal-title": "Cardiovasc Res"}, {"key": "5_CR87", "doi-asserted-by": "publisher", "first-page": "e34", "DOI": "10.1161/hh0202.105292", "volume": "90", "author": "SC Whitman", "year": "2002", "unstructured": "Whitman SC, Ravisankar P, Daugherty A. Interleukin-18 enhances atherosclerosis in Apolipoprotein E-/- mice through release of interferon-\u03b3. Circ Res 2002;90:e34\u2013e38.", "journal-title": "Circ Res"}, {"key": "5_CR88", "doi-asserted-by": "publisher", "first-page": "791", "DOI": "10.1161/01.ATV.0000153516.02782.65", "volume": "25", "author": "C Tenger", "year": "2005", "unstructured": "Tenger C, Sundborger A, Jawien J, Zhou X. IL-18 accelerates atherosclerosis accompanied by elevation of IFN-\u03b3 and CXCL16 expression independently of T cells. Arterioscler Thromb Vasc Biol 2005;25:791\u2013796.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR89", "doi-asserted-by": "publisher", "first-page": "2313", "DOI": "10.1161/01.ATV.0000147126.99529.0a", "volume": "24", "author": "R Nooijer de", "year": "2004", "unstructured": "de Nooijer R, von der Thusen JH, Verkleij CJ, Kuiper J, Jukema JW, van der Wall EE, van Berkel JC, Biessen EA. Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein-E-deficient mice. Arterioscler Thromb Vasc Biol 2004;24:2313\u20132319.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR90", "doi-asserted-by": "crossref", "first-page": "467", "DOI": "10.1136/heart.88.5.467", "volume": "88", "author": "Z Mallat", "year": "2002", "unstructured": "Mallat Z, Henry P, Fressonnet R, Alouani S, Scoazec A, Beaufils P, Chvatchko Y, Tedgui A. Increased plasma concentrations of interleukin-18 in acute coronary syndromes. Heart 2002;88: 467\u2013469.", "journal-title": "Heart"}, {"key": "5_CR91", "doi-asserted-by": "publisher", "first-page": "45", "DOI": "10.1016/j.ijcard.2003.08.020", "volume": "98", "author": "R Rosso", "year": "2005", "unstructured": "Rosso R, Roth A, Herz I, Miller H, Keren G, George J. Serum levels of interleukin-18 in patients with stable and unstable angina pectoris. Int J Cardiol 2005;98:45\u201348.", "journal-title": "Int J Cardiol"}, {"key": "5_CR92", "doi-asserted-by": "publisher", "first-page": "1258", "DOI": "10.1016/S0002-9149(03)00279-0", "volume": "91", "author": "D Kawasaki", "year": "2003", "unstructured": "Kawasaki D, Tsujino T, Morimoto S, Fujioka Y, Naito Y, Okumura T, Masutani M, Shimizu H, Yuba M, Ueda A, Ohyanagi M, Kashiwamura S, Okamura H, Iwasaki T. Usefulness of circulating interleukin-18 concentration in acute myocardial infarction as a risk factor for late restenosis after emergency coronary angioplasty. Am J Cardiol 2003;91:1258\u20131261.", "journal-title": "Am J Cardiol"}, {"key": "5_CR93", "doi-asserted-by": "publisher", "first-page": "133", "DOI": "10.1016/S0002-9149(02)03097-7", "volume": "91", "author": "H Yamashita", "year": "2003", "unstructured": "Yamashita H, Shimada K, Seki E, Mokuno H, Daida H. Concentrations of interleukins, interferon, and C-reactive protein in stable and unstable angina pectoris. Am J Cardiol 2003;91:133\u2013136.", "journal-title": "Am J Cardiol"}, {"key": "5_CR94", "doi-asserted-by": "publisher", "first-page": "1285", "DOI": "10.1016/j.amjcard.2004.07.114", "volume": "94", "author": "CR Narins", "year": "2004", "unstructured": "Narins CR, Lin DA, Burton PB, Jin Z-G, Berk BC. Interleukin-18 and interleukin-18 binding protein levels before and after percutaneous coronary intervention in patients with and without recent myocardial infarction. Am J Cardiol 2004;94:1285\u20131287.", "journal-title": "Am J Cardiol"}, {"key": "5_CR95", "doi-asserted-by": "crossref", "first-page": "135", "DOI": "10.1016/j.atherosclerosis.2005.02.002", "volume": "182", "author": "GK Chalikias", "year": "2005", "unstructured": "Chalikias GK, Tziakas DN, Kaski JC, Hatzinikolaou EI, Stakos DA, Tentes IK, Kortsaris A, Hatseras DI. Interleukin-18: Interleukin-10 ratio and in-hospital adverse events in patients with acute coronary syndrome. Atherosclerosis 2005;182:135\u2013143.", "journal-title": "Atherosclerosis"}, {"key": "5_CR96", "doi-asserted-by": "publisher", "first-page": "24", "DOI": "10.1161/01.CIR.0000020546.30940.92", "volume": "106", "author": "S Blankenberg", "year": "2002", "unstructured": "Blankenberg S, Tiret L, Bickel C, Peetz D, Cambien F, Meyer J, Rupprecht HJ; AtheroGene Investigators. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 2002;106:24\u201330.", "journal-title": "Circulation"}, {"key": "5_CR97", "doi-asserted-by": "publisher", "first-page": "643", "DOI": "10.1161/CIRCULATIONAHA.104.519702", "volume": "112", "author": "L Tiret", "year": "2005", "unstructured": "Tiret L, Godefroy T, Lubos E, Nicaud V, Tregouet DA, Barbaux S, Schnabel R, Bickel C, Espinola-Klein C, Poirier O, Perret C, Munzel T, Rupprecht HJ, Lackner K, Cambien F, Blankenberg S; AtheroGene Investigators. Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease. Circulation 2005;112:643\u2013650.", "journal-title": "Circulation"}, {"key": "5_CR98", "doi-asserted-by": "publisher", "first-page": "2453", "DOI": "10.1161/01.CIR.0000099509.76044.A2", "volume": "108", "author": "S Blankenberg", "year": "2003", "unstructured": "Blankenberg S, Luc G, Ducimetiere P, Arveiler D, Ferrieres J, Amouyel P, Evans A, Cambien F, Tiret L; PRIME Study Group. Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 2003;108:2453\u20132459.", "journal-title": "Circulation"}, {"key": "5_CR99", "unstructured": "Koenig W, Khuseyinova N, Baumert J, Thorand B, Loewel H, Chambless L, Meisinger C, Schneider A, Martin S, Kolb H, Herder C. Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women: Results from the MONICA/KORA Augsburg Case-Cohort Study, 1984\u20132002. 2006;26:2745\u20132751.", "DOI": "10.1161/01.ATV.0000248096.62495.73", "doi-asserted-by": "crossref"}, {"key": "5_CR100", "doi-asserted-by": "publisher", "first-page": "3666", "DOI": "10.1073/pnas.72.9.3666", "volume": "72", "author": "EA Carswell", "year": "1975", "unstructured": "Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975;72:3666\u20133670.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "5_CR101", "doi-asserted-by": "publisher", "first-page": "729", "DOI": "10.1038/385729a0", "volume": "385", "author": "RA Black", "year": "1997", "unstructured": "Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 1997;385:729\u2013733.", "journal-title": "Nature"}, {"key": "5_CR102", "doi-asserted-by": "publisher", "first-page": "963", "DOI": "10.1074/jbc.M309552200", "volume": "279", "author": "HD Anderson", "year": "2004", "unstructured": "Anderson HD, Rahmutula D, Gardner DG. Tumor necrosis factor-alpha inhibits endothelial nitric-oxide synthase gene promoter activity in bovine aortic endothelial cells. J Biol Chem 2004;279: 963\u2013969.", "journal-title": "J Biol Chem"}, {"key": "5_CR103", "doi-asserted-by": "publisher", "first-page": "L37", "DOI": "10.1152/ajplung.00116.2003", "volume": "286", "author": "N Gertzberg", "year": "2004", "unstructured": "Gertzberg N, Neumann P, Rizzo V, Johnson A. NAD(P)H oxidase mediates the endothelial barrier dysfunction induced by TNF-alpha. Am J Physiol Lung Cell Mol Physiol 2004;286:L37\u2013L48.", "journal-title": "Am J Physiol Lung Cell Mol Physiol"}, {"key": "5_CR104", "doi-asserted-by": "crossref", "first-page": "407", "DOI": "10.1161/01.ATV.13.3.407", "volume": "13", "author": "T Couffinhal", "year": "1993", "unstructured": "Couffinhal T, Duplaa C, Labat L, Lamaziere JM, Moreau C, Printseva O, Bonnet J. Tumor necrosis factor-alpha stimulates ICAM-1 expression in human vascular smooth muscle cells. Arterioscler Thromb 1993;13:407\u2013414.", "journal-title": "Arterioscler Thromb"}, {"key": "5_CR105", "first-page": "62", "volume": "61", "author": "L Schuger", "year": "1989", "unstructured": "Schuger L, Varani J, Marks RM, Kunkel SL, Johnson KJ, Ward PA. Cytotoxicity of tumor necrosis factor-alpha for human umbilical vein endothelial cells. Lab Invest 1989;61:62\u201368.", "journal-title": "Lab Invest"}, {"key": "5_CR106", "first-page": "L57", "volume": "258", "author": "SE Goldblum", "year": "1990", "unstructured": "Goldblum SE, Sun WL. Tumor necrosis factor-alpha augments pulmonary arterial transendothelial albumin flux in vitro. Am J Physiol 1990;258:L57\u2013L67.", "journal-title": "Am J Physiol"}, {"key": "5_CR107", "doi-asserted-by": "crossref", "first-page": "322", "DOI": "10.1161/01.RES.83.3.322", "volume": "83", "author": "N Kume", "year": "1998", "unstructured": "Kume N, Murase T, Moriwaki H, Aoyama T, Sawamura T, Masaki T, Kita T. Inducible expression of lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ Res 1998;83:322\u2013327.", "journal-title": "Circ Res"}, {"key": "5_CR108", "doi-asserted-by": "publisher", "first-page": "507", "DOI": "10.1016/j.cardiores.2004.07.020", "volume": "64", "author": "KE Porter", "year": "2004", "unstructured": "Porter KE, Turner NA, O\u2019Regan DJ, Ball SG. Tumor necrosis factor alpha induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: inhibition by simvastatin. Cardiovasc Res 2004;64:507\u2013515.", "journal-title": "Cardiovasc Res"}, {"key": "5_CR109", "doi-asserted-by": "publisher", "first-page": "553", "DOI": "10.1046/j.1365-2567.1996.d01-789.x", "volume": "89", "author": "K Migita", "year": "1996", "unstructured": "Migita K, Eguchi K, Kawabe Y, Ichinose Y, Tsukada T, Aoyagi T, Nakamura H, Nagataki S. TNF-alpha-mediated expression of membrane-type matrix metalloproteinase in rheumatoid synovial fibroblasts. Immunology 1996;89:553\u2013557.", "journal-title": "Immunology"}, {"key": "5_CR110", "doi-asserted-by": "publisher", "first-page": "2004", "DOI": "10.1161/hq1201.098945", "volume": "21", "author": "WH Lee", "year": "2001", "unstructured": "Lee WH, Kim SH, Lee Y, Lee BB, Kwon B, Song H, Kwon BS, Park JE. Tumor necrosis factor receptor superfamily 14 is involved in atherogenesis by inducing proinflammatory cytokines and matrix metalloproteinases. it Arterioscler Thromb Vasc Biol 2001;21:2004\u20132010.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR111", "doi-asserted-by": "publisher", "first-page": "201", "DOI": "10.1161/hh1501.094396", "volume": "89", "author": "EE Creemers", "year": "2001", "unstructured": "Creemers EE, Cleutjens JP, Smits JF, Daemen MJ. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? Circ Res 2001;89:201\u2013210.", "journal-title": "Circ Res"}, {"key": "5_CR112", "doi-asserted-by": "crossref", "first-page": "145", "DOI": "10.1111/j.1365-2249.1993.tb05992.x", "volume": "94", "author": "M Shingu", "year": "199", "unstructured": "Shingu M, Nagai Y, Isayama T, Naono T, Nobunaga M, Nagai Y. The effects of cytokines on metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes and TIMP production by synovial cells and endothelial cells. it Clin Exp Immunol 199;94:145\u2013149.", "journal-title": "it Clin Exp Immunol"}, {"key": "5_CR113", "doi-asserted-by": "publisher", "first-page": "1553", "DOI": "10.1161/01.ATV.0000086961.44581.B7", "volume": "23", "author": "JJ Boyle", "year": "2003", "unstructured": "Boyle JJ, Weissberg PL, Bennett MR. Tumor necrosis factor-alpha promotes macrophage-induced vascular smooth muscle cell apoptosis by direct and autocrine mechanisms. Arterioscler Thromb Vasc Biol 2003;23:1553\u20131558.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR114", "doi-asserted-by": "publisher", "first-page": "2137", "DOI": "10.1161/01.ATV.0000143933.20616.1b", "volume": "24", "author": "L Branen", "year": "2004", "unstructured": "Branen L, Hovgaard L, Nitulescu M, Bengtsson E, Nilsson J, Jovinge S. Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2004;24:2137\u20132142.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR115", "doi-asserted-by": "publisher", "first-page": "11", "DOI": "10.1016/j.atherosclerosis.2004.11.016", "volume": "180", "author": "H Ohta", "year": "2005", "unstructured": "Ohta H, Wada H, Niwa T, Kirii H, Iwamoto N, Fujii H, Saito K, Sekikawa K, Seishima M. Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice. Atherosclerosis 2005;180:11\u201317.", "journal-title": "Atherosclerosis"}, {"key": "5_CR116", "doi-asserted-by": "crossref", "first-page": "37", "DOI": "10.3109/07853890109002058", "volume": "33", "author": "H Koukkunen", "year": "2001", "unstructured": "Koukkunen H, Penttila K, Kemppainen A, Halinen M, Penttila I, Rantanen T, Pyorala K. C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris. Ann Med 2001;33:37\u201347.", "journal-title": "Ann Med"}, {"key": "5_CR117", "doi-asserted-by": "crossref", "first-page": "2149", "DOI": "10.1161/01.CIR.101.18.2149", "volume": "101", "author": "PM Ridker", "year": "2000", "unstructured": "Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000;101:2149\u20132153.", "journal-title": "Circulation"}, {"key": "5_CR118", "doi-asserted-by": "publisher", "first-page": "2317", "DOI": "10.1161/01.CIR.0000097109.90783.FC", "volume": "108", "author": "M Cesari", "year": "2003", "unstructured": "Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, Rubin SM, Ding J, Simonsick EM, Harris TB, Pahor M. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 2003;108:2317\u20132322.", "journal-title": "Circulation"}, {"key": "5_CR119", "author": "A Henschen", "first-page": "171", "year": "1986", "unstructured": "Henschen A, McDonagh J. Fibrinogen, fibrin and factor XIII. In: Zwaal RFA, Henker HC, eds. Blood Coagulation. Amsterdam: Elsevier, 1986:171\u2013242.", "volume-title": "Blood Coagulation", "DOI": "10.1016/S0167-7306(08)60053-8", "doi-asserted-by": "crossref"}, {"key": "5_CR120", "doi-asserted-by": "crossref", "first-page": "719", "DOI": "10.1097/00001721-199410000-00007", "volume": "5", "author": "MC Scrutton", "year": "1994", "unstructured": "Scrutton MC, Ross-Murphy SB, Bennett GM, Stirling Y, Meade TW. Changes in clot deformability\u2014a possible explanation for the epidemiological association between plasma fibrinogen concentration and myocardial infarction. Blood Coagul Fibrinolysis 1994;5:719\u2013723.", "journal-title": "Blood Coagul Fibrinolysis"}, {"key": "5_CR121", "doi-asserted-by": "publisher", "first-page": "13", "DOI": "10.1016/S0268-9499(97)80015-X", "volume": "11", "author": "J McDonagh", "year": "1997", "unstructured": "McDonagh J, Lee MH. How does hyperfibrinogenemia lead to thrombosis? Fibrinol Proteol 1997;11(Suppl 1):13\u201317.", "journal-title": "Fibrinol Proteol"}, {"key": "5_CR122", "doi-asserted-by": "crossref", "first-page": "601", "DOI": "10.1055/s-0037-1613566", "volume": "89", "author": "W. Koenig", "year": "2003", "unstructured": "Koenig W. Fibrin(ogen) in cardiovascular disease: an update. Thromb Haemost 2003;89:601\u2013609.", "journal-title": "Thromb Haemost"}, {"key": "5_CR123", "doi-asserted-by": "crossref", "first-page": "1948", "DOI": "10.1161/01.ATV.18.12.1948", "volume": "18", "author": "GS Retzinger", "year": "1998", "unstructured": "Retzinger GS, DeAnglis AP, Patuto SJ. Adsorption of fibrinogen to droplets of liquid hydrophobic phases. Functionality of the bound protein and biological implications. Arterioscler Thromb Vasc Biol 1998;18:1948\u20131957.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR124", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/0021-9150(94)90002-7", "volume": "105", "author": "LE Rabbani", "year": "1994", "unstructured": "Rabbani LE, Loscalzo J. Recent observations on the role of hemostatic determinants in the development of the atherothrombotic plaque. Atherosclerosis 1994;105:1\u20137.", "journal-title": "Atherosclerosis"}, {"key": "5_CR125", "doi-asserted-by": "publisher", "first-page": "261", "DOI": "10.1016/S0735-1097(98)00515-4", "volume": "33", "author": "DJ Schneider", "year": "1999", "unstructured": "Schneider DJ, Taatjes DJ, Howard DB, Sobel BE. Increased reactivity of platelets induced by fibrinogen independent of its bindings to the IIb-IIIa surface glycoprotein: a potential contributor to cardiovascular risk. J Am Coll Cardiol 1999;33:261\u2013266.", "journal-title": "J Am Coll Cardiol"}, {"key": "5_CR126", "doi-asserted-by": "crossref", "first-page": "130", "DOI": "10.1055/s-0038-1656337", "volume": "68", "author": "K Fatah", "year": "1992", "unstructured": "Fatah K, Hamsten A, Blomback B, Blomback M. Fibrin gel network characteristics and coronary heart disease: relations to plasma fibrinogen concentration, acute phase protein, serum lipoproteins and coronary atherosclerosis. Thromb Haemost 1992;68:130\u2013135.", "journal-title": "Thromb Haemost"}, {"key": "5_CR127", "doi-asserted-by": "publisher", "first-page": "93", "DOI": "10.1016/0021-9150(92)90234-8", "volume": "94", "author": "W Koenig", "year": "1992", "unstructured": "Koenig W, Ernst E: The possible role of hemorheology in atherothrombogenesis. Atherosclerosis 1992;94:93\u2013107.", "journal-title": "Atherosclerosis"}, {"key": "5_CR128", "first-page": "1799", "volume": "294", "author": "Fibrinogen Studies Collaboration", "year": "2005", "unstructured": "Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 2005;294: 1799\u20131809.", "journal-title": "JAMA"}, {"key": "5_CR129", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1159/000469153", "volume": "40", "author": "EK. Kruithof", "year": "1988", "unstructured": "Kruithof EK. Plasminogen activator inhibitors\u2014a review. Enzyme 1988;40:113\u2013121.", "journal-title": "Enzyme"}, {"key": "5_CR130", "doi-asserted-by": "publisher", "first-page": "1879", "DOI": "10.1111/j.1538-7836.2005.01420.x", "volume": "3", "author": "DE. Vaughan", "year": "2005", "unstructured": "Vaughan DE. PAI-1 and atherothrombosis. J Thromb Haemost 2005;3:1879\u20131883.", "journal-title": "J Thromb Haemost"}, {"key": "5_CR131", "doi-asserted-by": "crossref", "first-page": "1346", "DOI": "10.1172/JCI115440", "volume": "88", "author": "MS Sawdey", "year": "1991", "unstructured": "Sawdey MS, Loskutoff DJ. Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta. J Clin Invest 1991;88:1346\u20131353.", "journal-title": "J Clin Invest"}, {"key": "5_CR132", "doi-asserted-by": "publisher", "first-page": "1260", "DOI": "10.1084/jem.163.5.1260", "volume": "163", "author": "JJ Emeis", "year": "1986", "unstructured": "Emeis JJ, Kooistra T. Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells. J Exp Med 1986;163:1260\u20131266.", "journal-title": "J Exp Med"}, {"key": "5_CR133", "doi-asserted-by": "publisher", "first-page": "3943", "DOI": "10.1182/blood-2004-04-1439", "volume": "104", "author": "H Brogren", "year": "2004", "unstructured": "Brogren H, Karlsson L, Andersson M, Wang L, Erlinge D, Jern S. Platelets synthesize large amounts of active plasminogen activator inhibitor 1. Blood 2004;104:3943\u20133948.", "journal-title": "Blood"}, {"key": "5_CR134", "doi-asserted-by": "crossref", "first-page": "109", "DOI": "10.1042/bj2650109", "volume": "265", "author": "TL Lindahl", "year": "1990", "unstructured": "Lindahl TL, Ohlsson PI, Wiman B. The mechanism of the reaction between human plasminogen-activator inhibitor 1 and tissue plasminogen activator. Biochem J 1990;265:109\u2013113.", "journal-title": "Biochem J"}, {"key": "5_CR135", "first-page": "933", "volume": "75", "author": "M Falkenberg", "year": "1996", "unstructured": "Falkenberg M, Tjarnstrom J, Ortenwall P, Olausson M, Risberg B. Localization of fibrinolytic activators and inhibitors in normal and atherosclerotic vessels. Thromb Haemost 1996;75:933\u2013938.", "journal-title": "Thromb Haemost"}, {"key": "5_CR136", "first-page": "4212", "volume": "96", "author": "DT Eitzman", "year": "2000", "unstructured": "Eitzman DT, Westrick RJ, Xu Z, Tyson J, Ginsburg D. Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid artery. Blood 2000;96:4212\u20134215.", "journal-title": "Blood"}, {"key": "5_CR137", "doi-asserted-by": "publisher", "first-page": "491", "DOI": "10.1161/01.CIR.0000023186.60090.FB", "volume": "106", "author": "M Eren", "year": "2002", "unstructured": "Eren M, Painter CA, Atkinson JB, Declerck PJ, Vaughan DE. Age-dependent spontaneous coronary arterial thrombosis in transgenic mice that express a stable form of human plasminogen activator inhibitor-1. Circulation 2002;106:491\u2013496.", "journal-title": "Circulation"}, {"key": "5_CR138", "doi-asserted-by": "publisher", "first-page": "499", "DOI": "10.1161/hq0302.104529", "volume": "22", "author": "A Luttun", "year": "2002", "unstructured": "Luttun A, Lupu F, Storkebaum E, Hoylaerts MF, Moons L, Crawley J, Bono F, Poole AR, Tipping P, Herbert JM, Collen D, Carmeliet P. Lack of plasminogen activator inhibitor-1 promotes growth and abnormal matrix remodeling of advanced atherosclerotic plaques in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2002;22:499\u2013505.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR139", "doi-asserted-by": "publisher", "first-page": "391", "DOI": "10.1161/01.CIR.0000083471.33820.3C", "volume": "108", "author": "JP Collet", "year": "2003", "unstructured": "Collet JP, Montalescot G, Vicaut E, Ankri A, Walylo F, Lesty C, Choussat R, Beygui F, Borentain M, Vignolles N, Thomas D. Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality. Circulation 2003;108:391\u2013394.", "journal-title": "Circulation"}, {"key": "5_CR140", "doi-asserted-by": "publisher", "first-page": "1557", "DOI": "10.1056/NEJM198512193132501", "volume": "313", "author": "A Hamsten", "year": "1985", "unstructured": "Hamsten A, Wiman B, de Faire U, Blomback M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 1985;313: 1557\u20131563.", "journal-title": "N Engl J Med"}, {"key": "5_CR141", "doi-asserted-by": "crossref", "first-page": "2057", "DOI": "10.1161/01.CIR.94.9.2057", "volume": "94", "author": "I Juhan-Vague", "year": "1996", "unstructured": "Juhan-Vague I, Pyke SD, Alessi MC, Jespersen J, Haverkate F, Thompson SG. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities. Circulation 1996;94: 2057\u20132063.", "journal-title": "Circulation"}, {"key": "5_CR142", "doi-asserted-by": "crossref", "first-page": "2241", "DOI": "10.1161/01.CIR.98.21.2241", "volume": "98", "author": "AM Thogersen", "year": "1998", "unstructured": "Thogersen AM, Jansson JH, Boman K, Nilsson TK, Weinehall L, Huhtasaari F, Hallmans G. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. Circulation 1998;98:2241\u20132247.", "journal-title": "Circulation"}, {"key": "5_CR143", "doi-asserted-by": "crossref", "first-page": "611", "DOI": "10.1161/01.ATV.21.4.611", "volume": "21", "author": "AR Folsom", "year": "2001", "unstructured": "Folsom AR, Aleksic N, Park E, Salomaa V, Juneja H, Wu KK. Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol 2001;21:611\u2013617.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR144", "doi-asserted-by": "crossref", "first-page": "493", "DOI": "10.1161/01.ATV.19.3.493", "volume": "19", "author": "M Cushman", "year": "1999", "unstructured": "Cushman M, Lemaitre RN, Kuller LH, Psaty BM, Macy EM, Sharrett AR, Tracy RP. Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1999;19:493\u2013498.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR145", "doi-asserted-by": "publisher", "first-page": "252", "DOI": "10.1016/j.ehj.2003.11.004", "volume": "25", "author": "GD Lowe", "year": "2004", "unstructured": "Lowe GD, Danesh J, Lewington S, Walker M, Lennon L, Thomson A, Rumley A, Whincup PH. Tissue plasminogen activator antigen and coronary heart disease. Prospective study and meta-analysis. Eur Heart J 2004;25:252\u2013259.", "journal-title": "Eur Heart J"}, {"key": "5_CR146", "doi-asserted-by": "publisher", "first-page": "3080", "DOI": "10.1161/CIRCULATIONAHA.105.557132", "volume": "112", "author": "A Smith", "year": "2005", "unstructured": "Smith A, Patterson C, Yarnell J, Rumley A, Ben-Shlomo Y, Lowe G. Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study. Circulation 2005;112:3080\u20133087.", "journal-title": "Circulation"}, {"key": "5_CR147", "doi-asserted-by": "publisher", "first-page": "821", "DOI": "10.1136/bmj.38226.719803.EB", "volume": "329", "author": "TL Fancher", "year": "2004", "unstructured": "Fancher TL, White RH, Kravitz RL. Combined use of rapid D-Dimer testing and estimation of clinical probability in the diagnosis of deep vein thrombosis: systematic review. BMJ 2004; 329:821\u2013828.", "journal-title": "BMJ"}, {"key": "5_CR148", "doi-asserted-by": "crossref", "first-page": "589", "DOI": "10.7326/0003-4819-140-8-200404200-00005", "volume": "140", "author": "PD Stein", "year": "2004", "unstructured": "Stein PD, Hull RD, Patel KC, Olson RE, Ghali WA, Brant R, Biel RK, Bharadia V, Kalra NK. D-Dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review. Ann Intern Med 2004;140:589\u2013602.", "journal-title": "Ann Intern Med"}, {"key": "5_CR149", "doi-asserted-by": "publisher", "first-page": "319", "DOI": "10.1136/emj.20.4.319", "volume": "20", "author": "A Wakai", "year": "2003", "unstructured": "Wakai A, Gleeson A, Winter D. Role of fibrin D-Dimer testing in emergency medicine. Emerg Med J 2003;20:319\u2013325.", "journal-title": "Emerg Med J"}, {"key": "5_CR150", "doi-asserted-by": "publisher", "first-page": "387", "DOI": "10.1055/s-2005-922485", "volume": "5", "author": "GD. Lowe", "year": "2005", "unstructured": "Lowe GD. Fibrin D-Dimer and cardiovascular risk. Semin Vasc Med 2005;5:387\u2013398.", "journal-title": "Semin Vasc Med"}, {"key": "5_CR151", "doi-asserted-by": "crossref", "first-page": "2236", "DOI": "10.1161/01.CIR.90.5.2236", "volume": "90", "author": "PM Ridker", "year": "1994", "unstructured": "Ridker PM, Hennekens CH, Cerskus A, Stampfer MJ. Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. Circulation 1994;90:2236\u20132240.", "journal-title": "Circulation"}, {"key": "5_CR152", "doi-asserted-by": "crossref", "first-page": "822", "DOI": "10.1055/s-0037-1616138", "volume": "86", "author": "GD Lowe", "year": "2001", "unstructured": "Lowe GD, Rumley A, Sweetnam PM, Yarnell JW, Rumley J. Fibrin D-dimer, markers of coagulation activation and the risk of major ischaemic heart disease in the caerphilly study. Thromb Haemost 2001;86:822\u2013827.", "journal-title": "Thromb Haemost"}, {"key": "5_CR153", "doi-asserted-by": "crossref", "first-page": "2323", "DOI": "10.1161/01.CIR.103.19.2323", "volume": "103", "author": "J Danesh", "year": "2001", "unstructured": "Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Rumley A, Lowe GD. Fibrin fontsize79selectfont D-dimer and coronary heart disease: prospective study and meta-analysis. Circulation 2001;103: 2323\u20132327.", "journal-title": "Circulation"}, {"key": "5_CR154", "doi-asserted-by": "publisher", "first-page": "1529", "DOI": "10.1161/01.ATV.0000135995.39488.6c", "volume": "24", "author": "GD Lowe", "year": "2004", "unstructured": "Lowe GD, Rumley A, McMahon AD, Ford I, O\u2019Reilly DS, Packard CJ; West of Scotland Coronary Prevention Study Group. Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease. Arterioscler Thromb Vasc Biol 2004;24:1529\u20131534.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR155", "doi-asserted-by": "publisher", "first-page": "292", "DOI": "10.1161/01.CIR.0000134965.73212.A6", "volume": "110", "author": "AD Pradhan", "year": "2004", "unstructured": "Pradhan AD, LaCroix AZ, Langer RD, Trevisan M, Lewis CE, Hsia JA, Oberman A, Kotchen JM, Ridker PM. Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women. Circulation 2004;110:292\u2013300.", "journal-title": "Circulation"}, {"key": "5_CR156", "doi-asserted-by": "publisher", "first-page": "142", "DOI": "10.1097/00062752-200303000-00008", "volume": "10", "author": "ZM. Ruggeri", "year": "2003", "unstructured": "Ruggeri ZM. Von Willebrand factor. Curr Opin Hematol 2003;10:142\u2013149.", "journal-title": "Curr Opin Hematol"}, {"key": "5_CR157", "doi-asserted-by": "publisher", "first-page": "217", "DOI": "10.1146/annurev.cb.06.110190.001245", "volume": "6", "author": "DD. Wagner", "year": "1990", "unstructured": "Wagner DD. Cell biology of von Willebrand factor. Annu Rev Cell Biol 1990;6:217\u2013246.", "journal-title": "Annu Rev Cell Biol"}, {"key": "5_CR158", "doi-asserted-by": "publisher", "first-page": "153", "DOI": "10.1111/j.1749-6632.1991.tb43700.x", "volume": "614", "author": "TN Mayadas", "year": "1991", "unstructured": "Mayadas TN, Wagner DD. von Willebrand factor biosynthesis and processing. Ann N Y Acad Sci 1991;614:153\u2013166.", "journal-title": "Ann N Y Acad Sci"}, {"key": "5_CR159", "doi-asserted-by": "publisher", "first-page": "113", "DOI": "10.1007/s00418-001-0368-9", "volume": "117", "author": "JA Mourik van", "year": "2002", "unstructured": "van Mourik JA, Romani de Wit T, Voorberg J. Biogenesis and exocytosis of Weibel-Palade bodies. Histochem Cell Biol 2002;117:113\u2013122.", "journal-title": "Histochem Cell Biol"}, {"key": "5_CR160", "doi-asserted-by": "publisher", "first-page": "683", "DOI": "10.1056/NEJMra040403", "volume": "351", "author": "PM. Mannucci", "year": "2004", "unstructured": "Mannucci PM. Treatment of von Willebrand\u2019s disease. N Engl J Med 2004;351:683\u2013694.", "journal-title": "N Engl J Med"}, {"key": "5_CR161", "doi-asserted-by": "crossref", "first-page": "1359", "DOI": "10.1161/01.ATV.18.9.1359", "volume": "18", "author": "PM. Mannucci", "year": "1998", "unstructured": "Mannucci PM. von Willebrand factor: a marker of endothelial damage? Arterioscler Thromb Vasc Biol 1998;18:1359\u20131362.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR162", "doi-asserted-by": "publisher", "first-page": "635", "DOI": "10.1056/NEJM199503093321003", "volume": "332", "author": "SG Thompson", "year": "1995", "unstructured": "Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med 1995;332:635\u2013641.", "journal-title": "N Engl J Med"}, {"key": "5_CR163", "doi-asserted-by": "crossref", "first-page": "2019", "DOI": "10.1161/01.ATV.20.8.2019", "volume": "20", "author": "B Wiman", "year": "2000", "unstructured": "Wiman B, Andersson T, Hallqvist J, Reuterwall C, Ahlbom A, deFaire U. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study. Arterioscler Thromb Vasc Biol 2000;20:2019\u20132023.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR164", "doi-asserted-by": "crossref", "first-page": "601", "DOI": "10.1111/j.1365-2141.1994.tb05079.x", "volume": "88", "author": "TW Meade", "year": "1994", "unstructured": "Meade TW, Cooper JA, Stirling Y, Howarth DJ, Ruddock V, Miller GJ. Factor VIII, ABO blood group and the incidence of ischaemic heart disease. Br J Haematol 1994;88:601\u2013607.", "journal-title": "Br J Haematol"}, {"key": "5_CR165", "doi-asserted-by": "publisher", "first-page": "1764", "DOI": "10.1053/euhj.2001.3237", "volume": "23", "author": "PH Whincup", "year": "200", "unstructured": "Whincup PH, Danesh J, Walker M, Lennon L, Thomson A, Appleby P, Rumley A, Lowe GD. von Willebrand factor and coronary heart disease: prospective study and meta-analysis. Eur Heart J 200;23:1764\u20131770.", "journal-title": "Eur Heart J"}, {"key": "5_CR166", "doi-asserted-by": "publisher", "first-page": "1343", "DOI": "10.1161/01.CIR.0000120705.55512.EC", "volume": "109", "author": "PE Morange", "year": "2004", "unstructured": "Morange PE, Simon C, Alessi MC, Luc G, Arveiler D, Ferrieres J, Amouyel P, Evans A, Ducimetiere P, Juhan-Vague I; PRIME Study Group. Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study. Circulation 2004;109:1343\u20131348.", "journal-title": "Circulation"}, {"key": "5_CR167", "doi-asserted-by": "publisher", "first-page": "1275", "DOI": "10.1056/NEJM197406062902302", "volume": "290", "author": "GD Friedman", "year": "1974", "unstructured": "Friedman GD, Klatsky AL, Siegelaub AB. The leukocyte count as a predictor of myocardial infarction. N Engl J Med 1974;290:1275\u20131278.", "journal-title": "N Engl J Med"}, {"key": "5_CR168", "doi-asserted-by": "publisher", "first-page": "1945", "DOI": "10.1016/j.jacc.2004.07.056", "volume": "44", "author": "M Madjid", "year": "2004", "unstructured": "Madjid M, Awan I, Willerson JT, Casscells SW. Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol 2004;44:1945\u20131956.", "journal-title": "J Am Coll Cardiol"}, {"key": "5_CR169", "doi-asserted-by": "publisher", "first-page": "658", "DOI": "10.1161/01.ATV.0000156877.94472.a5", "volume": "25", "author": "BS. Coller", "year": "2005", "unstructured": "Coller BS. Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene? Arterioscler Thromb Vasc Biol 2005;25:658\u2013670.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR170", "doi-asserted-by": "publisher", "first-page": "2894", "DOI": "10.1161/01.CIR.0000042674.89762.20", "volume": "106", "author": "T Naruko", "year": "2002", "unstructured": "Naruko T, Ueda M, Haze K, van der Wal AC, van der Loos CM, Itoh A, Komatsu R, Ikura Y, Ogami M, Shimada Y, Ehara S, Yoshiyama M, Takeuchi K, Yoshikawa J, Becker AE. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 2002;106:2894\u20132900.", "journal-title": "Circulation"}, {"key": "5_CR171", "doi-asserted-by": "publisher", "first-page": "2191", "DOI": "10.1073/pnas.81.7.2191", "volume": "81", "author": "RL Hoover", "year": "1984", "unstructured": "Hoover RL, Karnovsky MJ, Austen KF, Corey EJ, Lewis RA. Leukotriene B4 action on endothelium mediates augmented neutrophil/endothelial adhesion. Proc Natl Acad Sci USA 1984;81: 2191\u20132193.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "5_CR172", "doi-asserted-by": "publisher", "first-page": "1761", "DOI": "10.1016/S0735-1097(02)02484-1", "volume": "40", "author": "MS Sabatine", "year": "2002", "unstructured": "Sabatine MS, Morrow DA, Cannon CP, Murphy SA, Demopoulos LA, DiBattiste PM, McCabe CH, Braunwald E, Gibson CM. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy\u2013Thrombolysis in Myocardial Infarction 18 trial) substudy. J Am Coll Cardiol 2002;40: 1761\u20131768.", "journal-title": "J Am Coll Cardiol"}, {"key": "5_CR173", "doi-asserted-by": "publisher", "first-page": "95", "DOI": "10.1067/mhj.2003.64", "volume": "145", "author": "CK Wong", "year": "2003", "unstructured": "Wong CK, French JK, Gao W, White HD. Relationship between initial white blood cell counts, stage of acute myocardial infarction evolution at presentation, and incidence of Thrombolysis in Myocardial Infarction-3 flow after streptokinase. Am Heart J 2003;145:95\u2013102.", "journal-title": "Am Heart J"}, {"key": "5_CR174", "doi-asserted-by": "publisher", "first-page": "1477", "DOI": "10.1001/jama.279.18.1477", "volume": "279", "author": "J Danesh", "year": "1998", "unstructured": "Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998;279:1477\u20131482.", "journal-title": "JAMA"}, {"key": "5_CR175", "doi-asserted-by": "publisher", "first-page": "500", "DOI": "10.1001/archinte.165.5.500", "volume": "165", "author": "KL Margolis", "year": "2005", "unstructured": "Margolis KL, Manson JE, Greenland P, Rodabough RJ, Bray PF, Safford M, Grimm RH Jr, Howard BV, Assaf AR, Prentice R; Women\u2019s Health Initiative Research Group. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women\u2019s Health Initiative Observational Study. Arch Intern Med 2005;165:500\u2013508.", "journal-title": "Arch Intern Med"}, {"key": "5_CR176", "doi-asserted-by": "publisher", "first-page": "433", "DOI": "10.1001/archinte.164.4.433", "volume": "164", "author": "M Haim", "year": "2004", "unstructured": "Haim M, Boyko V, Goldbourt U, Battler A, Behar S. Predictive value of elevated white blood cell count in patients with preexisting coronary heart disease: the Bezafibrate Infarction Prevention Study. Arch Intern Med 2004;164:433\u2013439.", "journal-title": "Arch Intern Med"}, {"key": "5_CR177", "doi-asserted-by": "publisher", "first-page": "1756", "DOI": "10.1161/01.CIR.0000160924.73417.26", "volume": "111", "author": "RA Stewart", "year": "2005", "unstructured": "Stewart RA, White HD, Kirby AC, Heritier SR, Simes RJ, Nestel PJ, West MJ, Colquhoun DM, Tonkin AM; Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Investigators. White blood cell count predicts reduction in coronary heart disease mortality with pravastatin. Circulation 2005;111:1756\u20131762.", "journal-title": "Circulation"}, {"key": "5_CR178", "doi-asserted-by": "publisher", "first-page": "1147", "DOI": "10.1161/01.STR.0000124122.71702.64", "volume": "35", "author": "AJ Grau", "year": "2004", "unstructured": "Grau AJ, Boddy AW, Dukovic DA, Buggle F, Lichy C, Brandt T, Hacke W; CAPRIE Investigators. Leukocyte count as an independent predictor of recurrent ischemic events. Stroke 2004;35: 1147\u20131152.", "journal-title": "Stroke"}, {"key": "5_CR179", "doi-asserted-by": "publisher", "first-page": "1638", "DOI": "10.1016/j.jacc.2005.02.054", "volume": "45", "author": "BD Horne", "year": "2005", "unstructured": "Horne BD, Anderson JL, John JM, Weaver A, Bair TL, Jensen KR, Renlund DG, Muhlestein JB; Intermountain Heart Collaborative Study Group. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 2005;45:1638\u20131643.", "journal-title": "J Am Coll Cardiol"}, {"key": "5_CR180", "doi-asserted-by": "publisher", "first-page": "1287", "DOI": "10.1016/j.ehj.2004.05.002", "volume": "25", "author": "JG Wheeler", "year": "2004", "unstructured": "Wheeler JG, Mussolino ME, Gillum RF, Danesh J. Associations between differential leukocyte count and incident coronary heart disease: 1764 incident cases from seven prospective studies of 30,374 individuals. Eur Heart J 2004;25:1287\u20131292.", "journal-title": "Eur Heart J"}, {"key": "5_CR181", "doi-asserted-by": "publisher", "first-page": "127", "DOI": "10.1007/s11883-005-0035-z", "volume": "7", "author": "V. Nambi", "year": "2005", "unstructured": "Nambi V. The use of myeloperoxidase as a risk marker for atherosclerosis. Curr Atheroscler Rep 2005;7:127\u2013131.", "journal-title": "Curr Atheroscler Rep"}, {"key": "5_CR182", "doi-asserted-by": "publisher", "first-page": "598", "DOI": "10.1189/jlb.1204697", "volume": "77", "author": "SJ. Klebanoff", "year": "2005", "unstructured": "Klebanoff SJ. Myeloperoxidase: friend and foe. J Leukoc Biol 2005;77:598\u2013625.", "journal-title": "J Leukoc Biol"}, {"key": "5_CR183", "doi-asserted-by": "crossref", "first-page": "437", "DOI": "10.1172/JCI117342", "volume": "94", "author": "A Daugherty", "year": "1994", "unstructured": "Daugherty A, Dunn JL, Rateri DL, Heinecke JW. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 1994;94:437\u2013444.", "journal-title": "J Clin Invest"}, {"key": "5_CR184", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1172/JCI119379", "volume": "99", "author": "SL Hazen", "year": "1997", "unstructured": "Hazen SL, Heinecke JW. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Invest 1997;99:1\u20137.", "journal-title": "J Clin Invest"}, {"key": "5_CR185", "doi-asserted-by": "publisher", "first-page": "4495", "DOI": "10.1046/j.1432-1327.2000.01498.x", "volume": "267", "author": "E Malle", "year": "2000", "unstructured": "Malle E, Waeg G, Schreiber R, Grone EF, Sattler W, Grone HJ. Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins. Eur J Biochem 2000;267:4495\u20134503.", "journal-title": "Eur J Biochem"}, {"key": "5_CR186", "doi-asserted-by": "publisher", "first-page": "2391", "DOI": "10.1126/science.1106830", "volume": "296", "author": "JP Eiserich", "year": "2002", "unstructured": "Eiserich JP, Baldus S, Brennan ML, Ma W, Zhang C, Tousson A, Castro L, Lusis AJ, Nauseef WM, White CR, Freeman BA. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 2002;296:2391\u20132394.", "journal-title": "Science"}, {"key": "5_CR187", "doi-asserted-by": "publisher", "first-page": "37524", "DOI": "10.1074/jbc.275.48.37524", "volume": "275", "author": "HM Abu-Soud", "year": "2000", "unstructured": "Abu-Soud HM, Hazen SL. Nitric oxide is a physiological substrate for mammalian peroxidases. J Biol Chem 2000;275:37524\u201337532.", "journal-title": "J Biol Chem"}, {"key": "5_CR188", "doi-asserted-by": "publisher", "first-page": "529", "DOI": "10.1172/JCI200421109", "volume": "114", "author": "L Zheng", "year": "2004", "unstructured": "Zheng L, Nukuna B, Brennan ML, Sun M, Goormastic M, Settle M, Schmitt D, Fu X, Thomson L, Fox PL, Ischiropoulos H, Smith JD, Kinter M, Hazen SL. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest 2004;114:529\u2013541.", "journal-title": "J Clin Invest"}, {"key": "5_CR189", "doi-asserted-by": "publisher", "first-page": "13032", "DOI": "10.1073/pnas.0405292101", "volume": "101", "author": "C Bergt", "year": "2004", "unstructured": "Bergt C, Pennathur S, Fu X, Byun J, O\u2019Brien K, McDonald TO, Singh P, Anantharamaiah GM, Chait A, Brunzell J, Geary RL, Oram JF, Heinecke JW. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc Natl Acad Sci USA 2004;101:13032\u201313037.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "5_CR190", "doi-asserted-by": "publisher", "first-page": "10", "DOI": "10.1159/000041062", "volume": "104", "author": "D Kutter", "year": "2000", "unstructured": "Kutter D, Devaquet P, Vanderstocken G, Paulus JM, Marchal V, Gothot A. Consequences of total and subtotal myeloperoxidase deficiency: risk or benefit? Acta Haematol 2000;104:10\u201315.", "journal-title": "Acta Haematol"}, {"key": "5_CR191", "doi-asserted-by": "crossref", "first-page": "419", "DOI": "10.1172/JCI8797", "volume": "107", "author": "ML Brennan", "year": "2001", "unstructured": "Brennan ML, Anderson MM, Shih DM, Qu XD, Wang X, Mehta AC, Lim LL, Shi W, Hazen SL, Jacob JS, Crowley JR, Heinecke JW, Lusis AJ. Increased atherosclerosis in myeloperoxidase-deficient mice. J Clin Invest 2001;107:419\u2013430.", "journal-title": "J Clin Invest"}, {"key": "5_CR192", "doi-asserted-by": "publisher", "first-page": "2798", "DOI": "10.1161/CIRCULATIONAHA.104.516278", "volume": "111", "author": "TS McMillen", "year": "2005", "unstructured": "McMillen TS, Heinecke JW, LeBoeuf RC. Expression of human myeloperoxidase by macrophages promotes atherosclerosis in mice. Circulation 2005;111:2798\u20132804.", "journal-title": "Circulation"}, {"key": "5_CR193", "doi-asserted-by": "publisher", "first-page": "41279", "DOI": "10.1074/jbc.M106958200", "volume": "276", "author": "X Fu", "year": "2001", "unstructured": "Fu X, Kassim SY, Parks WC, Heinecke JW. Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J Biol Chem 2001;276:41279\u201341287.", "journal-title": "J Biol Chem"}, {"key": "5_CR194", "doi-asserted-by": "publisher", "first-page": "115", "DOI": "10.3109/10715769809065797", "volume": "28", "author": "F Shabani", "year": "1998", "unstructured": "Shabani F, McNeil J, Tippett L. The oxidative inactivation of tissue inhibitor of metalloproteinase-1 (TIMP-1) by hypochlorous acid (HOCl) is suppressed by anti-rheumatic drugs. Free Radic Res 1998;28:115\u2013123.", "journal-title": "Free Radic Res"}, {"key": "5_CR195", "doi-asserted-by": "publisher", "first-page": "1440", "DOI": "10.1161/01.CIR.0000090690.67322.51", "volume": "108", "author": "S Baldus", "year": "2003", "unstructured": "Baldus S, Heeschen C, Meinertz T, Zeiher AM, Eiserich JP, Munzel T, Simoons ML, Hamm CW; CAPTURE Investigators. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003;108:1440\u20131445.", "journal-title": "Circulation"}, {"key": "5_CR196", "doi-asserted-by": "publisher", "first-page": "1595", "DOI": "10.1056/NEJMoa035003", "volume": "349", "author": "ML Brennan", "year": "2003", "unstructured": "Brennan ML, Penn MS, Van Lente F, Nambi V, Shishehbor MH, Aviles RJ, Goormastic M, Pepoy ML, McErlean ES, Topol EJ, Nissen SE, Hazen SL. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 2003;349:1595\u20131604.", "journal-title": "N Engl J Med"}, {"key": "5_CR197", "doi-asserted-by": "publisher", "first-page": "2136", "DOI": "10.1001/jama.286.17.2136", "volume": "286", "author": "R Zhang", "year": "2001", "unstructured": "Zhang R, Brennan ML, Fu X, Aviles RJ, Pearce GL, Penn MS, Topol EJ, Sprecher DL, Hazen SL. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 2001;286:2136\u20132142.", "journal-title": "JAMA"}, {"key": "5_CR198", "doi-asserted-by": "publisher", "first-page": "1134", "DOI": "10.1161/01.CIR.0000140262.20831.8F", "volume": "110", "author": "JA Vita", "year": "2004", "unstructured": "Vita JA, Brennan ML, Gokce N, Mann SA, Goormastic M, Shishehbor MH, Penn MS, Keaney JF Jr, Hazen SL. Serum myeloperoxidase levels independently predict endothelial dysfunction in humans. Circulation 2004;110:1134\u20131139.", "journal-title": "Circulation"}, {"key": "5_CR199", "doi-asserted-by": "publisher", "first-page": "20963", "DOI": "10.1074/jbc.272.34.20963", "volume": "272", "author": "D. Steinberg", "year": "1997", "unstructured": "Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 1997;272:20963\u201320966.", "journal-title": "J Biol Chem"}, {"key": "5_CR200", "doi-asserted-by": "publisher", "first-page": "134", "DOI": "10.1042/BST0320134", "volume": "32", "author": "W Jessup", "year": "2004", "unstructured": "Jessup W, Kritharides L, Stocker R. Lipid oxidation in atherogenesis: an overview. Biochem Soc Trans 2004;32:134\u2013138.", "journal-title": "Biochem Soc Trans"}, {"key": "5_CR201", "doi-asserted-by": "crossref", "first-page": "2640", "DOI": "10.1161/01.ATV.19.11.2640", "volume": "19", "author": "Y Huang", "year": "1999", "unstructured": "Huang Y, Mironova M, Lopes-Virella MF. Oxidized LDL stimulates matrix metalloproteinase-1 expression in human vascular endothelial cells. Arterioscler Thromb Vasc Biol 1999;19:2640\u20132647.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR202", "doi-asserted-by": "crossref", "first-page": "993", "DOI": "10.1161/01.CIR.99.8.993", "volume": "99", "author": "XP Xu", "year": "1999", "unstructured": "Xu XP, Meisel SR, Ong JM, Kaul S, Cercek B, Rajavashisth TB, Sharifi B, Shah PK. Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages. Circulation 1999;99:993\u2013998.", "journal-title": "Circulation"}, {"key": "5_CR203", "doi-asserted-by": "publisher", "first-page": "612", "DOI": "10.1161/01.CIR.0000047276.52039.FB", "volume": "107", "author": "D Li", "year": "2003", "unstructured": "Li D, Liu L, Chen H, Sawamura T, Ranganathan S, Mehta JL. LOX-1 mediates oxidized low-density lipoprotein-induced expression of matrix metalloproteinases in human coronary artery endothelial cells. Circulation 2003;107:612\u2013617.", "journal-title": "Circulation"}, {"key": "5_CR204", "doi-asserted-by": "publisher", "first-page": "816", "DOI": "10.1161/01.ATV.0000066685.13434.FA", "volume": "23", "author": "D Li", "year": "2003", "unstructured": "Li D, Liu L, Chen H, Sawamura T, Mehta JL. LOX-1, an oxidized LDL endothelial receptor, induces CD40/CD40L signaling in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol 2003;23:816\u2013821.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR205", "doi-asserted-by": "crossref", "first-page": "1487", "DOI": "10.1161/01.CIR.98.15.1487", "volume": "98", "author": "P Holvoet", "year": "1998", "unstructured": "Holvoet P, Vanhaecke J, Janssens S, Van de Werf F, Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 1998;98:1487\u20131494.", "journal-title": "Circulation"}, {"key": "5_CR206", "doi-asserted-by": "crossref", "first-page": "2243", "DOI": "10.1161/01.ATV.20.10.2243", "volume": "20", "author": "S Toshima", "year": "2000", "unstructured": "Toshima S, Hasegawa A, Kurabayashi M, Itabe H, Takano T, Sugano J, Shimamura K, Kimura J, Michishita I, Suzuki T, Nagai R. Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease. Arterioscler Thromb Vasc Biol 2000;20:2243\u20132247.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR207", "doi-asserted-by": "crossref", "first-page": "1955", "DOI": "10.1161/01.CIR.103.15.1955", "volume": "103", "author": "S Ehara", "year": "2001", "unstructured": "Ehara S, Ueda M, Naruko T, Haze K, Itoh A, Otsuka M, Komatsu R, Matsuo T, Itabe H, Takano T, Tsukamoto Y, Yoshiyama M, Takeuchi K, Yoshikawa J, Becker AE. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 2001;103:1955\u20131960.", "journal-title": "Circulation"}, {"key": "5_CR208", "doi-asserted-by": "publisher", "first-page": "844", "DOI": "10.1161/hq1201.100221", "volume": "21", "author": "P Holvoet", "year": "2001", "unstructured": "Holvoet P, Mertens A, Verhamme P, Bogaerts K, Beyens G, Verhaeghe R, Collen D, Muls E, Van de Werf F. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2001;21:844\u2013848.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR209", "doi-asserted-by": "crossref", "first-page": "100", "DOI": "10.1161/01.ATV.18.1.100", "volume": "18", "author": "P Holvoet", "year": "1998", "unstructured": "Holvoet P, Stassen JM, Van Cleemput J, Collen D, Vanhaecke J. Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease. Arterioscler Thromb Vasc Biol 1998;18:100\u2013107.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR210", "doi-asserted-by": "publisher", "first-page": "1492", "DOI": "10.1161/01.ATV.0000135982.60383.48", "volume": "24", "author": "ML Liu", "year": "2004", "unstructured": "Liu ML, Ylitalo K, Salonen R, Salonen JT, Taskinen MR. Circulating oxidized low-density lipoprotein and its association with carotid intima-media thickness in asymptomatic members of familial combined hyperlipidemia families. Arterioscler Thromb Vasc Biol 2004;24:1492\u20131497.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR211", "doi-asserted-by": "publisher", "first-page": "1162", "DOI": "10.1161/01.ATV.0000021150.63480.CD", "volume": "22", "author": "J Hulthe", "year": "2002", "unstructured": "Hulthe J, Fagerberg B. Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study). Arterioscler Thromb Vasc Biol 2002;22: 1162\u20131167.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR212", "doi-asserted-by": "publisher", "first-page": "883", "DOI": "10.1016/0140-6736(92)90926-T", "volume": "339", "author": "JT Salonen", "year": "1992", "unstructured": "Salonen JT, Yla-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssonen K, Palinski W, Witztum JL. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 1992;339:883\u2013887.", "journal-title": "Lancet"}, {"key": "5_CR213", "doi-asserted-by": "publisher", "first-page": "425", "DOI": "10.1046/j.1365-2796.2003.01128.x", "volume": "253", "author": "G Nordin Fredrikson", "year": "2003", "unstructured": "Nordin Fredrikson G, Hedblad B, Berglund G, Nilsson J. Plasma oxidized LDL: a predictor for acute myocardial infarction? J Intern Med 2003;253:425\u2013429.", "journal-title": "J Intern Med"}, {"key": "5_CR214", "doi-asserted-by": "publisher", "first-page": "651", "DOI": "10.1161/CIRCULATIONAHA.104.529297", "volume": "112", "author": "C Meisinger", "year": "2005", "unstructured": "Meisinger C, Baumert J, Khuseyinova N, Loewel H, Koenig W. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Circulation 2005;112:651\u2013657.", "journal-title": "Circulation"}, {"key": "5_CR215", "doi-asserted-by": "publisher", "first-page": "529", "DOI": "10.1038/ncpcardio0321", "volume": "2", "author": "MJ Caslake", "year": "2005", "unstructured": "Caslake MJ, Packard CJ. Lipoprotein-associated phospholipase A2 as a biomarker for coronary disease and stroke. Nat Clin Pract Cardiovasc Med 2005;2:529\u2013535.", "journal-title": "Nat Clin Pract Cardiovasc Med"}, {"key": "5_CR216", "doi-asserted-by": "publisher", "first-page": "511", "DOI": "10.1006/bbrc.1999.1066", "volume": "261", "author": "K Asano", "year": "1999", "unstructured": "Asano K, Okamoto S, Fukunaga K, Shiomi T, Mori T, Iwata M, Ikeda Y, Yamaguchi K. Cellular source(s) of platelet-activating-factor acetylhydrolase activity in plasma. Biochem Biophys Res Commun 1999;261:511\u2013514.", "journal-title": "Biochem Biophys Res Commun"}, {"key": "5_CR217", "first-page": "16667", "volume": "266", "author": "EB Tarbet", "year": "1991", "unstructured": "Tarbet EB, Stafforini DM, Elstad MR, Zimmerman GA, McIntyre TM, Prescott SM. Liver cells secrete the plasma form of platelet-activating factor acetylhydrolase. J Biol Chem 1991;266: 16667\u201316673.", "journal-title": "J Biol Chem"}, {"key": "5_CR218", "doi-asserted-by": "crossref", "first-page": "2909", "DOI": "10.1161/01.ATV.19.12.2909", "volume": "19", "author": "T Hakkinen", "year": "1999", "unstructured": "Hakkinen T, Luoma JS, Hiltunen MO, Macphee CH, Milliner KJ, Patel L, Rice SQ, Tew DG, Karkola K, Yla-Herttuala S. Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1999;19:2909\u20132917.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"issue": "III", "key": "5_CR219", "first-page": "III", "volume": "110", "author": "F Kolodgie", "year": "2004", "unstructured": "Kolodgie F, Burke A, Taye A, Liu W, Sudhir K, Virmani R. Lipoprotein-associated phospholipase A2 is highly expressed in macrophages of coronary lesions prone to rupture. Circulation 2004;110 (Suppl III):III-246.Abstract.", "journal-title": "Circulation"}, {"key": "5_CR220", "doi-asserted-by": "publisher", "first-page": "413", "DOI": "10.1016/S0021-9150(99)00406-2", "volume": "150", "author": "MJ Caslake", "year": "2000", "unstructured": "Caslake MJ, Packard CJ, Suckling KE, Holmes SD, Chamberlain P, Macphee CH. Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease. Atherosclerosis 2000;150:413\u2013419.", "journal-title": "Atherosclerosis"}, {"key": "5_CR221", "first-page": "256", "volume": "43", "author": "V Tsimihodimos", "year": "2002", "unstructured": "Tsimihodimos V, Karabina SA, Tambaki AP, Bairaktari E, Miltiadous G, Goudevenos JA, Cariolou MA, Chapman MJ, Tselepis AD, Elisaf M. Altered distribution of platelet-activating factor-acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia. J Lipid Res 2002;43:256\u2013263.", "journal-title": "J Lipid Res"}, {"key": "5_CR222", "doi-asserted-by": "crossref", "first-page": "549", "DOI": "10.1038/374549a0", "volume": "374", "author": "LW Tjoelker", "year": "1995", "unstructured": "Tjoelker LW, Wilder C, Eberhardt C, Stafforini DM, Dietsch G, Schimpf B, Hooper S, Le Trong H, Cousens LS, Zimmerman GA, Yamadat O, Mclntyre TM, Prescott SM, Gray PW. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature 1995;374: 549\u2013553.", "journal-title": "Nature"}, {"key": "5_CR223", "doi-asserted-by": "crossref", "first-page": "102", "DOI": "10.1016/S1388-1981(00)00114-1", "volume": "1488", "author": "LW Tjoelker", "year": "2000", "unstructured": "Tjoelker LW, Stafforini DM. Platelet-activating factor acetylhydrolases in health and disease. Biochim Biophys Acta 2000;1488:102\u2013123.", "journal-title": "Biochim Biophys Acta"}, {"key": "5_CR224", "doi-asserted-by": "crossref", "first-page": "2495", "DOI": "10.1161/01.CIR.103.20.2495", "volume": "103", "author": "R Quarck", "year": "2001", "unstructured": "Quarck R, De Geest B, Stengel D, Mertens A, Lox M, Theilmeier G, Michiels C, Raes M, Bult H, Collen D, Van Veldhoven P, Ninio E, Holvoet P. Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice. Circulation 2001;103: 2495\u20132500.", "journal-title": "Circulation"}, {"key": "5_CR225", "doi-asserted-by": "crossref", "first-page": "923", "DOI": "10.1161/01.ATV.0000160551.21962.a7", "volume": "25", "author": "A Zalewski", "year": "2005", "unstructured": "Zalewski A, Macphee C. Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target. Arterioscler Thromb Vasc Biol 2005;25: 923\u2013931.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR226", "doi-asserted-by": "publisher", "first-page": "479", "DOI": "10.1042/0264-6021:3380479", "volume": "338", "author": "CH Macphee", "year": "1999", "unstructured": "Macphee CH, Moores KE, Boyd HF, Dhanak D, Ife RJ, Leach CA, Leake DS, Milliner KJ, Patterson RA, Suckling KE, Tew DG, Hickey DM. Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor. Biochem J 1999;338:479\u2013487.", "journal-title": "Biochem J"}, {"key": "5_CR227", "doi-asserted-by": "crossref", "first-page": "1138", "DOI": "10.1172/JCI115932", "volume": "90", "author": "N Kume", "year": "1992", "unstructured": "Kume N, Cybulsky MI, Gimbrone MA Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 1992;90:1138\u20131144.", "journal-title": "J Clin Invest"}, {"key": "5_CR228", "doi-asserted-by": "publisher", "first-page": "2805", "DOI": "10.1073/pnas.85.8.2805", "volume": "85", "author": "MT Quinn", "year": "1988", "unstructured": "Quinn MT, Parthasarathy S, Steinberg D. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci USA 1988;85:2805\u20132809.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "5_CR229", "doi-asserted-by": "publisher", "first-page": "671", "DOI": "10.1517/13543784.14.6.671", "volume": "14", "author": "C Macphee", "year": "2005", "unstructured": "Macphee C, Benson GM, Shi Y, Zalewski A. Lipoprotein-associated phospholipase A2: a novel marker of cardiovascular risk and potential therapeutic target. Expert Opin Investig Drugs 2005;14:671\u2013679.", "journal-title": "Expert Opin Investig Drugs"}, {"key": "5_CR230", "doi-asserted-by": "publisher", "first-page": "1148", "DOI": "10.1056/NEJM200010193431603", "volume": "343", "author": "CJ Packard", "year": "2000", "unstructured": "Packard CJ, O\u2019Reilly DS, Caslake MJ, McMahon AD, Ford I, Cooney J, Macphee CH, Suckling KE, Krishna M, Wilkinson FE, Rumley A, Lowe GD. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med 2000;343:1148\u20131155.", "journal-title": "N Engl J Med"}, {"key": "5_CR231", "doi-asserted-by": "publisher", "first-page": "1903", "DOI": "10.1161/01.CIR.0000143377.53389.C8", "volume": "110", "author": "W Koenig", "year": "2004", "unstructured": "Koenig W, Khuseyinova N, Lowel H, Trischler G, Meisinger C. Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern Germany. Circulation 2004;110:1903\u20131908.", "journal-title": "Circulation"}, {"key": "5_CR232", "doi-asserted-by": "publisher", "first-page": "570", "DOI": "10.1161/01.CIR.0000154553.12214.CD", "volume": "111", "author": "van der Oei HH", "year": "2005", "unstructured": "Oei HH, van der Meer IM, Hofman A, Koudstaal PJ, Stijnen T, Breteler MMB, Witteman JCM. Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study. Circulation 2005;111:570\u2013575.", "journal-title": "Circulation"}, {"key": "5_CR233", "doi-asserted-by": "publisher", "first-page": "1302", "DOI": "10.1016/S0735-1097(01)01554-6", "volume": "38", "author": "GJ Blake", "year": "2001", "unstructured": "Blake GJ, Dada N, Fox JC, Manson JE, Ridker PM. A prospective evaluation of lipoprotein-associated phospholipase A2 levels and the risk of future cardiovascular events in women. J Am Coll Cardiol 2001;38:1302\u20131306.", "journal-title": "J Am Coll Cardiol"}, {"key": "5_CR234", "doi-asserted-by": "publisher", "first-page": "837", "DOI": "10.1161/01.CIR.0000116763.91992.F1", "volume": "109", "author": "CM Ballantyne", "year": "2004", "unstructured": "Ballantyne CM, Hoogeveen RC, Bang H, Coresh J, Folsom AR, Heiss G, Sharrett AR. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2004;109:837\u2013842.", "journal-title": "Circulation"}, {"key": "5_CR235", "doi-asserted-by": "publisher", "first-page": "137", "DOI": "10.1093/eurheartj/ehi010", "volume": "26", "author": "ES Brilakis", "year": "2005", "unstructured": "Brilakis ES, McConnell JP, Lennon RJ, Elesber AA, Meyer JG, Berger PB. Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up. Eur Heart J 2005;26: 137\u2013144.", "journal-title": "Eur Heart J"}, {"key": "5_CR236", "doi-asserted-by": "crossref", "first-page": "1586", "DOI": "10.1161/01.ATV.0000222983.73369.c8", "volume": "26", "author": "W Koenig", "year": "2006", "unstructured": "Koenig W, Twardella D, Brenner H, Rothenbacher D. Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress. Arterioscler Thromb Vasc Biol 2006;26: 1586\u20131593.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR237", "doi-asserted-by": "publisher", "first-page": "2479", "DOI": "10.1001/archinte.165.21.2479", "volume": "165", "author": "CM Ballantyne", "year": "2005", "unstructured": "Ballantyne CM, Hoogeveen RC, Bang H, Coresh J, Folsom AR, Chambless LE, Myerson M, Wu KK, Sharrett AR, Boerwinkle E. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Arch Intern Med 2005;165:2479\u20132484.", "journal-title": "Arch Intern Med"}, {"key": "5_CR238", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/j.cccn.2004.02.020", "volume": "344", "author": "K Shimada", "year": "2004", "unstructured": "Shimada K, Miyazaki T, Daida H. Adiponectin and atherosclerotic disease. Clin Chim Acta 2004;344:1\u201312.", "journal-title": "Clin Chim Acta"}, {"key": "5_CR239", "doi-asserted-by": "crossref", "first-page": "H2031", "DOI": "10.1152/ajpheart.01058.2004", "volume": "288", "author": "DC Lau", "year": "2005", "unstructured": "Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol 2005;288: H2031\u2013H2041.", "journal-title": "Am J Physiol Heart Circ Physiol"}, {"key": "5_CR240", "doi-asserted-by": "crossref", "first-page": "2473", "DOI": "10.1161/01.CIR.100.25.2473", "volume": "100", "author": "N Ouchi", "year": "1999", "unstructured": "Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999;100:2473\u20132476.", "journal-title": "Circulation"}, {"key": "5_CR241", "doi-asserted-by": "crossref", "first-page": "1057", "DOI": "10.1161/01.CIR.103.8.1057", "volume": "103", "author": "N Ouchi", "year": "2001", "unstructured": "Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, Ishigami M, Kuriyama H, Kishida K, Nishizawa H, Hotta K, Muraguchi M, Ohmoto Y, Yamashita S, Funahashi T, Matsuzawa Y. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001;103:1057\u20131063.", "journal-title": "Circulation"}, {"key": "5_CR242", "doi-asserted-by": "publisher", "first-page": "37487", "DOI": "10.1074/jbc.M206083200", "volume": "277", "author": "M Matsuda", "year": "2002", "unstructured": "Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N, Kumada M, Okamoto Y, Nagaretani H, Nishizawa H, Kishida K, Komuro R, Ouchi N, Kihara S, Nagai R, Funahashi T, Matsuzawa Y. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 2002;277:37487\u201337491.", "journal-title": "J Biol Chem"}, {"key": "5_CR243", "doi-asserted-by": "publisher", "first-page": "25863", "DOI": "10.1074/jbc.C200251200", "volume": "277", "author": "N Kubota", "year": "2002", "unstructured": "Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, Eto K, Yamashita T, Kamon J, Satoh H, Yano W, Froguel P, Nagai R, Kimura S, Kadowaki T, Noda T. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 2002;277:25863\u201325866.", "journal-title": "J Biol Chem"}, {"key": "5_CR244", "doi-asserted-by": "publisher", "first-page": "731", "DOI": "10.1038/nm724", "volume": "8", "author": "N Maeda", "year": "2002", "unstructured": "Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y, Komuro R, Ouchi N, Kihara S, Tochino Y, Okutomi K, Horie M, Takeda S, Aoyama T, Funahashi T, Matsuzawa Y. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002;8:731\u2013737.", "journal-title": "Nat Med"}, {"key": "5_CR245", "doi-asserted-by": "publisher", "first-page": "2767", "DOI": "10.1161/01.CIR.0000042707.50032.19", "volume": "106", "author": "Y Okamoto", "year": "2002", "unstructured": "Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M, Ohashi K, Sakai N, Shimomura I, Kobayashi H, Terasaka N, Inaba T, Funahashi T, Matsuzawa Y. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 2002;106:2767\u20132770.", "journal-title": "Circulation"}, {"key": "5_CR246", "doi-asserted-by": "publisher", "first-page": "85", "DOI": "10.1161/01.ATV.0000048856.22331.50", "volume": "23", "author": "M Kumada", "year": "2003", "unstructured": "Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y, Shimomura I, Hiraoka H, Nakamura T, Funahashi T, Matsuzawa Y; Osaka CAD Study Group. Coronary artery disease. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003;23:85\u201389.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR247", "doi-asserted-by": "crossref", "first-page": "1595", "DOI": "10.1161/01.ATV.20.6.1595", "volume": "20", "author": "K Hotta", "year": "2000", "unstructured": "Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000;20:1595\u20131599.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "5_CR248", "doi-asserted-by": "publisher", "first-page": "1640", "DOI": "10.1093/eurheartj/ehi340", "volume": "26", "author": "D Rothenbacher", "year": "2005", "unstructured": "Rothenbacher D, Brenner H, M\u00e4rz W, Koenig W. Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. Eur Heart J 2005;26:1640\u20131646.", "journal-title": "Eur Heart J"}, {"key": "5_CR249", "doi-asserted-by": "publisher", "first-page": "528", "DOI": "10.1136/hrt.2003.011114", "volume": "90", "author": "Y Nakamura", "year": "2004", "unstructured": "Nakamura Y, Shimada K, Fukuda D, Shimada Y, Ehara S, Hirose M, Kataoka T, Kamimori K, Shimodozono S, Kobayashi Y, Yoshiyama M, Takeuchi K, Yoshikawa J. Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart 2004;90:528\u2013533.", "journal-title": "Heart"}, {"key": "5_CR250", "doi-asserted-by": "publisher", "first-page": "667", "DOI": "10.1136/heart.89.6.667", "volume": "89", "author": "S Kojima", "year": "2003", "unstructured": "Kojima S, Funahashi T, Sakamoto T, Miyamoto S, Soejima H, Hokamaki J, Kajiwara I, Sugiyama S, Yoshimura M, Fujimoto K, Miyao Y, Suefuji H, Kitagawa A, Ouchi N, Kihara S, Matsuzawa Y, Ogawa H. The variation of plasma concentrations of a novel, adipocyte derived protein, adiponectin, in patients with acute myocardial infarction. Heart 2003;89:667.", "journal-title": "Heart"}, {"key": "5_CR251", "doi-asserted-by": "publisher", "first-page": "1730", "DOI": "10.1001/jama.291.14.1730", "volume": "291", "author": "T Pischon", "year": "2004", "unstructured": "Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004;291:1730\u20131737.", "journal-title": "JAMA"}, {"key": "5_CR252", "doi-asserted-by": "publisher", "first-page": "5677", "DOI": "10.1210/jc.2005-0825", "volume": "90", "author": "DA Lawlor", "year": "2005", "unstructured": "Lawlor DA, Davey Smith G, Ebrahim S, Thompson C, Sattar N. Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women. J Clin Endocrinol Metab 2005;90:5677\u20135683.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "5_CR253", "doi-asserted-by": "publisher", "first-page": "1369", "DOI": "10.1016/j.jacc.2006.06.053", "volume": "48", "author": "W Koenig", "year": "2006", "unstructured": "Koenig W, Khuseyinova N, Baumert J, Meisinger C, L\u00f6wel H. Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-years follow-up of a large cohort from southern Germany. J Am Coll Cardiol 2006;48:1369\u20131377.", "journal-title": "J Am Coll Cardiol"}, {"key": "5_CR254", "doi-asserted-by": "publisher", "first-page": "2925", "DOI": "10.2337/diacare.27.12.2925", "volume": "27", "author": "M Eynatten von", "year": "2004", "unstructured": "von Eynatten M, Schneider JG, Humpert PM, Rudofsky G, Schmidt N, Barosch P, Hamann A, Morcos M, Kreuzer J, Bierhaus A, Nawroth PP, Dugi KA. Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance. Diabetes Care 2004;27:2925\u20132929.", "journal-title": "Diabetes Care"}, {"key": "5_CR255", "doi-asserted-by": "publisher", "first-page": "1587", "DOI": "10.1056/NEJMp038136", "volume": "349", "author": "T. Manolio", "year": "2003", "unstructured": "Manolio T. Novel risk markers and clinical practice. N Engl J Med 2003;349:1587\u20131589.", "journal-title": "N Engl J Med"}, {"issue": "Abstract Suppl", "key": "5_CR256", "first-page": "II", "volume": "112", "author": "J Persson Nilsson", "year": "2005", "unstructured": "Persson Nilsson J, Hedblad B, Nelson JJ, Bergland G. Lipoprotein-associated phospholipase A2 predicts cardiovascular events. Circulation 2005;112(Abstract Suppl):II-802.", "journal-title": "Circulation"}, {"issue": "1", "key": "5_CR257", "doi-asserted-by": "publisher", "first-page": "109", "DOI": "10.1016/S0002-9149(98)00791-7", "volume": "83", "author": "RV Shohet", "year": "1999", "unstructured": "Shohet RV, Anwar A, Johnston JM, Cohen JC. Plasma platelet-activating factor acetylhydrolase activity is not associated with premature coronary atherosclerosis. Am J Cardiol 1999;83(1):109\u2013111, A8\u2013A9.", "journal-title": "Am J Cardiol"}, {"issue": "7", "key": "5_CR258", "first-page": "7", "volume": "44", "author": "S Blankenberg", "year": "2003", "unstructured": "Blankenberg S, Stengel D, Rupprecht HJ, Bickel C, Meyer J, Cambien F, Tiret L, Ninio E. Plasma PAF-acetylhydrolase in patients with coronary artery disease: results of a cross-sectional analysis. it J Lipid Res 2003;44(7):7\u20131381.", "journal-title": "it J Lipid Res"}, {"issue": "3", "key": "5_CR259", "doi-asserted-by": "publisher", "first-page": "1153", "DOI": "10.1210/jc.2003-031494", "volume": "89", "author": "K Winkler", "year": "2004", "unstructured": "Winkler K, Abletshauser C, Friedrich I, Hoffmann MM, Wieland H, Marz W. Fluvastatin slow-release lowers platelet-activating factor acetyl hydrolase activity: a placebo-controlled trial in patients with type 2 diabetes. J Clin Endocrinol Metab 2004;89(3):1153\u20131159", "journal-title": "J Clin Endocrinol Metab"}, {"issue": "1", "key": "5_CR260", "doi-asserted-by": "crossref", "first-page": "181", "DOI": "10.1016/j.atherosclerosis.2004.10.046", "volume": "182", "author": "N Khuseyinova", "year": "2005", "unstructured": "Khuseyinova N, Imhof A, Rothenbacher D, Trischler G, Kuelb S, Scharnagl H, Maerz W, Brenner H, Koenig W. Association between Lp-PLA2 and coronary artery disease: focus on its relationship with lipoproteins and markers of inflammation and hemostasis. Atherosclerosis 2005;182(1): 181\u2013188.", "journal-title": "Atherosclerosis"}, {"issue": "8", "key": "5_CR261", "doi-asserted-by": "publisher", "first-page": "980", "DOI": "10.1161/01.CIR.0000156457.35971.C8", "volume": "111", "author": "K Winkler", "year": "2005", "unstructured": "Winkler K, Winkelmann BR, Scharnagl H, Hoffmann MM, Grawitz AB, Nauck M, Bohm BO, Marz W. Platelet-activating factor acetylhydrolase activity indicates angiographic coronary artery disease independently of systemic inflammation and other risk factors: the Ludwigshafen Risk and Cardiovascular Health Study. Circulation 2005;111(8):980\u2013987.", "journal-title": "Circulation"}, {"issue": "1", "key": "5_CR262", "doi-asserted-by": "crossref", "first-page": "216", "DOI": "10.1161/01.ATV.0000148322.89911.44", "volume": "25", "author": "C Iribarren", "year": "2005", "unstructured": "Iribarren C, Gross MD, Darbinian JA, Jacobs DR Jr, Sidney S, Loria CM. Association of lipoprotein-associated phospholipase A2 mass and activity with calcified coronary plaque in young adults: the CARDIA study. Arterioscler Thromb Vasc Biol 2005;25(1):216\u2013221.", "journal-title": "Arterioscler Thromb Vasc Biol"}], "container-title": ["Contemporary Cardiology", "Therapeutic Lipidology"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-1-59745-533-6_5", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 6]], "date-time": "2019-05-06T06:42:49Z", "timestamp": 1557124969000}, "score": 20.682526, "issued": {"date-parts": [[null]]}, "ISBN": ["9781588295514", "9781597455336"], "references-count": 262, "URL": "http://dx.doi.org/10.1007/978-1-59745-533-6_5", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T18:48:59Z", "timestamp": 1574707739926}, "reference-count": 9, "publisher": "Wiley", "issue": "8", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2017, 2, 14]], "date-time": "2017-02-14T00:00:00Z", "timestamp": 1487030400000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://onlinelibrary.wiley.com/termsAndConditions", "start": {"date-parts": [[2017, 2, 14]], "date-time": "2017-02-14T00:00:00Z", "timestamp": 1487030400000}, "delay-in-days": 0, "content-version": "vor"}], "funder": [{"name": "F\u00f6rderpreis des Deutschen Psoriasis Bund e.V.", "award": []}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Exp Dermatol"], "published-print": {"date-parts": [[2017, 8]]}, "DOI": "10.1111/exd.13235", "type": "journal-article", "created": {"date-parts": [[2016, 10, 13]], "date-time": "2016-10-13T04:37:34Z", "timestamp": 1476333454000}, "page": "677-680", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Molecular diagnostics of inflammatory disease: New tools and perspectives"], "prefix": "10.1111", "volume": "26", "author": [{"given": "Natalie", "family": "Garzorz-Stark", "sequence": "first", "affiliation": [{"name": "Department of Dermatology and Allergy; Technical University of Munich; Munich Germany"}]}, {"given": "Felix", "family": "Lauffer", "sequence": "additional", "affiliation": [{"name": "Department of Dermatology and Allergy; Technical University of Munich; Munich Germany"}]}], "member": "311", "published-online": {"date-parts": [[2017, 2, 14]]}, "reference": [{"key": "10.1111/exd.13235-BIB0001|exd13235-cit-0001", "author": "Yoon", "volume": "27", "first-page": "889", "year": "2013", "journal-title": "J. Eur. Acad. Dermatol. Venereol.", "DOI": "10.1111/j.1468-3083.2012.04602.x", "doi-asserted-by": "crossref"}, {"key": "10.1111/exd.13235-BIB0002|exd13235-cit-0002", "author": "Aydin", "volume": "35", "first-page": "169", "year": "2008", "journal-title": "J. Cutan. Pathol."}, {"key": "10.1111/exd.13235-BIB0003|exd13235-cit-0003", "author": "Garzorz", "volume": "11", "first-page": "167", "year": "2015", "journal-title": "Exp. Rev. Clin. Immunol.", "DOI": "10.1586/1744666X.2015.996549", "doi-asserted-by": "crossref"}, {"key": "10.1111/exd.13235-BIB0004|exd13235-cit-0004", "author": "Schon", "volume": "17", "first-page": "703", "year": "2008", "journal-title": "Exp. Dermatol.", "DOI": "10.1111/j.1600-0625.2008.00751.x", "doi-asserted-by": "crossref"}, {"key": "10.1111/exd.13235-BIB0005|exd13235-cit-0005", "author": "Swindell", "volume": "6", "first-page": "e18266", "year": "2011", "journal-title": "PLoS ONE", "DOI": "10.1371/journal.pone.0018266", "doi-asserted-by": "crossref"}, {"key": "10.1111/exd.13235-BIB0006|exd13235-cit-0006", "author": "Fecher", "volume": "25", "first-page": "1606", "year": "2007", "journal-title": "J. Clin. Oncol.", "DOI": "10.1200/JCO.2006.06.0442", "doi-asserted-by": "crossref"}, {"key": "10.1111/exd.13235-BIB0007|exd13235-cit-0007", "author": "Suarez-Farinas", "volume": "132", "first-page": "361", "year": "2013", "journal-title": "J. Allergy Clin. Immunol.", "DOI": "10.1016/j.jaci.2013.04.046", "doi-asserted-by": "crossref"}, {"key": "10.1111/exd.13235-BIB0008|exd13235-cit-0008", "author": "Guinot", "volume": "18", "first-page": "712", "year": "2009", "journal-title": "Exp. Dermatol.", "DOI": "10.1111/j.1600-0625.2009.00871.x", "doi-asserted-by": "crossref"}, {"key": "10.1111/exd.13235-BIB0009|exd13235-cit-0009", "author": "Garzorz", "volume": "25", "first-page": "767", "year": "2016", "journal-title": "Exp. Dermatol.", "DOI": "10.1111/exd.13077", "doi-asserted-by": "crossref"}], "container-title": ["Experimental Dermatology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fexd.13235", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fexd.13235", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://onlinelibrary.wiley.com/wol1/doi/10.1111/exd.13235/fullpdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 7, 27]], "date-time": "2017-07-27T06:22:30Z", "timestamp": 1501136550000}, "score": 19.986687, "issued": {"date-parts": [[2017, 2, 14]]}, "references-count": 9, "journal-issue": {"published-print": {"date-parts": [[2017, 8]]}, "issue": "8"}, "URL": "http://dx.doi.org/10.1111/exd.13235", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0906-6705"], "issn-type": [{"value": "0906-6705", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T16:21:20Z", "timestamp": 1574353280871}, "reference-count": 15, "publisher": "Oxford University Press (OUP)", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Inflammatory Bowel Diseases"], "published-print": {"date-parts": [[2008, 6]]}, "DOI": "10.1002/ibd.20406", "type": "journal-article", "created": {"date-parts": [[2008, 2, 25]], "date-time": "2008-02-25T20:20:07Z", "timestamp": 1203970807000}, "page": "738-743", "source": "Crossref", "is-referenced-by-count": 72, "title": ["Autoimmune disease concomitance among inflammatory bowel disease patients in the United States, 2001-2002"], "prefix": "10.1093", "volume": "14", "author": [{"given": "Russell", "family": "Cohen", "sequence": "first", "affiliation": []}, {"given": "Don", "family": "Robinson", "sequence": "additional", "affiliation": []}, {"given": "Clark", "family": "Paramore", "sequence": "additional", "affiliation": []}, {"given": "Kathy", "family": "Fraeman", "sequence": "additional", "affiliation": []}, {"given": "Kevin", "family": "Renahan", "sequence": "additional", "affiliation": []}, {"given": "Mohan", "family": "Bala", "sequence": "additional", "affiliation": []}], "member": "286", "reference": [{"key": "R1-2-20130704", "author": "Bernstein", "volume": "96", "first-page": "1116", "year": "2001", "journal-title": "Am J Gastroenterol", "DOI": "10.1111/j.1572-0241.2001.03756.x", "doi-asserted-by": "crossref"}, {"key": "R2-2-20130704", "author": "Bernstein", "volume": "129", "first-page": "827", "year": "2005", "journal-title": "Gastroenterology", "DOI": "10.1053/j.gastro.2005.06.021", "doi-asserted-by": "crossref"}, {"key": "R3-2-20130704", "author": "Cucino", "volume": "96", "first-page": "2107", "year": "2001", "journal-title": "Am J Gastroenterol", "DOI": "10.1111/j.1572-0241.2001.03943.x", "doi-asserted-by": "crossref"}, {"key": "R4-2-20130704", "author": "Gupta", "volume": "129", "first-page": "819", "year": "2005", "journal-title": "Gastroenterology", "DOI": "10.1053/j.gastro.2005.06.022", "doi-asserted-by": "crossref"}, {"key": "R5-2-20130704", "author": "Weng", "volume": "102", "first-page": "1429", "year": "2007", "journal-title": "Am J Gastroenterol", "DOI": "10.1111/j.1572-0241.2007.01215.x", "doi-asserted-by": "crossref"}, {"key": "R6-2-20130704", "author": "Davidson", "volume": "345", "first-page": "340", "year": "2001", "journal-title": "N Engl J Med", "DOI": "10.1056/NEJM200108023450506", "doi-asserted-by": "crossref"}, {"key": "R8-2-20130704", "author": "Robinson", "volume": "22", "first-page": "989", "year": "2006", "journal-title": "Curr Med Res Opin", "DOI": "10.1185/030079906X104641", "doi-asserted-by": "crossref"}, {"key": "R10-2-20130704", "author": "Rector", "volume": "39", "first-page": "1839", "year": "2004", "journal-title": "Health Serv Res", "DOI": "10.1111/j.1475-6773.2004.00321.x", "doi-asserted-by": "crossref"}, {"key": "R12-2-20130704", "author": "Bernstein", "volume": "101", "first-page": "1559", "year": "2006", "journal-title": "Am J Gastroenterol", "DOI": "10.1111/j.1572-0241.2006.00603.x", "doi-asserted-by": "crossref"}, {"key": "R13-2-20130704", "author": "Longobardi", "volume": "4", "first-page": "731", "year": "2006", "journal-title": "Clin Gastroenterol Hepatol", "DOI": "10.1016/j.cgh.2006.02.013", "doi-asserted-by": "crossref"}, {"key": "R14-2-20130704", "author": "Longobardi", "volume": "99", "first-page": "650", "year": "2004", "journal-title": "Am J Gastroenterol", "DOI": "10.1111/j.1572-0241.2004.04132.x", "doi-asserted-by": "crossref"}, {"key": "R15-2-20130704", "author": "Loftus", "volume": "31", "first-page": "1", "year": "2002", "journal-title": "Gastroenterol Clin North Am", "DOI": "10.1016/S0889-8553(01)00002-4", "doi-asserted-by": "crossref"}, {"key": "R16-2-20130704", "author": "Sloka", "volume": "18", "first-page": "251", "year": "2002", "journal-title": "J Autoimmun", "DOI": "10.1006/jaut.2002.0588", "doi-asserted-by": "crossref"}, {"key": "R17-2-20130704", "author": "Bernklev", "volume": "39", "first-page": "365", "year": "2004", "journal-title": "Scand J Gastroenterol", "DOI": "10.1080/00365520310008386", "doi-asserted-by": "crossref"}, {"key": "R18-2-20130704", "author": "Loftus", "volume": "126", "first-page": "1504", "year": "2004", "journal-title": "Gastroenterology", "DOI": "10.1053/j.gastro.2004.01.063", "doi-asserted-by": "crossref"}], "container-title": ["Inflammatory Bowel Diseases"], "language": "en", "deposited": {"date-parts": [[2018, 3, 22]], "date-time": "2018-03-22T09:48:26Z", "timestamp": 1521712106000}, "score": 19.426788, "subtitle": [""], "issued": {"date-parts": [[2008, 6]]}, "references-count": 15, "journal-issue": {"issue": "6"}, "URL": "http://dx.doi.org/10.1002/ibd.20406", "relation": {"cites": []}, "ISSN": ["1078-0998"], "issn-type": [{"value": "1078-0998", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T18:48:33Z", "timestamp": 1574448513804}, "publisher-location": "Oxford, UK", "reference-count": 18, "publisher": "Wiley-Blackwell", "isbn-type": [{"value": "9781444334548", "type": "print"}, {"value": "9781444342574", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1002/9781444342574.ch40", "type": "book-chapter", "created": {"date-parts": [[2012, 1, 30]], "date-time": "2012-01-30T17:40:05Z", "timestamp": 1327945205000}, "page": "182-185", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Optimizing Management of Perianal Crohn's Disease"], "prefix": "10.1002", "author": [{"given": "David A.", "family": "Schwartz", "sequence": "first", "affiliation": []}, {"suffix": "III", "given": "Norman R.", "family": "Clark", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2012, 1, 30]]}, "reference": [{"issue": "1", "key": "10.1002/9781444342574.ch40-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "5", "DOI": "10.1111/j.1445-2197.1996.tb00690.x", "article-title": "Anal pathology in patients with Crohn's disease", "volume": "66", "author": "Platell", "year": "1996", "journal-title": "Aust N Z J Surg"}, {"key": "10.1002/9781444342574.ch40-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "1508", "DOI": "10.1016/j.gastro.2003.08.025", "article-title": "AGA technical review on perianal Crohn's disease", "volume": "125", "author": "Sandborn", "year": "2003", "journal-title": "Gastroenterology"}, {"key": "10.1002/9781444342574.ch40-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "653", "DOI": "10.1002/bjs.1800750711", "article-title": "Natural history and treatment of anorectal strictures complicating Crohn's disease", "volume": "75", "author": "Linares", "year": "1988", "journal-title": "Br J Surg"}, {"key": "10.1002/9781444342574.ch40-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "642", "DOI": "10.1016/0002-9610(80)90048-3", "article-title": "Natural history of perianal Crohn's disease. Ten year follow-up: a plea for conservatism", "volume": "140", "author": "Buchmann", "year": "1980", "journal-title": "Am J Surg"}, {"issue": "5", "key": "10.1002/9781444342574.ch40-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "970", "DOI": "10.1007/s10350-004-0873-8", "article-title": "Efficacy of topical metronidazole (10%) in the treatment of anorectal Crohn's disease", "volume": "48", "author": "Stringer", "year": "2005", "journal-title": "Dis Colon Rectum"}, {"key": "10.1002/9781444342574.ch40-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "545", "DOI": "10.1007/BF02049859", "article-title": "Surgery for symptomatic hemorrhoids and anal fissures in Crohn's disease", "volume": "36", "author": "Wolkomir", "year": "1993", "journal-title": "Dis Colon Rectum"}, {"key": "10.1002/9781444342574.ch40-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "443", "DOI": "10.1007/BF02258390", "article-title": "Perianal abscess in Crohn's disease", "volume": "40", "author": "Makowiec", "year": "1997", "journal-title": "Dis Colon Rectum"}, {"key": "10.1002/9781444342574.ch40-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "875", "DOI": "10.1053/gast.2002.32362", "article-title": "The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota", "volume": "122", "author": "Schwartz", "year": "2002", "journal-title": "Gastroenterology"}, {"key": "10.1002/9781444342574.ch40-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "644", "DOI": "10.1177/014107687807100904", "article-title": "Surgical pathology and management of anorectal Crohn's disease", "volume": "71", "author": "Hughes", "year": "1978", "journal-title": "J R Soc Med"}, {"key": "10.1002/9781444342574.ch40-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "1064", "DOI": "10.1053/gast.2001.28676", "article-title": "A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn's perianal fistulas", "volume": "121", "author": "Schwartz", "year": "2001", "journal-title": "Gastroenterology"}, {"key": "10.1002/9781444342574.ch40-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "727", "DOI": "10.1097/01.MIB.0000172811.57242.18", "article-title": "Use of endoscopic ultrasound to guide combination medical and surgical therapy for patients with Crohn's perianal fistulas", "volume": "11", "author": "Schwartz", "year": "2005", "journal-title": "Inflamm Bowel Dis"}, {"key": "10.1002/9781444342574.ch40-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "2527", "DOI": "10.1111/j.1572-0241.2008.02063.x", "article-title": "A randomized prospective trial of endoscopic ultrasound to guide combination medical and surgical treatment for Crohn's perianal fistulas", "volume": "103", "author": "Spradlin", "year": "2008", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/9781444342574.ch40-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "906", "DOI": "10.7326/0003-4819-135-10-200111200-00011", "article-title": "Diagnosis and treatment of perianal fistulas in Crohn disease", "volume": "135", "author": "Schwartz", "year": "2001", "journal-title": "Ann Intern Med"}, {"key": "10.1002/9781444342574.ch40-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "799", "DOI": "10.1007/s10350-004-0898-z", "article-title": "Treatment of fistulas-inano with fibrin sealant in combination with intra-adhesive antibiotics and/or surgical closure of the internal fistula opening", "volume": "48", "author": "Singer", "year": "2005", "journal-title": "Dis Colon Rectum"}, {"key": "10.1002/9781444342574.ch40-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "838", "DOI": "10.1007/s10350-007-9191-2", "article-title": "Collagen fistula plug for the treatment of anal fistulas", "volume": "51", "author": "Ky", "year": "2008", "journal-title": "Dis Colon Rectum"}, {"key": "10.1002/9781444342574.ch40-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "1984", "DOI": "10.1111/j.1572-0241.2004.40462.x", "article-title": "An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease", "volume": "99", "author": "Sandborn", "year": "2004", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/9781444342574.ch40-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "52", "DOI": "10.1053/j.gastro.2006.11.041", "article-title": "Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial", "volume": "132", "author": "Colombel", "year": "2007", "journal-title": "Gastroenterology"}, {"key": "10.1002/9781444342574.ch40-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "98", "DOI": "10.1097/00054725-200303000-00003", "article-title": "Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement", "volume": "9", "author": "Regueiro", "year": "2003", "journal-title": "Inflamm Bowel Dis"}], "container-title": ["Clinical Dilemmas in Inflammatory Bowel Disease"], "link": [{"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/9781444342574.ch40", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 5]], "date-time": "2018-08-05T15:16:48Z", "timestamp": 1533482208000}, "score": 19.399883, "issued": {"date-parts": [[2012, 1, 30]]}, "ISBN": ["9781444342574", "9781444334548"], "references-count": 18, "URL": "http://dx.doi.org/10.1002/9781444342574.ch40", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T15:26:43Z", "timestamp": 1575386803998}, "reference-count": 6, "publisher": "Wiley", "issue": "2", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 671, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Dev Med Child Neurol"], "published-print": {"date-parts": [[2014, 2]]}, "DOI": "10.1111/dmcn.12330", "type": "journal-article", "created": {"date-parts": [[2013, 10, 30]], "date-time": "2013-10-30T13:04:32Z", "timestamp": 1383138272000}, "page": "101-102", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Breastfeeding and child neurodevelopment - a role for gut microbiota?"], "prefix": "10.1111", "volume": "56", "author": [{"given": "Natalie", "family": "Parletta", "sequence": "first", "affiliation": [{"name": "School of Population Health; Samsom Institute for Health Research; University of South Australia; Adelaide SA Australia"}]}], "member": "311", "published-online": {"date-parts": [[2013, 10, 30]]}, "reference": [{"key": "10.1111/dmcn.12330-BIB0001|dmcn12330-cit-0001", "author": "Julvez", "year": "2013", "article-title": "A cohort study about full breastfeeding and child neuropsychological development: the role of maternal, social, psychological, and nutritional factors", "journal-title": "Dev Med Child Neurol"}, {"key": "10.1111/dmcn.12330-BIB0002|dmcn12330-cit-0002", "doi-asserted-by": "crossref", "first-page": "578", "DOI": "10.1001/archpsyc.65.5.578", "article-title": "Breastfeeding and child cognitive development: new evidence from a large randomized trial", "volume": "65", "author": "Kramer", "year": "2008", "journal-title": "Arch Gen Psychiatry"}, {"key": "10.1111/dmcn.12330-BIB0003|dmcn12330-cit-0003", "unstructured": "Butte NF Lopez-Alarcon MG Garza C Nutrient adequacy of exclusive breastfeeding for the term infant during the first six months of life 2002 http://www.who.int/maternal_child_adolescent/documents/9241562110/en/"}, {"key": "10.1111/dmcn.12330-BIB0004|dmcn12330-cit-0004", "doi-asserted-by": "crossref", "first-page": "327", "DOI": "10.1038/nature10213", "article-title": "Human nutrition, the gut microbiome and the immune system", "volume": "474", "author": "Kau", "year": "2011", "journal-title": "Nature"}, {"key": "10.1111/dmcn.12330-BIB0005|dmcn12330-cit-0005", "doi-asserted-by": "crossref", "first-page": "511", "DOI": "10.1542/peds.2005-2824", "article-title": "Factors influencing the composition of the intestinal microbiota in early infancy", "volume": "118", "author": "Penders", "year": "2006", "journal-title": "Pediatrics"}, {"key": "10.1111/dmcn.12330-BIB0006|dmcn12330-cit-0006", "doi-asserted-by": "crossref", "first-page": "1394", "DOI": "10.1053/j.gastro.2013.02.043", "article-title": "Consumption of fermented milk product with probiotic modulates brain activity", "volume": "144", "author": "Tillisch", "year": "2013", "journal-title": "Gastroenterology"}], "container-title": ["Developmental Medicine & Child Neurology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fdmcn.12330", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 22]], "date-time": "2017-06-22T01:04:52Z", "timestamp": 1498093492000}, "score": 19.13211, "issued": {"date-parts": [[2013, 10, 30]]}, "references-count": 6, "journal-issue": {"published-print": {"date-parts": [[2014, 2]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.1111/dmcn.12330", "relation": {"cites": []}, "ISSN": ["0012-1622"], "issn-type": [{"value": "0012-1622", "type": "print"}], "subject": ["Pediatrics, Perinatology, and Child Health", "Developmental Neuroscience", "Clinical Neurology"]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T07:31:35Z", "timestamp": 1574321495621}, "reference-count": 25, "publisher": "BMJ", "issue": "Suppl 1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Gut"], "published-print": {"date-parts": [[1986, 11, 1]]}, "DOI": "10.1136/gut.27.suppl_1.72", "type": "journal-article", "created": {"date-parts": [[2007, 9, 18]], "date-time": "2007-09-18T21:41:31Z", "timestamp": 1190151691000}, "page": "72-75", "source": "Crossref", "is-referenced-by-count": 13, "title": ["Role of nutrition in inflammatory bowel disease: an overview."], "prefix": "10.1136", "volume": "27", "author": [{"given": "M L", "family": "Clark", "sequence": "first", "affiliation": []}], "member": "239", "reference": [{"key": "ref_1", "first-page": "134", "article-title": "Long-term total parenteral nutrition with growth, development and positive nitrogen balance", "volume": "64", "author": "Dudrick, S.J.; Wilmore, D.W.; Wars, H.M.; Rhoads, J.E.", "year": "1968", "unstructured": "Dudrick SJ, Wilmore DW, Wars HM, Rhoads JE. Long-term total parenteral nutrition with growth, development and positive nitrogen balance. Surgery 1968; 64: 134.", "journal-title": "Surgery"}, {"key": "ref_2", "doi-asserted-by": "crossref", "first-page": "165", "DOI": "10.1016/0002-9610(73)90022-6", "article-title": "Hyperalimentation as primary therapy for inflammatory bowel disease", "volume": "125", "author": "Fischer, J.E.; Foster, G.S.; Abel, R.M.", "year": "1973", "unstructured": "Fischer JE, Foster GS, Abel RM, et al. Hyperalimentation as primary therapy for inflammatory bowel disease. Am J Surg 1973; 125: 165.", "journal-title": "Am J Surg"}, {"key": "ref_3", "doi-asserted-by": "crossref", "first-page": "192", "DOI": "10.1016/0002-9610(76)90096-9", "article-title": "Hyperalimentation in inflammatory bowel disease", "volume": "131", "author": "Reilly, J.; Ryan, J.A.; Strole, W.", "year": "1976", "unstructured": "Reilly J, Ryan JA, Strole W, et al. Hyperalimentation in inflammatory bowel disease. Am J Surg 1976; 131: 192.", "journal-title": "Am J Surg"}, {"key": "ref_4", "doi-asserted-by": "crossref", "first-page": "460", "DOI": "10.1001/archsurg.1974.01350280066012", "article-title": "Intravenous hyperalimentation in the treatment of inflammatory diseases of the bowel", "volume": "108", "author": "Vogel, C.M.; Corwin, T.R.; Baue, A.E.", "year": "1974", "unstructured": "Vogel CM, Corwin TR, Baue AE. Intravenous hyperalimentation in the treatment of inflammatory diseases of the bowel. Arch Surg 1974; 108: 460.", "journal-title": "Arch Surg"}, {"key": "ref_5", "author": "Dudrick, S.J.; BV, Jr, MacFayden; Daly, J.M.", "first-page": "193", "year": "1976", "unstructured": "Dudrick SJ, MacFayden BV Jr, Daly JM. Management of inflammatory bowel disease with parenteral hyperalimentation. In: Clearfield HR, Dinoso VP Jr, eds. Gastrointestinal emergencies. New York: Grune and Stratton, 1976: 193-9.", "article-title": "Management of inflammatory bowel disease with parenteral hyperalimentation"}, {"key": "ref_6", "doi-asserted-by": "crossref", "first-page": "523", "DOI": "10.1097/00000658-197805000-00010", "article-title": "Ten years experience with intravenous hyperalimentation and inflammatory bowel disease", "volume": "187", "author": "Mullen, J.L.; Hargrove, W.; Clark, M.L.; Dudrick, S.J.; WT, Jr, Fitts; Rosato, E.F.", "year": "1978", "unstructured": "Mullen JL, Hargrove W, Clark ML, Dudrick SJ, Fitts WT Jr, Rosato EF. Ten years experience with intravenous hyperalimentation and inflammatory bowel disease. Ann Surg 1978; 187: 523-9.", "journal-title": "Ann Surg"}, {"key": "ref_7", "doi-asserted-by": "crossref", "first-page": "185", "DOI": "10.1016/S0025-7125(16)31831-4", "article-title": "Total parenteral nutrition in inflammatory bowel disease", "volume": "62", "author": "RH, Jr, Driscoll; IH, Rosenberg", "year": "1978", "unstructured": "Driscoll RH Jr, Rosenberg IH. Total parenteral nutrition in inflammatory bowel disease. Med Clin North Am 1978; 62: 185-201.", "journal-title": "Med Clin North Am"}, {"key": "ref_8", "doi-asserted-by": "crossref", "first-page": "1199", "DOI": "10.1016/0016-5085(80)90913-0", "article-title": "Controlled trial of intravenous hyperalimentation and total bowel rest as an adjunct to the routine therapy of acute colitis", "volume": "79", "author": "Dickinson, R.J.; Ashton, M.G.; Axon, A.T.R.; Smith, R.C.; Yeung, K.; Hill, G.L.", "year": "1980", "unstructured": "Dickinson RJ, Ashton MG, Axon ATR, Smith RC, Yeung K, Hill GL. Controlled trial of intravenous hyperalimentation and total bowel rest as an adjunct to the routine therapy of acute colitis. Gastroenterology 1980; 79: 1199-204.", "journal-title": "Gastroenterology"}, {"key": "ref_9", "author": "Truelove, S.C.; Willoughby, C.P.; Lee, E.G.; Kettlewell, M.G.W.", "year": "1978", "unstructured": "Truelove SC, Willoughby CP, Lee EG, Kettlewell MGW. Further experience in the treatment of severe attacks of ulcerative colitis. Lancet 1978; ii: 1086.", "article-title": "Further experience in the treatment of severe attacks of ulcerative colitis", "journal-title": "Lancet"}, {"key": "ref_10", "doi-asserted-by": "crossref", "first-page": "293", "DOI": "10.1002/bjs.1800710416", "article-title": "Management of enterocutaneous fistulas: a review of 132 cases", "volume": "71", "author": "McIntyre, P.B.; Richie, J.K.; Hawley, P.R.; Bartram, C.I.; Lennard-Jones, J.E.", "year": "1984", "unstructured": "McIntyre PB, Richie JK, Hawley PR, Bartram CI, Lennard-Jones JE. Management of enterocutaneous fistulas: a review of 132 cases. Br J Surg 1984; 71: 293-6.", "journal-title": "Br J Surg"}, {"key": "ref_11", "doi-asserted-by": "crossref", "first-page": "1017", "DOI": "10.1016/S0016-5085(76)80301-0", "article-title": "Reversal of growth arrest in adolescents with Crohn's disease after parenteral alimentation", "volume": "70", "author": "Layden, T.; Rosenberg, J.; Nemchausky, B.; Elston, C.; Rosenberg, I.", "year": "1976", "unstructured": "Layden T, Rosenberg J, Nemchausky B, Elston C, Rosenberg I. Reversal of growth arrest in adolescents with Crohn's disease after parenteral alimentation. Gastroenterology 1976; 70: 1017-21.", "journal-title": "Gastroenterology"}, {"key": "ref_12", "doi-asserted-by": "crossref", "first-page": "444", "DOI": "10.1203/00006450-197704000-00445", "article-title": "Reversal of growth arrest in Crohn's disease (CD): a new approach", "volume": "11", "author": "Grand, R.J.; Shen, G.; Werlin, S.L.", "year": "1977", "unstructured": "Grand RJ, Shen G, Werlin SL et al. Reversal of growth arrest in Crohn's disease (CD): a new approach. Pediatr Res 1977; 11: 444.", "journal-title": "Pediatr Res"}, {"key": "ref_13", "first-page": "720", "article-title": "Nutritional basis of growth failure in children and adolescents with Crohn's disease", "volume": "76", "author": "Kelts, D.G.; Grand, R.J.; Shen, G.", "year": "1979", "unstructured": "Kelts DG, Grand RJ, Shen G et al. Nutritional basis of growth failure in children and adolescents with Crohn's disease. Gastroenterology 1979; 76: 720.", "journal-title": "Gastroenterology"}, {"key": "ref_14", "doi-asserted-by": "crossref", "first-page": "182", "DOI": "10.1097/00005176-198504000-00005", "article-title": "Influence of preoperative parenteral alimentation on postoperative growth in adolescent Crohn's disease", "volume": "4", "author": "Lake, A.M.; Kim, S.; Mathis, R.K.; Walker, W.A.", "year": "1985", "unstructured": "Lake AM, Kim S, Mathis RK, Walker WA. Influence of preoperative parenteral alimentation on postoperative growth in adolescent Crohn's disease. J Pediair Gastroenterol Nutr 1985; 4: 182-6.", "journal-title": "J Pediair Gastroenterol Nutr"}, {"issue": "170", "key": "ref_15", "first-page": "642", "article-title": "Use of concentrated balanced liquid elemental diet for nutritional management of catabolic states", "volume": "1969", "author": "Stephens, R.V.; Randall, H.T.", "unstructured": "Stephens RV, Randall HT. Use of concentrated balanced liquid elemental diet for nutritional management of catabolic states. Ann Surg 1969; 170: 642-68.", "journal-title": "Ann Surg"}, {"key": "ref_16", "doi-asserted-by": "crossref", "first-page": "751", "DOI": "10.1016/S0016-5085(19)33446-8", "article-title": "Surgical management of regional enteritis", "volume": "61", "author": "Glotzer, D.J.; Silen, W.", "year": "1971", "unstructured": "Glotzer DJ, Silen W. Surgical management of regional enteritis. Gastroenterology 1971; 61: 751-6.", "journal-title": "Gastroenterology"}, {"key": "ref_17", "first-page": "122", "article-title": "Use of an elemental diet for long-term nutritional support in Crohn's disease", "volume": "i:", "author": "Goode, A.; Hawkins, T.; Feggeiter, J.G.W.", "year": "1976", "unstructured": "Goode A, Hawkins T, Feggeiter JGW, et al. Use of an elemental diet for long-term nutritional support in Crohn's disease. Lancet 1976; i: 122.", "journal-title": "Lancet"}, {"key": "ref_18", "first-page": "68", "article-title": "Elemental diet in the treatment of fistulas of the alimentary tract", "volume": "137", "author": "Voitk, A.J.; Echave, V.; Brown, R.A.; McArle, A.H.; Gurd, F.H.", "year": "1973", "unstructured": "Voitk AJ, Echave V, Brown RA, McArle AH, Gurd FH. Elemental diet in the treatment of fistulas of the alimentary tract. Surg Gynecol Obstet 1973; 137: 68-72.", "journal-title": "Surg Gynecol Obstet"}, {"key": "ref_19", "author": "Kaminski, V.M.; Deitel, M.", "year": "1975", "unstructured": "Kaminski VM, Deitel M. Nutritional support in the management of external fistulas of the alimentary tract. Br J Surg 1975; 62: 100.", "article-title": "Nutritional support in the management of external fistulas of the alimentary tract", "journal-title": "Br J Surg", "DOI": "10.1002/bjs.1800620205", "doi-asserted-by": "crossref"}, {"key": "ref_20", "first-page": "1", "article-title": "Reversal of growth retardation in Crohn's disease with therapy emphasizing oral nutritional restitution", "volume": "80", "author": "Kirschner, B.S.; Klich, JR, Kalman; SS, DeFavaro; MV, Rosenberg; I.H.", "year": "1981", "unstructured": "Kirschner BS, Klich JR, Kalman SS, DeFavaro MV, Rosenberg IH. Reversal of growth retardation in Crohn's disease with therapy emphasizing oral nutritional restitution. Gastroenterology 1981; 80: 1(-15.", "journal-title": "Gastroenterology"}, {"key": "ref_21", "doi-asserted-by": "crossref", "first-page": "933", "DOI": "10.1136/gut.22.11.933", "article-title": "Nocturnal growth hormone and gonadotrophin secretion in growth retarded children with Crohn's disease", "volume": "22", "author": "Farthing, M.J.G.; Campbell, C.A.; Walker-Smith, J.A.; Edwards, C.R.W.; Rees, L.H.; Dawson, A.M.", "year": "1981", "unstructured": "Farthing MJG, Campbell CA, Walker-Smith JA, Edwards CRW, Rees LH, Dawson AM. Nocturnal growth hormone and gonadotrophin secretion in growth retarded children with Crohn's disease. Gut 1981; 22: 933.", "journal-title": "Gut"}, {"key": "ref_22", "first-page": "481", "article-title": "Growth failure and inflammatory bowel disease: approach to treatment of a complicated adolescent problem", "volume": "72", "author": "Rosenthal, SR, Snyder; JD, Hendricks; KM, Walker; W.A.", "year": "1983", "unstructured": "Rosenthal SR, Snyder JD, Hendricks KM, Walker WA. Growth failure and inflammatory bowel disease: approach to treatment of a complicated adolescent problem. Pediatrics 1983; 72: 481-90.", "journal-title": "Pediatrics"}, {"key": "ref_23", "doi-asserted-by": "crossref", "first-page": "1173", "DOI": "10.1136/bmj.281.6249.1173", "article-title": "Elemental diets in treatment of acute Crohn's disease", "volume": "281", "author": "O'Morian, C.; Segal, A.W.; Levi, A.J.", "year": "1980", "unstructured": "O'Morian C, Segal AW, Levi AJ. Elemental diets in treatment of acute Crohn's disease. Br Med J 1980; 281: 1173.", "journal-title": "Br Med J"}, {"key": "ref_24", "doi-asserted-by": "crossref", "first-page": "1859", "DOI": "10.1136/bmj.288.6434.1859", "article-title": "Elemental diets in treatment of acute Crohn's disease: a controlled trial", "volume": "288", "author": "O'Morian, C.; Segal, A.W.; Levi, A.J.", "year": "1984", "unstructured": "O'Morian C, Segal AW, Levi AJ. Elemental diets in treatment of acute Crohn's disease: a controlled trial. Br Med J 1984; 288: 1859-62.", "journal-title": "Br Med J"}, {"key": "ref_25", "author": "Sanderson, I.R.; Udeen, S.; Walker-Smith, J.A.", "unstructured": "Sanderson IR, Udeen S, Walker-Smith JA. A controlled trial of Vivonex versus Prednisolone in children with Crohn's disease. Arch Dis Child (In press).", "article-title": "A controlled trial of Vivonex versus Prednisolone in children with Crohn's disease", "journal-title": "Arch Dis Child"}], "container-title": ["Gut"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1136/gut.27.Suppl_1.72", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 3]], "date-time": "2019-05-03T03:32:43Z", "timestamp": 1556854363000}, "score": 19.113314, "issued": {"date-parts": [[1986, 11, 1]]}, "references-count": 25, "journal-issue": {"published-print": {"date-parts": [[1986, 11, 1]]}, "issue": "Suppl 1"}, "URL": "http://dx.doi.org/10.1136/gut.27.suppl_1.72", "relation": {"cites": []}, "ISSN": ["0017-5749"], "issn-type": [{"value": "0017-5749", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T03:20:02Z", "timestamp": 1574738402793}, "reference-count": 66, "publisher": "Elsevier BV", "issue": "6", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2015, 12, 1]], "date-time": "2015-12-01T00:00:00Z", "timestamp": 1448928000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["clinicalkey.jp", "clinicalkey.com", "clinicalkey.es", "theclinics.com", "clinicalkey.com.au", "clinicalkey.fr", "surgical.theclinics.com", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Surgical Clinics of North America"], "published-print": {"date-parts": [[2015, 12]]}, "DOI": "10.1016/j.suc.2015.07.008", "type": "journal-article", "created": {"date-parts": [[2015, 10, 24]], "date-time": "2015-10-24T21:01:14Z", "timestamp": 1445720474000}, "page": "1123-1141", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Diagnostic Modalities for Inflammatory Bowel Disease"], "prefix": "10.1016", "volume": "95", "author": [{"given": "Clarence", "family": "Clark", "sequence": "first", "affiliation": []}, {"given": "Jacquelyn", "family": "Turner", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Surgical Clinics of North America"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0039610915001425?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0039610915001425?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 8, 31]], "date-time": "2019-08-31T22:30:56Z", "timestamp": 1567290656000}, "score": 19.113314, "issued": {"date-parts": [[2015, 12]]}, "references-count": 66, "journal-issue": {"published-print": {"date-parts": [[2015, 12]]}, "issue": "6"}, "alternative-id": ["S0039610915001425"], "URL": "http://dx.doi.org/10.1016/j.suc.2015.07.008", "ISSN": ["0039-6109"], "issn-type": [{"value": "0039-6109", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Diagnostic Modalities for Inflammatory Bowel Disease", "name": "articletitle", "label": "Article Title"}, {"value": "Surgical Clinics of North America", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.suc.2015.07.008", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "Copyright \u00a9 2015 Elsevier Inc. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T21:15:25Z", "timestamp": 1575148525447}, "reference-count": 27, "publisher": "Informa Healthcare", "issue": "7", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Expert Opinion on Investigational Drugs"], "published-print": {"date-parts": [[1998, 7]]}, "DOI": "10.1517/13543784.7.7.1115", "type": "journal-article", "created": {"date-parts": [[2005, 5, 4]], "date-time": "2005-05-04T18:08:53Z", "timestamp": 1115230133000}, "page": "1115-1120", "source": "Crossref", "is-referenced-by-count": 1, "title": ["The therapeutic potential of anti-cytokine antibodies in the treatment of chronic inflammatory disease"], "prefix": "10.1517", "volume": "7", "author": [{"given": "Natalie J", "family": "Davidson", "sequence": "first", "affiliation": []}], "member": "3197", "published-online": {"date-parts": [[2005, 2, 23]]}, "reference": [{"key": "CIT0001", "DOI": "10.1146/annurev.immunol.14.1.397", "doi-asserted-by": "publisher"}, {"key": "CIT0002", "DOI": "10.1016/S0065-2776(08)60891-3", "doi-asserted-by": "publisher"}, {"key": "CIT0004", "DOI": "10.1159/000171464", "doi-asserted-by": "publisher"}, {"key": "CIT0005", "author": "BRAEGGER CP", "volume": "72", "first-page": "135", "year": "1994", "journal-title": "Ann. Allergy"}, {"key": "CIT0006", "DOI": "10.1016/S0016-5085(97)70128-8", "doi-asserted-by": "publisher"}, {"key": "CIT0007", "author": "VAN HOGEZAND RA", "volume": "223", "first-page": "105", "year": "1997", "journal-title": "Scand. Gastroenterol"}, {"key": "CIT0009", "DOI": "10.1073/pnas.89.20.9784", "doi-asserted-by": "publisher"}, {"key": "CIT0010", "author": "LUDVIKSSON BR", "volume": "5", "first-page": "202", "year": "1997", "journal-title": "Role in human intestinal in-flammation. Immunologist"}, {"key": "CIT0012", "DOI": "10.1056/NEJM199109263251306", "doi-asserted-by": "publisher"}, {"key": "CIT0013", "DOI": "10.1056/NEJM199110033251406", "doi-asserted-by": "publisher"}, {"key": "CIT0014", "DOI": "10.1016/0016-5085(95)90277-5", "doi-asserted-by": "publisher"}, {"key": "CIT0015", "DOI": "10.1002/eji.1830270722", "doi-asserted-by": "publisher"}, {"key": "CIT0016", "DOI": "10.1111/j.1365-2249.1997.291-ce1184.x", "doi-asserted-by": "publisher"}, {"key": "CIT0020", "DOI": "10.1172/JCI118861", "doi-asserted-by": "publisher"}, {"key": "CIT0024", "DOI": "10.1084/jem.184.1.241", "doi-asserted-by": "publisher"}, {"key": "CIT0025", "DOI": "10.1016/S1074-7613(00)80413-6", "doi-asserted-by": "publisher"}, {"key": "CIT0026", "author": "TRINCHIERI G", "volume": "84", "first-page": "4008", "year": "1994", "journal-title": "Blood"}, {"key": "CIT0028", "author": "EHRHARDT RO", "volume": "158", "first-page": "566", "year": "1997", "journal-title": "J. Immunol."}, {"key": "CIT0029", "DOI": "10.1084/jem.187.8.1225", "doi-asserted-by": "publisher"}, {"key": "CIT0030", "DOI": "10.1084/jem.182.5.1281", "doi-asserted-by": "publisher"}, {"key": "CIT0031", "DOI": "10.1084/jem.181.2.817", "doi-asserted-by": "publisher"}, {"key": "CIT0032", "author": "LEONARD JP", "volume": "17", "first-page": "545", "year": "1997", "journal-title": "Grit. Rev. Immunol."}, {"key": "CIT0033", "DOI": "10.1002/eji.1830270310", "doi-asserted-by": "publisher"}, {"key": "CIT0034", "DOI": "10.1002/eji.1830261219", "doi-asserted-by": "publisher"}, {"key": "CIT0035", "DOI": "10.1046/j.1365-2249.1998.00485.x", "doi-asserted-by": "publisher"}, {"key": "CIT0036", "DOI": "10.1111/j.1365-2249.1995.tb03835.x", "doi-asserted-by": "publisher"}, {"key": "CIT0037", "author": "MOLLER DR", "volume": "159", "first-page": "5157", "year": "1997", "journal-title": "J. Immunol."}], "container-title": ["Expert Opinion on Investigational Drugs"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.1517/13543784.7.7.1115", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 13]], "date-time": "2016-12-13T13:30:02Z", "timestamp": 1481635802000}, "score": 19.06967, "issued": {"date-parts": [[1998, 7]]}, "references-count": 27, "journal-issue": {"published-online": {"date-parts": [[2005, 2, 23]]}, "published-print": {"date-parts": [[1998, 7]]}, "issue": "7"}, "alternative-id": ["10.1517/13543784.7.7.1115"], "URL": "http://dx.doi.org/10.1517/13543784.7.7.1115", "relation": {"cites": []}, "ISSN": ["1354-3784", "1744-7658"], "issn-type": [{"value": "1354-3784", "type": "print"}, {"value": "1744-7658", "type": "electronic"}], "subject": ["Pharmacology (medical)", "Pharmacology", "General Medicine"]}, {"indexed": {"date-parts": [[2019, 12, 9]], "date-time": "2019-12-09T16:41:21Z", "timestamp": 1575909681831}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The American Journal of Gastroenterology"], "published-print": {"date-parts": [[2019, 12]]}, "DOI": "10.14309/01.ajg.0000613312.92767.6e", "type": "journal-article", "created": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T19:11:33Z", "timestamp": 1575400293000}, "page": "S22-S23", "source": "Crossref", "is-referenced-by-count": 0, "title": ["P086\u2003Increased Need for Psychotropic Medication and Mental Health Service Usage in Pediatric Patients With Inflammatory Bowel Disease (IBD)"], "prefix": "10.14309", "volume": "114", "author": [{"given": "Natalie", "family": "Conboy", "sequence": "first", "affiliation": []}, {"given": "Lawrence", "family": "Saubermann", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["The American Journal of Gastroenterology"], "language": "en", "link": [{"URL": "http://journals.lww.com/ajg/Fulltext/10.14309/01.ajg.0000613312.92767.6e", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 12, 9]], "date-time": "2019-12-09T16:18:28Z", "timestamp": 1575908308000}, "score": 19.06967, "subtitle": [""], "issued": {"date-parts": [[2019, 12]]}, "references-count": 0, "URL": "http://dx.doi.org/10.14309/01.ajg.0000613312.92767.6e", "ISSN": ["0002-9270"], "issn-type": [{"value": "0002-9270", "type": "print"}], "subject": ["Hepatology", "Gastroenterology"]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T16:13:56Z", "timestamp": 1575303236354}, "reference-count": 64, "publisher": "Oxford University Press (OUP)", "issue": "11", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2018, 10, 12]]}, "DOI": "10.1093/ibd/izy157", "type": "journal-article", "created": {"date-parts": [[2018, 5, 18]], "date-time": "2018-05-18T13:15:51Z", "timestamp": 1526649351000}, "page": "2322-2326", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Heart Under Attack: Cardiac Manifestations of Inflammatory Bowel Disease"], "prefix": "10.1093", "volume": "24", "author": [{"given": "Natalie E", "family": "Mitchell", "sequence": "first", "affiliation": [{"name": "Department of Internal Medicine, Walter Reed National Military Medical Center, Bethesda, Maryland"}]}, {"given": "Nicole", "family": "Harrison", "sequence": "additional", "affiliation": [{"name": "Gastroenterology Service , Walter Reed National Military Medical Center, Bethesda, Maryland"}]}, {"given": "Zachary", "family": "Junga", "sequence": "additional", "affiliation": [{"name": "Gastroenterology Service , Walter Reed National Military Medical Center, Bethesda, Maryland"}]}, {"given": "Manish", "family": "Singla", "sequence": "additional", "affiliation": [{"name": "Department of Internal Medicine, Walter Reed National Military Medical Center, Bethesda, Maryland"}, {"name": "Gastroenterology Service , Walter Reed National Military Medical Center, Bethesda, Maryland"}]}], "member": "286", "published-online": {"date-parts": [[2018, 5, 18]]}, "reference": [{"key": "key\n\t\t\t\t20181012112940634_CIT0001", "doi-asserted-by": "crossref", "first-page": "241", "DOI": "10.1038/ajg.2016.537", "article-title": "ACG clinical guideline: preventive care in inflammatory bowel disease", "volume": "112", "author": "Farraye", "year": "2017", "journal-title": "Am J Gastroenterol"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0002", "doi-asserted-by": "crossref", "first-page": "1690", "DOI": "10.1002/art.24092", "article-title": "Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies", "volume": "59", "author": "Avi\u00f1a-Zubieta", "year": "2008", "journal-title": "Arthritis Rheum"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0003", "doi-asserted-by": "crossref", "first-page": "1580", "DOI": "10.1002/art.25009", "article-title": "Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis", "volume": "61", "author": "Rho", "year": "2009", "journal-title": "Arthritis Rheum"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0004", "doi-asserted-by": "crossref", "first-page": "2905", "DOI": "10.1002/art.22809", "article-title": "Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register", "volume": "56", "author": "Dixon", "year": "2007", "journal-title": "Arthritis Rheum"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0005", "doi-asserted-by": "crossref", "first-page": "2599", "DOI": "10.1056/NEJMoa040967", "article-title": "Inflammatory markers and the risk of coronary heart disease in men and women", "volume": "351", "author": "Pai", "year": "2004", "journal-title": "N Engl J Med"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0006", "doi-asserted-by": "crossref", "first-page": "1557", "DOI": "10.1056/NEJMoa021993", "article-title": "Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events", "volume": "347", "author": "Ridker", "year": "2002", "journal-title": "N Engl J Med"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0007", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1186/1741-7015-12-47", "article-title": "Is atherosclerosis an autoimmune disease", "volume": "12", "author": "Matsuura", "year": "2014", "journal-title": "BMC Med"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0008", "doi-asserted-by": "crossref", "first-page": "1685", "DOI": "10.1056/NEJMra043430", "article-title": "Inflammation, atherosclerosis, and coronary artery disease", "volume": "352", "author": "Hansson", "year": "2005", "journal-title": "N Engl J Med"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0009", "doi-asserted-by": "crossref", "first-page": "539", "DOI": "10.1016/j.bcp.2009.04.029", "article-title": "Inflammatory cytokines in vascular dysfunction and vascular disease", "volume": "78", "author": "Sprague", "year": "2010", "journal-title": "Biochem Pharmacol"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0010", "doi-asserted-by": "crossref", "first-page": "703", "DOI": "10.1586/egh.11.74", "article-title": "Cells, cytokines and inflammatory bowel disease: a clinical perspective", "volume": "5", "author": "Roberts-Thomson", "year": "2011", "journal-title": "Expert Rev Gastroenterol Hepatol"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0011", "doi-asserted-by": "crossref", "first-page": "70", "DOI": "10.1038/sj.clpt.6100229", "article-title": "Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn\u2019s disease", "volume": "83", "author": "Schinzari", "year": "2008", "journal-title": "Clin Pharmacol Ther"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0012", "doi-asserted-by": "crossref", "first-page": "741", "DOI": "10.1038/ajg.2011.63", "article-title": "Inflammatory bowel disease is associated with an increased incidence of cardiovascular events", "volume": "106", "author": "Yarur", "year": "2011", "journal-title": "Am J Gastroenterol"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0013", "doi-asserted-by": "crossref", "first-page": "382", "DOI": "10.1016/j.cgh.2013.08.023", "article-title": "Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis", "volume": "12", "author": "Singh", "year": "2014", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0014", "doi-asserted-by": "crossref", "first-page": "477", "DOI": "10.1093/europace/eut312", "article-title": "Increased risk of atrial fibrillation and stroke during active stages of inflammatory bowel disease: a nationwide study", "volume": "16", "author": "Kristensen", "year": "2014", "journal-title": "Europace"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0015", "doi-asserted-by": "crossref", "first-page": "1637", "DOI": "10.1097/MIB.0000000000001187", "article-title": "Extraintestinal manifestations are common in obese patients with Crohn\u2019s disease", "volume": "23", "author": "Singla", "year": "2017", "journal-title": "Inflamm Bowel Dis"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0016", "doi-asserted-by": "crossref", "first-page": "257", "DOI": "10.14740/jocmr2102w", "article-title": "Inflammatory bowel disease as a risk factor for premature coronary artery disease", "volume": "7", "author": "Ruisi", "year": "2015", "journal-title": "J Clin Med Res"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0017", "doi-asserted-by": "crossref", "first-page": "287", "DOI": "10.1016/j.crohns.2011.01.011", "article-title": "Comprehensive study of cardiovascular morbidity in hospitalized inflammatory bowel disease patients", "volume": "5", "author": "Sridhar", "year": "2011", "journal-title": "J Crohns Colitis"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0018", "doi-asserted-by": "crossref", "first-page": "662", "DOI": "10.1111/j.1572-0241.2006.01018.x", "article-title": "Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and meta-analysis", "volume": "102", "author": "Dorn", "year": "2007", "journal-title": "Am J Gastroenterol"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0019", "doi-asserted-by": "crossref", "first-page": "875", "DOI": "10.1016/j.cgh.2011.06.032", "article-title": "No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn\u2019s disease", "volume": "9", "author": "Osterman", "year": "2011", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0020", "doi-asserted-by": "crossref", "first-page": "1445", "DOI": "10.1038/ajg.2009.81", "article-title": "Risk of arterial thrombotic events in inflammatory bowel disease", "volume": "104", "author": "Ha", "year": "2009", "journal-title": "Am J Gastroenterol"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0021", "doi-asserted-by": "crossref", "first-page": "599", "DOI": "10.1097/MIB.0b013e31827f27ae", "article-title": "Crohn\u2019s disease and ulcerative colitis are associated with elevated standardized mortality ratios: a meta-analysis", "volume": "19", "author": "Bewtra", "year": "2013", "journal-title": "Inflamm Bowel Dis"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0022", "doi-asserted-by": "crossref", "first-page": "2229", "DOI": "10.1097/MIB.0000000000000899", "article-title": "Hospitalizations for acute myocardial infarction are decreased among patients with inflammatory bowel disease using a Nationwide Inpatient Database", "volume": "22", "author": "Barnes", "year": "2016", "journal-title": "Inflamm Bowel Dis"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0023", "doi-asserted-by": "crossref", "first-page": "41", "DOI": "10.1016/j.cgh.2007.09.016", "article-title": "The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study", "volume": "6", "author": "Bernstein", "year": "2008", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0024", "doi-asserted-by": "crossref", "first-page": "e33442", "DOI": "10.1371/journal.pone.0033442", "article-title": "Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden", "volume": "7", "author": "Z\u00f6ller", "year": "2012", "journal-title": "PLoS One"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0025", "doi-asserted-by": "crossref", "first-page": "689", "DOI": "10.1136/gutjnl-2012-303285", "article-title": "Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study", "volume": "62", "author": "Rungoe", "year": "2013", "journal-title": "Gut"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0026", "doi-asserted-by": "crossref", "first-page": "e56944", "DOI": "10.1371/journal.pone.0056944", "article-title": "Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death\u2013a Danish nationwide cohort study", "volume": "8", "author": "Kristensen", "year": "2013", "journal-title": "PLoS One"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0027", "doi-asserted-by": "crossref", "first-page": "502", "DOI": "10.1097/01.MIB.0000441200.10454.4f", "article-title": "Long-term risk of acute coronary syndrome in patients with inflammatory bowel disease", "volume": "20", "author": "Tsai", "year": "2014", "journal-title": "Inflamm Bowel Dis"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0028", "doi-asserted-by": "crossref", "first-page": "e0139745", "DOI": "10.1371/journal.pone.0139745", "article-title": "Risk of ischaemic heart disease in patients with inflammatory bowel disease: cohort study using the general practice research database", "volume": "10", "author": "Close", "year": "2015", "journal-title": "PLoS One"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0029", "doi-asserted-by": "crossref", "first-page": "1655", "DOI": "10.1185/03007995.2015.1065242", "article-title": "Occurrence of adverse events among patients with inflammatory bowel disease in the Healthcore Integrated Research Database", "volume": "31", "author": "McAuliffe", "year": "2015", "journal-title": "Curr Med Res Opin"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0030", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1161/JAHA.117.005892", "article-title": "Inflammatory bowel disease and risk of ischemic heart disease: an updated meta-analysis of cohort studies", "volume": "6", "author": "Feng", "year": "2017", "journal-title": "J Am Heart Assoc"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0031", "doi-asserted-by": "crossref", "first-page": "743", "DOI": "10.1161/CIRCULATIONAHA.107.699579", "article-title": "General cardiovascular risk profile for use in primary care", "volume": "117", "author": "D\u2019Agostino", "year": "2008", "journal-title": "Circulation"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0032", "doi-asserted-by": "crossref", "first-page": "464", "DOI": "10.1136/hrt.2002.007005", "article-title": "Inflammatory mediators in chronic heart failure: an overview", "volume": "90", "author": "Anker", "year": "2004", "journal-title": "Heart"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0033", "doi-asserted-by": "crossref", "first-page": "236", "DOI": "10.1056/NEJM199007263230405", "article-title": "Elevated circulating levels of tumor necrosis factor in severe chronic heart failure", "volume": "323", "author": "Levine", "year": "1990", "journal-title": "N Engl J Med"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0034", "doi-asserted-by": "crossref", "first-page": "1226", "DOI": "10.1016/S0002-9149(02)02839-4", "article-title": "Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure", "volume": "90", "author": "Genth-Zotz", "year": "2002", "journal-title": "Am J Cardiol"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0035", "doi-asserted-by": "crossref", "first-page": "1838", "DOI": "10.1016/S0140-6736(98)09286-1", "article-title": "Endotoxin and immune activation in chronic heart failure: a prospective cohort study", "volume": "353", "author": "Niebauer", "year": "1999", "journal-title": "Lancet"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0036", "doi-asserted-by": "crossref", "first-page": "426", "DOI": "10.1093/eurheartj/eht271", "article-title": "The heart and the gut", "volume": "35", "author": "Rogler", "year": "2014", "journal-title": "Eur Heart J"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0037", "doi-asserted-by": "crossref", "first-page": "H1288", "DOI": "10.1152/ajpheart.00526.2001", "article-title": "TNF-alpha and myocardial matrix metalloproteinases in heart failure: relationship to Lv remodeling", "volume": "282", "author": "Bradham", "year": "2002", "journal-title": "Am J Physiol Heart Circ Physiol"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0038", "doi-asserted-by": "crossref", "first-page": "298", "DOI": "10.1002/ibd.21424", "article-title": "Systemic toll-like receptor ligands modify B-cell responses in human inflammatory bowel disease", "volume": "17", "author": "McDonnell", "year": "2011", "journal-title": "Inflamm Bowel Dis"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0039", "doi-asserted-by": "crossref", "first-page": "1688", "DOI": "10.1093/rheumatology/kem212", "article-title": "Heart failure among younger rheumatoid arthritis and Crohn\u2019s patients exposed to TNF-alpha antagonists", "volume": "46", "author": "Curtis", "year": "2007", "journal-title": "Rheumatology (Oxford)"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0040", "doi-asserted-by": "crossref", "first-page": "1594", "DOI": "10.1161/01.CIR.0000124490.27666.B2", "article-title": "Targeted anticytokine therapy in patients with chronic heart failure: results of the randomized etanercept worldwide evaluation (RENEWAL)", "volume": "109", "author": "Mann", "year": "2004", "journal-title": "Circulation"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0041", "doi-asserted-by": "crossref", "first-page": "3133", "DOI": "10.1161/01.CIR.0000077913.60364.D2", "article-title": "Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-\u03b1, in patients with moderate-to-severe heart failure", "volume": "107", "author": "Chung", "year": "2003", "journal-title": "Circulation"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0042", "doi-asserted-by": "crossref", "first-page": "807", "DOI": "10.7326/0003-4819-138-10-200305200-00008", "article-title": "Case reports of heart failure after therapy with a tumor necrosis factor antagonist", "volume": "138", "author": "Kwon", "year": "2003", "journal-title": "Ann Intern Med"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0043", "doi-asserted-by": "crossref", "first-page": "1719", "DOI": "10.1016/j.ijcard.2012.11.112", "article-title": "Is it safe to use TNF-\u03b1 blockers for systemic inflammatory disease in patients with heart failure? Importance of dosage and receptor specificity", "volume": "167", "author": "Diamantopoulos", "year": "2013", "journal-title": "Int J Cardiol"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0044", "doi-asserted-by": "crossref", "first-page": "717", "DOI": "10.1161/CIRCHEARTFAILURE.114.001152", "article-title": "Inflammatory bowel disease is associated with an increased risk of hospitalization for heart failure: a Danish nationwide cohort study", "volume": "7", "author": "Kristensen", "year": "2014", "journal-title": "Circ Heart Fail"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0045", "doi-asserted-by": "crossref", "first-page": "6960810", "DOI": "10.1155/2017/6960810", "article-title": "Prolonged P-wave and QT dispersion in children with inflammatory bowel disease in remission", "volume": "2017", "author": "Bornaun", "year": "2017", "journal-title": "Biomed Res Int"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0046", "doi-asserted-by": "crossref", "first-page": "136", "DOI": "10.5152/tjg.2015.150349", "article-title": "Prevalence of QT interval prolongation in inflammatory bowel disease", "volume": "27", "author": "Pattanshetty", "year": "2016", "journal-title": "Turk J Gastroenterol"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0047", "doi-asserted-by": "crossref", "first-page": "1309", "DOI": "10.1111/echo.13261", "article-title": "Atrial electromechanical properties in inflammatory bowel disease", "volume": "33", "author": "Efe", "year": "2016", "journal-title": "Echocardiography"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0048", "doi-asserted-by": "crossref", "first-page": "65", "DOI": "10.3748/wjg.v19.i1.65", "article-title": "Prolonged QT dispersion in inflammatory bowel disease", "volume": "19", "author": "Yorulmaz", "year": "2013", "journal-title": "World J Gastroenterol"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0049", "doi-asserted-by": "crossref", "first-page": "540", "DOI": "10.7150/ijms.8.540", "article-title": "Evaluation of QT and P wave dispersion and mean platelet volume among inflammatory bowel disease patients", "volume": "8", "author": "Dogan", "year": "2011", "journal-title": "Int J Med Sci"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0050", "doi-asserted-by": "crossref", "first-page": "307", "DOI": "10.1007/s11739-010-0382-9", "article-title": "A study on QT interval in patients affected with inflammatory bowel disease without cardiac involvement", "volume": "5", "author": "Curione", "year": "2010", "journal-title": "Intern Emerg Med"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0051", "doi-asserted-by": "crossref", "first-page": "325", "DOI": "10.4103/1319-3767.166208", "article-title": "Inflammatory bowel \u201ccardiac\u201d disease: point prevalence of atrial fibrillation in inflammatory bowel disease population", "volume": "21", "author": "Pattanshetty", "year": "2015", "journal-title": "Saudi J Gastroenterol"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0052", "doi-asserted-by": "crossref", "first-page": "2370", "DOI": "10.1001/jama.285.18.2370", "article-title": "Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study", "volume": "285", "author": "Go", "year": "2001", "journal-title": "JAMA"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0053", "first-page": "314", "article-title": "Pericarditis\u2013an extraintestinal complication of inflammatory bowel disease", "volume": "153", "author": "Abid", "year": "1990", "journal-title": "West J Med"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0054", "doi-asserted-by": "crossref", "first-page": "334", "DOI": "10.1097/01.MIB.0000209788.19952.b7", "article-title": "Myopericarditis and mitral insufficiency associated with ulcerative colitis treated with mesalazine", "volume": "12", "author": "Garc\u00eda-Mor\u00e1n", "year": "2006", "journal-title": "Inflamm Bowel Dis"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0055", "doi-asserted-by": "crossref", "first-page": "1099", "DOI": "10.1016/S0002-9270(99)00078-7", "article-title": "Pericarditis associated with inflammatory bowel disease: case report", "volume": "94", "author": "Moln\u00e1r", "year": "1999", "journal-title": "Am J Gastroenterol"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0056", "doi-asserted-by": "crossref", "first-page": "827", "DOI": "10.1053/j.gastro.2005.06.021", "article-title": "The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study", "volume": "129", "author": "Bernstein", "year": "2005", "journal-title": "Gastroenterology"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0057", "doi-asserted-by": "crossref", "first-page": "1123", "DOI": "10.1007/s00384-007-0327-6", "article-title": "Parallel manifestation of Crohn\u2019s disease and acute pericarditis: a report of two cases", "volume": "22", "author": "Stasinopoulou", "year": "2007", "journal-title": "Int J Colorectal Dis"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0058", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1097/00054725-200501000-00016", "article-title": "Pericarditis as the presenting sign of Crohn\u2019s disease", "volume": "11", "author": "Jackson", "year": "2005", "journal-title": "Inflamm Bowel Dis"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0059", "doi-asserted-by": "crossref", "first-page": "154", "DOI": "10.4250/jcu.2012.20.3.154", "article-title": "Recurrent mesalazine-induced myopericarditis in a patient with ulcerative colitis", "volume": "20", "author": "Park", "year": "2012", "journal-title": "J Cardiovasc Ultrasound"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0060", "doi-asserted-by": "crossref", "first-page": "391", "DOI": "10.1592/phco.22.5.391.33188", "article-title": "Possible mesalamine-induced pericarditis: case report and literature review", "volume": "22", "author": "Waite", "year": "2002", "journal-title": "Pharmacotherapy"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0061", "doi-asserted-by": "crossref", "first-page": "344", "DOI": "10.1097/00005176-199809000-00015", "article-title": "Recurrent pericarditis due to mesalamine hypersensitivity: a pediatric case report and review of the literature", "volume": "27", "author": "Sentongo", "year": "1998", "journal-title": "J Pediatr Gastroenterol Nutr"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0062", "doi-asserted-by": "crossref", "first-page": "730", "DOI": "10.1016/j.crohns.2012.02.016", "article-title": "A rare case of pericarditis, complication of infliximab treatment for Crohn\u2019s disease", "volume": "6", "author": "Devasahayam", "year": "2012", "journal-title": "J Crohns Colitis"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0063", "doi-asserted-by": "crossref", "first-page": "428", "DOI": "10.1002/ibd.20270", "article-title": "Pericarditis as a complication of infliximab therapy in Crohn\u2019s disease", "volume": "14", "author": "Burke", "year": "2008", "journal-title": "Inflamm Bowel Dis"}, {"key": "key\n\t\t\t\t20181012112940634_CIT0064", "doi-asserted-by": "crossref", "first-page": "217", "DOI": "10.1155/1997/694167", "article-title": "Azathioprine-induced pericarditis in a patient with ulcerative colitis", "volume": "11", "author": "Simpson", "year": "1997", "journal-title": "Can J Gastroenterol"}], "container-title": ["Inflammatory Bowel Diseases"], "language": "en", "link": [{"URL": "http://academic.oup.com/ibdjournal/article-pdf/24/11/2322/26034770/izy157.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 18]], "date-time": "2019-10-18T06:07:35Z", "timestamp": 1571378855000}, "score": 18.758102, "issued": {"date-parts": [[2018, 5, 18]]}, "references-count": 64, "journal-issue": {"published-online": {"date-parts": [[2018, 5, 18]]}, "published-print": {"date-parts": [[2018, 10, 12]]}, "issue": "11"}, "URL": "http://dx.doi.org/10.1093/ibd/izy157", "relation": {"cites": []}, "ISSN": ["1078-0998", "1536-4844"], "issn-type": [{"value": "1078-0998", "type": "print"}, {"value": "1536-4844", "type": "electronic"}], "subject": ["Immunology and Allergy", "Gastroenterology"]}, {"institution": {"name": "The University of Queensland", "place": ["-"], "department": ["School of Medicine"], "acronym": ["-"]}, "indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T23:01:40Z", "timestamp": 1574722900430}, "reference-count": 0, "publisher": "University of Queensland Library", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.14264/uql.2016.1085", "type": "dissertation", "created": {"date-parts": [[2016, 12, 2]], "date-time": "2016-12-02T06:58:31Z", "timestamp": 1480661911000}, "approved": {"date-parts": [[2016, 11, 18]]}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["The role of cytokines and inflammatory markers in depression in adolescents"], "prefix": "10.14264", "author": [{"given": "Natalie", "family": "Mills", "sequence": "first", "affiliation": []}], "member": "5387", "deposited": {"date-parts": [[2016, 12, 2]], "date-time": "2016-12-02T06:58:31Z", "timestamp": 1480661911000}, "score": 18.45673, "degree": ["PhD Thesis"], "issued": {"date-parts": [[null]]}, "references-count": 0, "URL": "http://dx.doi.org/10.14264/uql.2016.1085"}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T14:47:06Z", "timestamp": 1575384426980}, "reference-count": 89, "publisher": "Frontiers Media SA", "license": [{"URL": "https://creativecommons.org/licenses/by/4.0/", "start": {"date-parts": [[2019, 1, 17]], "date-time": "2019-01-17T00:00:00Z", "timestamp": 1547683200000}, "delay-in-days": 0, "content-version": "vor"}], "content-domain": {"domain": ["frontiersin.org"], "crossmark-restriction": true}, "short-container-title": ["Front. Immunol."], "DOI": "10.3389/fimmu.2018.03179", "type": "journal-article", "created": {"date-parts": [[2019, 1, 17]], "date-time": "2019-01-17T04:18:45Z", "timestamp": 1547698725000}, "update-policy": "http://dx.doi.org/10.3389/crossmark-policy", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Intestinal Microbiota Influence Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation and Intestinal GVHD"], "prefix": "10.3389", "volume": "9", "author": [{"given": "Natalie", "family": "K\u00f6hler", "sequence": "first", "affiliation": []}, {"given": "Robert", "family": "Zeiser", "sequence": "additional", "affiliation": []}], "member": "1965", "published-online": {"date-parts": [[2019, 1, 17]]}, "reference": [{"key": "B1", "unstructured": "D'Souza FrethamC Current Uses and Outcomes of Hematopoietic Cell Transplantation (HCT): CIBMTR Summary Slides2017"}, {"key": "B2", "doi-asserted-by": "publisher", "first-page": "191", "DOI": "10.1111/bjh.14295", "article-title": "Pathogenesis of acute graft-versus-host disease: from intestinal microbiota alterations to donor T cell activation", "volume": "175", "author": "Zeiser", "year": "2016", "journal-title": "Br j haematol."}, {"key": "B3", "doi-asserted-by": "publisher", "first-page": "1150", "DOI": "10.1016/j.bbmt.2012.04.005", "article-title": "First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the american society of blood and marrow transplantation", "volume": "18", "author": "Martin", "year": "2012", "journal-title": "Biol blood marrow transplant."}, {"key": "B4", "doi-asserted-by": "publisher", "first-page": "601953", "DOI": "10.1155/2011/601953", "article-title": "Steroid-refractory acute GVHD: predictors and outcomes", "volume": "2011", "author": "Westin", "year": "2011", "journal-title": "Adv hematol."}, {"key": "B5", "doi-asserted-by": "publisher", "first-page": "966", "DOI": "10.1038/bmt.2014.69", "article-title": "Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation", "volume": "49", "author": "Castilla-Llorente", "year": "2014", "journal-title": "Bone marrow transplantat."}, {"key": "B6", "doi-asserted-by": "publisher", "first-page": "648", "DOI": "10.1038/nm.3517", "article-title": "Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage", "volume": "20", "author": "Schwab", "year": "2014", "journal-title": "Nat med."}, {"key": "B7", "doi-asserted-by": "publisher", "first-page": "50", "DOI": "10.1182/blood-2003-03-0909", "article-title": "Prognostic value of apoptotic cells and infiltrating neutrophils in graft-versus-host disease of the gastrointestinal tract in humans: TNF and fas expression", "volume": "103", "author": "Soci\u00e9", "year": "2004", "journal-title": "Blood"}, {"key": "B8", "doi-asserted-by": "publisher", "first-page": "1734", "DOI": "10.1182/blood-2010-05-287649", "article-title": "SMAD3 prevents graft-versus-host disease by restraining Th1 differentiation and granulocyte-mediated tissue damage", "volume": "117", "author": "Giroux", "year": "2011", "journal-title": "Blood"}, {"key": "B9", "doi-asserted-by": "publisher", "first-page": "5795", "DOI": "10.4049/jimmunol.1501357", "article-title": "A novel function for P2Y2 in myeloid recipient\u2013derived cells during graft-versus-host disease", "volume": "195", "author": "Kl\u00e4mbt", "year": "2015", "journal-title": "J Immunol."}, {"key": "B10", "doi-asserted-by": "publisher", "first-page": "1858", "DOI": "10.1182/blood-2017-10-812891", "article-title": "Neutrophils provide cellular communication between ileum and mesenteric lymph nodes at graft-versus-host disease onset", "volume": "131", "author": "Hulsdunker", "year": "2018", "journal-title": "Blood"}, {"key": "B11", "doi-asserted-by": "publisher", "first-page": "577", "DOI": "10.2307/3573066", "article-title": "Mortality and gross pathology of secondary disease in germfree mouse radiation chimeras", "volume": "45", "author": "Jones", "year": "1971", "journal-title": "Radiat Res."}, {"key": "B12", "doi-asserted-by": "publisher", "first-page": "787", "DOI": "10.1093/jnci/58.3.787", "article-title": "Role of bacterial microflora in development of intestinal lesions from graft-versus-host reaction", "volume": "58", "author": "van Bekkum", "year": "1977", "journal-title": "J Natl Cancer Inst."}, {"key": "B13", "doi-asserted-by": "publisher", "first-page": "401", "DOI": "10.1093/jnci/52.2.401", "article-title": "Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora", "volume": "52", "author": "van Bekkum", "year": "1974", "journal-title": "J Natl Cancer Inst."}, {"key": "B14", "doi-asserted-by": "publisher", "first-page": "893", "DOI": "10.7326/0003-4819-89-6-893", "article-title": "Protective environment for marrow transplant recipients: a prospective study", "volume": "89", "author": "Buckner", "year": "1978", "journal-title": "Ann Intern Med."}, {"key": "B15", "doi-asserted-by": "publisher", "first-page": "586", "DOI": "10.1017/S0195941700065437", "article-title": "Prevention of nosocomial infections in marrow transplant patients: a prospective randomized comparison of systemic antibiotics versus granulocyte transfusions", "volume": "7", "author": "Petersen", "year": "1986", "journal-title": "Infect Control"}, {"key": "B16", "doi-asserted-by": "publisher", "first-page": "115", "DOI": "10.1007/BF01643474", "article-title": "Laminar air flow isolation and decontamination: a prospective randomized study of the effects of prophylactic systemic antibiotics in bone marrow transplant patients", "volume": "14", "author": "Petersen", "year": "1986", "journal-title": "Infection"}, {"key": "B17", "doi-asserted-by": "publisher", "first-page": "302", "DOI": "10.1056/NEJM198302103080602", "article-title": "Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings", "volume": "308", "author": "Storb", "year": "1983", "journal-title": "N Engl j med."}, {"key": "B18", "doi-asserted-by": "publisher", "first-page": "19", "DOI": "10.1007/BF01646924", "article-title": "Antimicrobial prophylaxis in neutropenic patients after bone marrow transplantation", "volume": "16", "author": "Schmeiser", "year": "1988", "journal-title": "Infection"}, {"key": "B19", "doi-asserted-by": "crossref", "first-page": "2668", "DOI": "10.1182/blood.V80.10.2668.2668", "article-title": "Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation", "volume": "80", "author": "Beelen", "year": "1992", "journal-title": "Blood"}, {"key": "B20", "doi-asserted-by": "publisher", "first-page": "339ra71", "DOI": "10.1126/scitranslmed.aaf2311", "article-title": "Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice", "volume": "8", "author": "Shono", "year": "2016", "journal-title": "Sci transl med."}, {"key": "B21", "author": "Weber", "year": "2018", "article-title": "Detrimental effect of broad-spectrum antibiotics on intestinal microbiome diversity in patients after allogeneic stem cell transplantation: lack of commensal sparing antibiotics", "journal-title": "Clin Infect Dis.", "DOI": "10.1093/cid/ciy711", "doi-asserted-by": "publisher"}, {"key": "B22", "doi-asserted-by": "publisher", "first-page": "1635", "DOI": "10.1126/science.1110591", "article-title": "Diversity of the human intestinal microbial flora", "volume": "308", "author": "Eckburg", "year": "2005", "journal-title": "Science"}, {"key": "B23", "doi-asserted-by": "publisher", "first-page": "1915", "DOI": "10.1126/science.1104816", "article-title": "Host-bacterial mutualism in the human intestine", "volume": "307", "author": "Backhed", "year": "2005", "journal-title": "Science"}, {"key": "B24", "doi-asserted-by": "publisher", "first-page": "640", "DOI": "10.1016/j.bbmt.2014.01.030", "article-title": "Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease", "volume": "20", "author": "Holler", "year": "2014", "journal-title": "Biol blood marrow transplant."}, {"key": "B25", "doi-asserted-by": "publisher", "first-page": "1174", "DOI": "10.1182/blood-2014-02-554725", "article-title": "The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation", "volume": "124", "author": "Taur", "year": "2014", "journal-title": "Blood"}, {"key": "B26", "doi-asserted-by": "crossref", "first-page": "1953", "DOI": "10.1182/blood.V126.23.1953.1953", "article-title": "Gut microbiome changes after stem cell transplantation", "volume": "126", "author": "Chiusolo", "year": "2015", "journal-title": "Blood"}, {"key": "B27", "doi-asserted-by": "publisher", "first-page": "1079", "DOI": "10.1136/gut.2009.197434", "article-title": "MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease", "volume": "59", "author": "Heimesaat", "year": "2010", "journal-title": "Gut"}, {"key": "B28", "doi-asserted-by": "publisher", "first-page": "S40", "DOI": "10.1016/j.bbmt.2017.12.594", "article-title": "Domination of the gut microbiota with Enterococcus species early after allogeneic bone marrow transplantation is an important contributor to the development of acute graft-versus-host disease (GHVD) in mouse and man", "volume": "24", "author": "Stein-Thoeringer", "year": "2018", "journal-title": "Biol Blood Marrow Transplant."}, {"key": "B29", "doi-asserted-by": "publisher", "first-page": "903", "DOI": "10.1084/jem.20112408", "article-title": "Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation", "volume": "209", "author": "Jenq", "year": "2012", "journal-title": "J exp med."}, {"key": "B30", "doi-asserted-by": "publisher", "first-page": "4365", "DOI": "10.1182/blood-2003-11-3769", "article-title": "Probiotic effects on experimental graft-versus-host disease: let them eat yogurt", "volume": "103", "author": "Gerbitz", "year": "2004", "journal-title": "Blood"}, {"key": "B31", "doi-asserted-by": "publisher", "first-page": "e12947", "DOI": "10.1111/ctr.12947", "article-title": "Lactobacillus rhamnosus GG probiotic enteric regimen does not appreciably alter the gut microbiome or provide protection against GVHD after allogeneic hematopoietic stem cell transplantation", "volume": "31", "author": "Gorshein", "year": "2017", "journal-title": "Clin transplant."}, {"key": "B32", "doi-asserted-by": "publisher", "first-page": "262", "DOI": "10.1038/bmt.2015.275", "article-title": "The safety and feasibility of probiotics in children and adolescents undergoing hematopoietic cell transplantation", "volume": "51", "author": "Ladas", "year": "2016", "journal-title": "Bone marrow transplant."}, {"key": "B33", "doi-asserted-by": "publisher", "first-page": "1373", "DOI": "10.1016/j.bbmt.2015.04.016", "article-title": "Intestinal blautia is associated with reduced death from graft-versus-host disease", "volume": "21", "author": "Jenq", "year": "2015", "journal-title": "Biol blood marrow transpl."}, {"key": "B34", "doi-asserted-by": "publisher", "first-page": "505", "DOI": "10.1038/ni.3400", "article-title": "Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease", "volume": "17", "author": "Mathewson", "year": "2016", "journal-title": "Nat immunol."}, {"key": "B35", "doi-asserted-by": "publisher", "first-page": "820", "DOI": "10.1016/j.bbmt.2017.02.004", "article-title": "Antibiotic-induced depletion of anti-inflammatory clostridia is associated with the development of graft-versus-host disease in pediatric stem cell transplantation patients", "volume": "23", "author": "Simms-Waldrip", "year": "2017", "journal-title": "Biol blood marrow transplant."}, {"key": "B36", "doi-asserted-by": "publisher", "first-page": "965", "DOI": "10.1128/IAI.01197-12", "article-title": "Intestinal microbiota containing barnesiella species cures vancomycin-resistant enterococcus faecium colonization", "volume": "81", "author": "Ubeda", "year": "2013", "journal-title": "Infect Immun."}, {"key": "B37", "doi-asserted-by": "publisher", "first-page": "1322", "DOI": "10.1016/j.bbmt.2018.02.009", "article-title": "The microbiome and hematopoietic cell transplantation: past, present, and future", "volume": "24", "author": "Andermann", "year": "2018", "journal-title": "Biol blood marrow transplant."}, {"key": "B38", "doi-asserted-by": "publisher", "first-page": "283", "DOI": "10.1038/nrc.2018.10", "article-title": "Gut microbiota injury in allogeneic haematopoietic stem cell transplantation", "volume": "18", "author": "Shono", "year": "2018", "journal-title": "Nat rev Cancer"}, {"key": "B39", "doi-asserted-by": "publisher", "first-page": "905", "DOI": "10.1093/cid/cis580", "article-title": "Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation", "volume": "55", "author": "Taur", "year": "2012", "journal-title": "Clin Infect Dis."}, {"key": "B40", "doi-asserted-by": "publisher", "first-page": "2178", "DOI": "10.1016/j.bbmt.2018.06.031", "article-title": "Impact of the use and type of antibiotics on acute graft-versus-host disease", "volume": "24", "author": "Nishi", "year": "2018", "journal-title": "Biol blood marrow transplant."}, {"key": "B41", "doi-asserted-by": "publisher", "first-page": "254", "DOI": "10.4161/gmic.1.4.12778", "article-title": "Mucin-bacterial interactions in the human oral cavity and digestive tract", "volume": "1", "author": "Derrien", "year": "2010", "journal-title": "Gut Microbes"}, {"key": "B42", "doi-asserted-by": "publisher", "first-page": "166", "DOI": "10.3389/fmicb.2011.00166", "article-title": "Modulation of mucosal immune response, tolerance, and proliferation in mice colonized by the mucin-degrader akkermansia muciniphila", "volume": "2", "author": "Derrien", "year": "2011", "journal-title": "Front Microbiol."}, {"key": "B43", "doi-asserted-by": "publisher", "first-page": "229", "DOI": "10.1177/1756283X15607414", "article-title": "Fecal microbiota transplantation: in perspective", "volume": "9", "author": "Gupta", "year": "2016", "journal-title": "Therap Adv Gastroenterol."}, {"key": "B44", "doi-asserted-by": "publisher", "first-page": "2195", "DOI": "10.3389/fimmu.2018.02195", "article-title": "Treating steroid refractory intestinal acute graft-vs.-host disease with fecal microbiota transplantation: a pilot study", "volume": "9", "author": "Qi", "year": "2018", "journal-title": "Front immunol."}, {"key": "B45", "doi-asserted-by": "publisher", "first-page": "745", "DOI": "10.1182/bloodadvances.2018017731", "article-title": "Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity", "volume": "2", "author": "DeFilipp", "year": "2018", "journal-title": "Blood Adv."}, {"key": "B46", "doi-asserted-by": "publisher", "first-page": "629", "DOI": "10.1016/j.cell.2011.09.025", "article-title": "Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation", "volume": "147", "author": "Li", "year": "2011", "journal-title": "Cell"}, {"key": "B47", "doi-asserted-by": "publisher", "first-page": "372", "DOI": "10.1016/j.immuni.2013.08.003", "article-title": "Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22", "volume": "39", "author": "Zelante", "year": "2013", "journal-title": "Immunity"}, {"key": "B48", "doi-asserted-by": "publisher", "first-page": "2506", "DOI": "10.1182/blood-2018-03-838193", "article-title": "Indoles derived from intestinal microbiota act via type i interferon signaling to limit graft-versus-host-disease", "volume": "32", "author": "Swimm", "year": "2018", "journal-title": "Blood"}, {"key": "B49", "doi-asserted-by": "publisher", "first-page": "517", "DOI": "10.1016/j.cmet.2011.02.018", "article-title": "The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon", "volume": "13", "author": "Donohoe", "year": "2011", "journal-title": "Cell Metab."}, {"key": "B50", "doi-asserted-by": "publisher", "first-page": "3674", "DOI": "10.1038/s41467-018-06048-w", "article-title": "Microbial metabolite sensor GPR43 controls severity of experimental GVHD", "volume": "9", "author": "Fujiwara", "year": "2018", "journal-title": "Nat commun."}, {"key": "B51", "doi-asserted-by": "publisher", "first-page": "1442", "DOI": "10.1136/gut.52.10.1442", "article-title": "Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts", "volume": "52", "author": "Willemsen", "year": "2003", "journal-title": "Gut"}, {"key": "B52", "first-page": "53.17", "article-title": "Microbiota metabolites SCFA promote intestinal epithelial repair and wound healing through promoting epithelial cell production of milk fat globule-EGF factor 8", "volume": "200", "author": "Bilotta", "year": "2018", "journal-title": "J Immunol."}, {"key": "B53", "doi-asserted-by": "publisher", "first-page": "543", "DOI": "10.1038/nature09646", "article-title": "Bifidobacteria can protect from enteropathogenic infection through production of acetate", "volume": "469", "author": "Fukuda", "year": "2011", "journal-title": "Nature"}, {"key": "B54", "doi-asserted-by": "publisher", "first-page": "3920", "DOI": "10.1073/pnas.0509592103", "article-title": "Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor", "volume": "103", "author": "Inagaki", "year": "2006", "journal-title": "Proc Natl Acad Sci USA."}, {"key": "B55", "doi-asserted-by": "publisher", "first-page": "C801", "DOI": "10.1152/ajpcell.00620.2008", "article-title": "Polyamines regulate E-cadherin transcription through c-Myc modulating intestinal epithelial barrier function", "volume": "296", "author": "Liu", "year": "2009", "journal-title": "Am J Physiol Cell Physiol."}, {"key": "B56", "doi-asserted-by": "publisher", "first-page": "1919", "DOI": "10.1172/JCI91646", "article-title": "Recipient mucosal-associated invariant T cells control GVHD within the colon", "volume": "128", "author": "Varelias", "year": "2018", "journal-title": "J clin invest."}, {"key": "B57", "doi-asserted-by": "publisher", "first-page": "228", "DOI": "10.1073/pnas.0906112107", "article-title": "The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation", "volume": "107", "author": "Bansal", "year": "2010", "journal-title": "Proc Natl Acad Sci USA."}, {"key": "B58", "doi-asserted-by": "publisher", "first-page": "144", "DOI": "10.1038/ni.2187", "article-title": "AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of notch", "volume": "13", "author": "Lee", "year": "2011", "journal-title": "Nat immunol."}, {"key": "B59", "doi-asserted-by": "publisher", "first-page": "92", "DOI": "10.1016/j.immuni.2011.11.011", "article-title": "The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells", "volume": "36", "author": "Qiu", "year": "2012", "journal-title": "Immunity"}, {"key": "B60", "doi-asserted-by": "publisher", "first-page": "1561", "DOI": "10.1126/science.1214914", "article-title": "Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles", "volume": "334", "author": "Kiss", "year": "2011", "journal-title": "Science"}, {"key": "B61", "doi-asserted-by": "publisher", "first-page": "2978", "DOI": "10.1182/blood-2018-01-828996", "article-title": "Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT", "volume": "131", "author": "Haak", "year": "2018", "journal-title": "Blood"}, {"key": "B62", "doi-asserted-by": "publisher", "first-page": "33", "DOI": "10.1186/s40168-016-0178-x", "article-title": "Variable responses of human microbiomes to dietary supplementation with resistant starch", "volume": "4", "author": "Venkataraman", "year": "2016", "journal-title": "Microbiome"}, {"key": "B63", "doi-asserted-by": "publisher", "first-page": "1899", "DOI": "10.1084/jem.20130084", "article-title": "The Nlrp3 inflammasome regulates acute graft-versus-host disease", "volume": "210", "author": "Jankovic", "year": "2013", "journal-title": "J exp med."}, {"key": "B64", "doi-asserted-by": "publisher", "first-page": "488", "DOI": "10.1016/j.immuni.2015.06.024", "article-title": "Growth factor FGF2 cooperates with interleukin-17 to repair intestinal epithelial damage", "volume": "43", "author": "Song", "year": "2015", "journal-title": "Immunity"}, {"key": "B65", "doi-asserted-by": "publisher", "first-page": "727", "DOI": "10.1016/j.immuni.2015.09.003", "article-title": "Interleukin-23-independent IL-17 production regulates intestinal epithelial permeability", "volume": "43", "author": "Lee", "year": "2015", "journal-title": "Immunity"}, {"key": "B66", "doi-asserted-by": "publisher", "first-page": "285", "DOI": "10.1084/jem.20101559", "article-title": "The Wnt agonist R-spondin1 regulates systemic graft-versus-host disease by protecting intestinal stem cells", "volume": "208", "author": "Takashima", "year": "2011", "journal-title": "J exp med."}, {"key": "B67", "doi-asserted-by": "publisher", "first-page": "3507", "DOI": "10.1084/jem.20170418", "article-title": "R-spondin1 expands paneth cells and prevents dysbiosis induced by graft-versus-host disease", "volume": "214", "author": "Hayase", "year": "2017", "journal-title": "J exp med."}, {"key": "B68", "doi-asserted-by": "publisher", "first-page": "223", "DOI": "10.1182/blood-2011-12-401166", "article-title": "Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting paneth cell production of alpha-defensins", "volume": "120", "author": "Eriguchi", "year": "2012", "journal-title": "Blood"}, {"key": "B69", "doi-asserted-by": "publisher", "first-page": "1505", "DOI": "10.1182/blood-2013-02-485813", "article-title": "Low paneth cell numbers at onset of gastrointestinal graft-versus-host disease identify patients at high risk for nonrelapse mortality", "volume": "122", "author": "Levine", "year": "2013", "journal-title": "Blood"}, {"key": "B70", "doi-asserted-by": "publisher", "first-page": "1373", "DOI": "10.1038/jid.2009.399", "article-title": "Circulating Th17, Th22, and Th1 cells are increased in psoriasis", "volume": "130", "author": "Kagami", "year": "2010", "journal-title": "J invest dermatol."}, {"key": "B71", "doi-asserted-by": "publisher", "first-page": "1015", "DOI": "10.1002/art.33446", "article-title": "Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts", "volume": "64", "author": "Kim", "year": "2012", "journal-title": "Arthritis rheum."}, {"key": "B72", "doi-asserted-by": "publisher", "first-page": "534", "DOI": "10.1172/JCI33194", "article-title": "IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis", "volume": "118", "author": "Sugimoto", "year": "2008", "journal-title": "J clin invest."}, {"key": "B73", "doi-asserted-by": "publisher", "first-page": "947", "DOI": "10.1016/j.immuni.2008.11.003", "article-title": "Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease", "volume": "29", "author": "Zenewicz", "year": "2008", "journal-title": "Immunity"}, {"key": "B74", "doi-asserted-by": "publisher", "first-page": "1605341", "DOI": "10.1155/2018/1605341", "article-title": "Anti-IL-22 antibody attenuates acute graft-versus-host disease via increasing Foxp3(+) T cell through modulation of CD11b(+) cell function", "volume": "2018", "author": "Wu", "year": "2018", "journal-title": "J Immunol Res."}, {"key": "B75", "doi-asserted-by": "publisher", "first-page": "810", "DOI": "10.1111/ajt.14513", "article-title": "A critical role for donor-derived IL-22 in cutaneous chronic GVHD", "volume": "18", "author": "Gartlan", "year": "2018", "journal-title": "Am J Transplant."}, {"key": "B76", "doi-asserted-by": "publisher", "first-page": "339", "DOI": "10.1016/j.immuni.2012.05.028", "article-title": "Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease", "volume": "37", "author": "Hanash", "year": "2012", "journal-title": "Immunity"}, {"key": "B77", "doi-asserted-by": "publisher", "first-page": "560", "DOI": "10.1038/nature16460", "article-title": "Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration", "volume": "528", "author": "Lindemans", "year": "2015", "journal-title": "Nature"}, {"key": "B78", "doi-asserted-by": "publisher", "first-page": "4970", "DOI": "10.1172/JCI99261", "article-title": "Survival signal REG3alpha prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease", "volume": "28", "author": "Zhao", "year": "2018", "journal-title": "J clin invest."}, {"key": "B79", "doi-asserted-by": "publisher", "first-page": "6702", "DOI": "10.1182/blood-2011-08-375006", "article-title": "Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease", "volume": "118", "author": "Ferrara", "year": "2011", "journal-title": "Blood"}, {"key": "B80", "doi-asserted-by": "publisher", "first-page": "282", "DOI": "10.1038/nm1720", "article-title": "Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens", "volume": "14", "author": "Zheng", "year": "2008", "journal-title": "Nat med."}, {"key": "B81", "doi-asserted-by": "publisher", "first-page": "83", "DOI": "10.1038/ni.1684", "article-title": "RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells", "volume": "10", "author": "Sanos", "year": "2009", "journal-title": "Nat immunol."}, {"key": "B82", "doi-asserted-by": "publisher", "first-page": "887", "DOI": "10.1111/bjh.15492", "article-title": "Recipient single nucleotide polymorphisms in paneth cell antimicrobial peptide genes and acute graft-versus-host disease: analysis of BMT CTN-0201 and\u22120901 samples", "volume": "182", "author": "Rashidi", "year": "2018", "journal-title": "Br j haematol."}, {"key": "B83", "doi-asserted-by": "publisher", "first-page": "1764", "DOI": "10.1172/JCI117524", "article-title": "Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract", "volume": "94", "author": "Housley", "year": "1994", "journal-title": "J clin invest."}, {"key": "B84", "doi-asserted-by": "publisher", "first-page": "248", "DOI": "10.2307/3579609", "article-title": "Enhancement of murine intestinal stem cell survival after irradiation by keratinocyte growth factor", "volume": "148", "author": "Khan", "year": "1997", "journal-title": "Radiat Res."}, {"key": "B85", "doi-asserted-by": "crossref", "first-page": "3960", "DOI": "10.1182/blood.V92.10.3960", "article-title": "Keratinocyte growth factor administered before conditioning ameliorates graft-versus-host disease after allogeneic bone marrow transplantation in mice", "volume": "92", "author": "Panoskaltsis-Mortari", "year": "1998", "journal-title": "Blood"}, {"key": "B86", "doi-asserted-by": "crossref", "first-page": "825", "DOI": "10.1182/blood.V94.2.825", "article-title": "Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease", "volume": "94", "author": "Krijanovski", "year": "1999", "journal-title": "Blood"}, {"key": "B87", "doi-asserted-by": "publisher", "first-page": "3216", "DOI": "10.1182/blood-2006-04-017780", "article-title": "Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT)", "volume": "108", "author": "Blazar", "year": "2006", "journal-title": "Blood"}, {"key": "B88", "doi-asserted-by": "publisher", "first-page": "1350", "DOI": "10.1038/bmt.2011.261", "article-title": "Palifermin for the reduction of acute GVHD: a randomized, double-blind, placebo-controlled trial", "volume": "47", "author": "Jagasia", "year": "2012", "journal-title": "Bone marrow transplant."}, {"key": "B89", "doi-asserted-by": "publisher", "first-page": "299", "DOI": "10.5114/wo.2017.72400", "article-title": "Efficacy of palifermin on oral mucositis and acute GVHD after hematopoietic stem cell transplantation (HSCT) in hematology malignancy patients: a meta-analysis of trials", "volume": "21", "author": "Mozaffari", "year": "2017", "journal-title": "Contemp Oncol."}], "container-title": ["Frontiers in Immunology"], "link": [{"URL": "https://www.frontiersin.org/article/10.3389/fimmu.2018.03179/full", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 14]], "date-time": "2019-11-14T15:39:36Z", "timestamp": 1573745976000}, "score": 18.157581, "issued": {"date-parts": [[2019, 1, 17]]}, "references-count": 89, "alternative-id": ["10.3389/fimmu.2018.03179"], "URL": "http://dx.doi.org/10.3389/fimmu.2018.03179", "relation": {"cites": []}, "ISSN": ["1664-3224"], "issn-type": [{"value": "1664-3224", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T03:00:55Z", "timestamp": 1575428455684}, "reference-count": 43, "publisher": "Oxford University Press (OUP)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Inflammatory Bowel Diseases"], "published-print": {"date-parts": [[2014, 3]]}, "DOI": "10.1097/01.mib.0000437984.92565.31", "type": "journal-article", "created": {"date-parts": [[2014, 1, 20]], "date-time": "2014-01-20T11:06:29Z", "timestamp": 1390215989000}, "page": "576-586", "source": "Crossref", "is-referenced-by-count": 65, "title": ["Fiber in the Treatment and Maintenance of Inflammatory Bowel Disease"], "prefix": "10.1093", "volume": "20", "author": [{"given": "Linda", "family": "Wedlake", "sequence": "first", "affiliation": []}, {"given": "Natalie", "family": "Slack", "sequence": "additional", "affiliation": []}, {"given": "H. Jervoise N.", "family": "Andreyev", "sequence": "additional", "affiliation": []}, {"given": "Kevin", "family": "Whelan", "sequence": "additional", "affiliation": []}], "member": "286", "reference": [{"key": "R1-19-20140212", "author": "Loftus", "volume": "126", "first-page": "1504", "year": "2004", "journal-title": "Gastroenterology", "DOI": "10.1053/j.gastro.2004.01.063", "doi-asserted-by": "crossref"}, {"key": "R2-19-20140212", "author": "Bernklev", "volume": "11", "first-page": "909", "year": "2005", "journal-title": "Inflamm Bowel Dis", "DOI": "10.1097/01.mib.0000179467.01748.99", "doi-asserted-by": "crossref"}, {"key": "R3-19-20140212", "author": "Gerasimidis", "volume": "24", "first-page": "313", "year": "2011", "journal-title": "J Hum Nutr Diet", "DOI": "10.1111/j.1365-277X.2011.01171.x", "doi-asserted-by": "crossref"}, {"key": "R4-19-20140212", "author": "Abraham", "volume": "140", "first-page": "1729", "year": "2011", "journal-title": "Gastroenterology", "DOI": "10.1053/j.gastro.2011.02.012", "doi-asserted-by": "crossref"}, {"key": "R5-19-20140212", "author": "Talley", "volume": "106", "first-page": "S2", "year": "2011", "journal-title": "Am J Gastroenterol", "DOI": "10.1038/ajg.2011.58", "doi-asserted-by": "crossref"}, {"key": "R7-19-20140212", "author": "Davies", "volume": "1", "first-page": "1524", "year": "1978", "journal-title": "Br Med J", "DOI": "10.1136/bmj.1.6126.1524", "doi-asserted-by": "crossref"}, {"key": "R8-19-20140212", "author": "Eswaran", "volume": "108", "first-page": "718", "year": "2013", "journal-title": "Am J Gastroenterol", "DOI": "10.1038/ajg.2013.63", "doi-asserted-by": "crossref"}, {"key": "R9-19-20140212", "author": "Gassull", "volume": "24", "first-page": "90", "year": "2006", "journal-title": "Aliment Pharmacol Ther", "DOI": "10.1111/j.1365-2036.2006.03067.x", "doi-asserted-by": "crossref"}, {"key": "R10-19-20140212", "author": "Woolner", "volume": "11", "first-page": "1", "year": "1998", "journal-title": "J Hum Nutr Diet", "DOI": "10.1046/j.1365-277X.1998.00075.x", "doi-asserted-by": "crossref"}, {"key": "R11-19-20140212", "author": "Heaton", "volume": "2", "first-page": "764", "year": "1979", "journal-title": "Br Med J", "DOI": "10.1136/bmj.2.6193.764", "doi-asserted-by": "crossref"}, {"key": "R13-19-20140212", "author": "Liberati", "volume": "151", "first-page": "W65", "year": "2009", "journal-title": "Ann Intern Med", "DOI": "10.7326/0003-4819-151-4-200908180-00136", "doi-asserted-by": "crossref"}, {"key": "R14-19-20140212", "author": "Moher", "volume": "88", "first-page": "1191", "year": "2008", "journal-title": "Am J Clin Nutr"}, {"key": "R16-19-20140212", "author": "Cummings", "volume": "373", "first-page": "365", "year": "2009", "journal-title": "Lancet", "DOI": "10.1016/S0140-6736(09)60117-3", "doi-asserted-by": "crossref"}, {"key": "R17-19-20140212", "author": "Mann", "volume": "19", "first-page": "226", "year": "2009", "journal-title": "Nutr Metab Cardiovasc Dis", "DOI": "10.1016/j.numecd.2009.02.002", "doi-asserted-by": "crossref"}, {"key": "R18-19-20140212", "author": "Jadad", "volume": "17", "first-page": "1", "year": "1996", "journal-title": "Assessing the quality of reports of randomised clinical trials: is blinding necessary Control Clin Trials"}, {"key": "R19-19-20140212", "author": "Fernandez-Banares", "volume": "94", "first-page": "427", "year": "1999", "journal-title": "Am J Gastroenterol", "DOI": "10.1111/j.1572-0241.1999.872_a.x", "doi-asserted-by": "crossref"}, {"key": "R20-19-20140212", "author": "Hallert", "volume": "26", "first-page": "747", "year": "1991", "journal-title": "Scand J Gastroenterol", "DOI": "10.3109/00365529108998594", "doi-asserted-by": "crossref"}, {"key": "R21-19-20140212", "author": "Copaci", "volume": "32", "first-page": "A2", "year": "2000", "journal-title": "Dig Liver Dis"}, {"key": "R22-19-20140212", "author": "Faghfoori", "volume": "48", "first-page": "233", "year": "2011", "journal-title": "Ann Clin Biochem", "DOI": "10.1258/acb.2010.010093", "doi-asserted-by": "crossref"}, {"key": "R23-19-20140212", "author": "Federico", "volume": "13", "first-page": "285", "year": "2009", "journal-title": "Eur Rev Med Pharmacol Sci"}, {"key": "R24-19-20140212", "author": "Furrie", "volume": "54", "first-page": "242", "year": "2005", "journal-title": "Gut", "DOI": "10.1136/gut.2004.044834", "doi-asserted-by": "crossref"}, {"key": "R25-19-20140212", "author": "Casellas", "volume": "25", "first-page": "1061", "year": "2007", "journal-title": "Aliment Pharmacol Ther", "DOI": "10.1111/j.1365-2036.2007.03288.x", "doi-asserted-by": "crossref"}, {"key": "R26-19-20140212", "author": "Kanauchi", "volume": "37", "first-page": "67", "year": "2002", "journal-title": "J Gastroenterol", "DOI": "10.1007/BF03326417", "doi-asserted-by": "crossref"}, {"key": "R27-19-20140212", "author": "Ishikawa", "volume": "84", "first-page": "128", "year": "2011", "journal-title": "Digestion", "DOI": "10.1159/000322977", "doi-asserted-by": "crossref"}, {"key": "R28-19-20140212", "author": "Fujimori", "volume": "25", "first-page": "520", "year": "2009", "journal-title": "Nutrition", "DOI": "10.1016/j.nut.2008.11.017", "doi-asserted-by": "crossref"}, {"key": "R29-19-20140212", "author": "Chermesh", "volume": "52", "first-page": "385", "year": "2007", "journal-title": "Dig Dis Sci", "DOI": "10.1007/s10620-006-9549-7", "doi-asserted-by": "crossref"}, {"key": "R30-19-20140212", "author": "Rutgeerts", "volume": "126", "first-page": "A467", "year": "2004", "journal-title": "Gastroenterology"}, {"key": "R31-19-20140212", "author": "Jones", "volume": "2", "first-page": "177", "year": "1985", "journal-title": "Lancet", "DOI": "10.1016/S0140-6736(85)91497-7", "doi-asserted-by": "crossref"}, {"key": "R32-19-20140212", "author": "Ritchie", "volume": "295", "first-page": "517", "year": "1987", "journal-title": "Br Med J (Clin Res Ed)", "DOI": "10.1136/bmj.295.6597.517", "doi-asserted-by": "crossref"}, {"key": "R33-19-20140212", "author": "Steed", "volume": "32", "first-page": "872", "year": "2010", "journal-title": "Aliment Pharmacol Ther", "DOI": "10.1111/j.1365-2036.2010.04417.x", "doi-asserted-by": "crossref"}, {"key": "R34-19-20140212", "author": "Benjamin", "volume": "60", "first-page": "923", "year": "2011", "journal-title": "Gut", "DOI": "10.1136/gut.2010.232025", "doi-asserted-by": "crossref"}, {"key": "R35-19-20140212", "author": "Koch", "volume": "34", "first-page": "4545", "year": "1984", "journal-title": "Therapiewoche"}, {"key": "R36-19-20140212", "author": "Bartel", "volume": "14", "first-page": "374", "year": "2008", "journal-title": "Inflamm Bowel Dis", "DOI": "10.1002/ibd.20295", "doi-asserted-by": "crossref"}, {"key": "R37-19-20140212", "author": "Brotherton", "volume": "26", "first-page": "1b338", "year": "2012", "journal-title": ""}, {"key": "R38-19-20140212", "author": "Joossens", "volume": "61", "first-page": "958", "year": "2012", "journal-title": "Gut", "DOI": "10.1136/gutjnl-2011-300413", "doi-asserted-by": "crossref"}, {"key": "R39-19-20140212", "author": "Levenstein", "volume": "26", "first-page": "989", "year": "1985", "journal-title": "Gut", "DOI": "10.1136/gut.26.10.989", "doi-asserted-by": "crossref"}, {"key": "R40-19-20140212", "author": "Stange", "volume": "28", "first-page": "561", "year": "1990", "journal-title": "Z Gastroenterol"}, {"key": "R41-19-20140212", "author": "Welters", "volume": "45", "first-page": "621", "year": "2002", "journal-title": "Dis Colon Rectum", "DOI": "10.1007/s10350-004-6257-2", "doi-asserted-by": "crossref"}, {"key": "R42-19-20140212", "author": "Sears", "volume": "22", "first-page": "349", "year": "2009", "journal-title": "Clin Microbiol Rev", "DOI": "10.1128/CMR.00053-08", "doi-asserted-by": "crossref"}, {"key": "R43-19-20140212", "author": "Freeman", "volume": "21", "first-page": "363", "year": "2007", "journal-title": "Can J Gastroenterol", "DOI": "10.1155/2007/951526", "doi-asserted-by": "crossref"}, {"key": "R44-19-20140212", "author": "Hallert", "volume": "9", "first-page": "116", "year": "2003", "journal-title": "Inflamm Bowel Dis", "DOI": "10.1097/00054725-200303000-00005", "doi-asserted-by": "crossref"}, {"key": "R45-19-20140212", "author": "Hanai", "volume": "13", "first-page": "643", "year": "2004", "journal-title": "Int J Mol Med"}, {"key": "R46-19-20140212", "author": "Van Loo", "volume": "20", "first-page": "A989", "year": "2006", "journal-title": "FASEB J"}], "container-title": ["Inflammatory Bowel Diseases"], "language": "en", "deposited": {"date-parts": [[2018, 3, 22]], "date-time": "2018-03-22T10:00:00Z", "timestamp": 1521712800000}, "score": 18.070198, "subtitle": ["A Systematic Review of Randomized Controlled Trials"], "issued": {"date-parts": [[2014, 3]]}, "references-count": 43, "journal-issue": {"issue": "3"}, "URL": "http://dx.doi.org/10.1097/01.mib.0000437984.92565.31", "relation": {"cites": []}, "ISSN": ["1078-0998"], "issn-type": [{"value": "1078-0998", "type": "print"}], "subject": ["Immunology and Allergy", "Gastroenterology"]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T13:29:56Z", "timestamp": 1574861396263}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "7", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1999, 7, 1]], "date-time": "1999-07-01T00:00:00Z", "timestamp": 930787200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Nat Biotechnol"], "published-print": {"date-parts": [[1999, 7]]}, "DOI": "10.1038/10825", "type": "journal-article", "created": {"date-parts": [[2017, 11, 21]], "date-time": "2017-11-21T19:21:24Z", "timestamp": 1511292084000}, "page": "626-626", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Anti-inflammatory antibodies"], "prefix": "10.1038", "volume": "17", "author": [{"given": "Natalie", "family": "DeWitt", "sequence": "first", "affiliation": []}], "member": "297", "container-title": ["Nature Biotechnology"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/nbt0799_626g.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/nbt0799_626g", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/nbt0799_626g.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 19]], "date-time": "2019-03-19T16:36:28Z", "timestamp": 1553013388000}, "score": 17.870403, "issued": {"date-parts": [[1999, 7]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1999, 7]]}, "issue": "7"}, "alternative-id": ["BFnbt0799_626g"], "URL": "http://dx.doi.org/10.1038/10825", "ISSN": ["1087-0156", "1546-1696"], "issn-type": [{"value": "1087-0156", "type": "print"}, {"value": "1546-1696", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T23:54:48Z", "timestamp": 1574294088098}, "reference-count": 0, "publisher": "BMJ", "issue": "6039", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["BMJ"], "published-print": {"date-parts": [[1976, 10, 2]]}, "DOI": "10.1136/bmj.2.6039.796", "type": "journal-article", "created": {"date-parts": [[2009, 4, 2]], "date-time": "2009-04-02T22:32:30Z", "timestamp": 1238711550000}, "page": "796-796", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Inflammatory bowel disease in West Indians."], "prefix": "10.1136", "volume": "2", "author": [{"given": "D P", "family": "O'Donoghue", "sequence": "first", "affiliation": []}, {"given": "M L", "family": "Clark", "sequence": "additional", "affiliation": []}], "member": "239", "container-title": ["BMJ"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1136/bmj.2.6039.796", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 24]], "date-time": "2016-12-24T04:27:10Z", "timestamp": 1482553630000}, "score": 17.78936, "issued": {"date-parts": [[1976, 10, 2]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1976, 10, 2]]}, "issue": "6039"}, "URL": "http://dx.doi.org/10.1136/bmj.2.6039.796", "ISSN": ["0959-8138", "1468-5833"], "issn-type": [{"value": "0959-8138", "type": "print"}, {"value": "1468-5833", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T12:08:02Z", "timestamp": 1574856482067}, "publisher-location": "Cham", "reference-count": 46, "publisher": "Springer International Publishing", "isbn-type": [{"value": "9783319602752", "type": "print"}, {"value": "9783319602769", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2017, 8, 3]], "date-time": "2017-08-03T00:00:00Z", "timestamp": 1501718400000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2018]]}, "DOI": "10.1007/978-3-319-60276-9_2", "type": "book-chapter", "created": {"date-parts": [[2017, 11, 9]], "date-time": "2017-11-09T12:26:37Z", "timestamp": 1510230397000}, "page": "13-32", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Antitumor Necrosis Factor Agents in Ulcerative Colitis"], "prefix": "10.1007", "author": [{"given": "Kindra", "family": "Clark-Snustad", "sequence": "first", "affiliation": []}, {"given": "Ives", "family": "Hot", "sequence": "additional", "affiliation": []}, {"given": "Scott", "family": "Lee", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2017, 8, 3]]}, "reference": [{"issue": "5", "key": "2_CR1", "doi-asserted-by": "crossref", "first-page": "1444", "DOI": "10.1016/0016-5085(92)91163-X", "volume": "103", "author": "E Langholz", "year": "1992", "unstructured": "Langholz E, Munkholm P, Davidsen M, Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology. 1992;103(5):1444\u201351.", "journal-title": "Gastroenterology"}, {"issue": "4", "key": "2_CR2", "doi-asserted-by": "crossref", "first-page": "431", "DOI": "10.1080/00365520802600961", "volume": "44", "author": "IC Solberg", "year": "2009", "unstructured": "Solberg IC, Lygren I, Jahnsen J, Aadland E, Hoie O, Cvancarova M, et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol. 2009;44(4):431\u201340.", "journal-title": "Scand J Gastroenterol"}, {"issue": "7", "key": "2_CR3", "doi-asserted-by": "crossref", "first-page": "613", "DOI": "10.1111/apt.13083", "volume": "41", "author": "JP Gisbert", "year": "2015", "unstructured": "Gisbert JP, Marin AC, McNicholl AG, Chaparro M. Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed. Aliment Pharmacol Ther. 2015;41(7):613\u201323.", "journal-title": "Aliment Pharmacol Ther"}, {"issue": "3", "key": "2_CR4", "doi-asserted-by": "crossref", "first-page": "501", "DOI": "10.1038/ajg.2009.727", "volume": "105", "author": "A Kornbluth", "year": "2010", "unstructured": "Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2010;105(3):501\u201323; quiz 24.", "journal-title": "Am J Gastroenterol"}, {"issue": "6", "key": "2_CR5", "doi-asserted-by": "crossref", "first-page": "507", "DOI": "10.1093/ecco-jcc/jjv059", "volume": "9", "author": "S Taleban", "year": "2015", "unstructured": "Taleban S, Colombel JF, Mohler MJ, Fain MJ. Inflammatory bowel disease and the elderly: a review. J Crohns Colitis. 2015;9(6):507\u201315.", "journal-title": "J Crohns Colitis"}, {"issue": "2", "key": "2_CR6", "doi-asserted-by": "crossref", "first-page": "338", "DOI": "10.1002/ibd.20997", "volume": "16", "author": "GR Lichtenstein", "year": "2010", "unstructured": "Lichtenstein GR, Rutgeerts P. Importance of mucosal healing in ulcerative colitis. Inflamm Bowel Dis. 2010;16(2):338\u201346.", "journal-title": "Inflamm Bowel Dis"}, {"issue": "1", "key": "2_CR7", "doi-asserted-by": "crossref", "first-page": "15", "DOI": "10.1038/nrgastro.2009.203", "volume": "7", "author": "G Pineton de Chambrun", "year": "2010", "unstructured": "Pineton de Chambrun G, Peyrin-Biroulet L, Lemann M, Colombel JF. Clinical implications of mucosal healing for the management of IBD. Nat Rev Gastroenterol Hepatol. 2010;7(1):15\u201329.", "journal-title": "Nat Rev Gastroenterol Hepatol"}, {"issue": "2", "key": "2_CR8", "doi-asserted-by": "crossref", "first-page": "451", "DOI": "10.1053/j.gastro.2003.11.010", "volume": "126", "author": "M Rutter", "year": "2004", "unstructured": "Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004;126(2):451\u20139.", "journal-title": "Gastroenterology"}, {"issue": "1", "key": "2_CR9", "first-page": "29", "volume": "8", "author": "M Dave", "year": "2012", "unstructured": "Dave M, Loftus EV Jr. Mucosal healing in inflammatory bowel disease-a true paradigm of success? Gastroenterol Hepatol (N Y). 2012;8(1):29\u201338.", "journal-title": "Gastroenterol Hepatol (N Y)"}, {"issue": "9", "key": "2_CR10", "doi-asserted-by": "crossref", "first-page": "1245", "DOI": "10.1016/j.cgh.2016.01.015", "volume": "14", "author": "SC Shah", "year": "2016", "unstructured": "Shah SC, Colombel JF, Sands BE, Narula N. Mucosal healing is associated with improved long-term outcomes of patients with ulcerative colitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016;14(9):1245\u201355.", "journal-title": "Clin Gastroenterol Hepatol"}, {"issue": "8785", "key": "2_CR11", "doi-asserted-by": "crossref", "first-page": "89", "DOI": "10.1016/0140-6736(92)90999-J", "volume": "339", "author": "CP Braegger", "year": "1992", "unstructured": "Braegger CP, Nicholls S, Murch SH, Stephens S, MacDonald TT. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet. 1992;339(8785):89\u201391.", "journal-title": "Lancet"}, {"issue": "12", "key": "2_CR12", "doi-asserted-by": "crossref", "first-page": "1705", "DOI": "10.1136/gut.34.12.1705", "volume": "34", "author": "SH Murch", "year": "1993", "unstructured": "Murch SH, Braegger CP, Walker-Smith JA, MacDonald TT. Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease. Gut. 1993;34(12):1705\u20139.", "journal-title": "Gut"}, {"issue": "8", "key": "2_CR13", "doi-asserted-by": "crossref", "first-page": "913", "DOI": "10.1136/gut.32.8.913", "volume": "32", "author": "SH Murch", "year": "1991", "unstructured": "Murch SH, Lamkin VA, Savage MO, Walker-Smith JA, MacDonald TT. Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease. Gut. 1991;32(8):913\u20137.", "journal-title": "Gut"}, {"key": "2_CR14", "unstructured": "Remicade (R) [package insert]. Horsham, PA: Jansenn Biotech; 2013."}, {"issue": "23", "key": "2_CR15", "doi-asserted-by": "crossref", "first-page": "2462", "DOI": "10.1056/NEJMoa050516", "volume": "353", "author": "P Rutgeerts", "year": "2005", "unstructured": "Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005;353(23):2462\u201376.", "journal-title": "N Engl J Med"}, {"issue": "2", "key": "2_CR16", "doi-asserted-by": "crossref", "first-page": "201", "DOI": "10.1002/ibd.21697", "volume": "18", "author": "W Reinisch", "year": "2012", "unstructured": "Reinisch W, Sandborn WJ, Rutgeerts P, Feagan BG, Rachmilewitz D, Hanauer SB, et al. Long-term infliximab maintenance therapy for ulcerative colitis: the ACT-1 and -2 extension studies. Inflamm Bowel Dis. 2012;18(2):201\u201311.", "journal-title": "Inflamm Bowel Dis"}, {"key": "2_CR17", "unstructured": "Humira (R) [package insert]. North Chicago, IL: AbbVie; 2016."}, {"issue": "6", "key": "2_CR18", "doi-asserted-by": "crossref", "first-page": "780", "DOI": "10.1136/gut.2010.221127", "volume": "60", "author": "W Reinisch", "year": "2011", "unstructured": "Reinisch W, Sandborn WJ, Hommes DW, D\u2019Haens G, Hanauer S, Schreiber S, et al. Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial. Gut. 2011;60(6):780\u20137.", "journal-title": "Gut"}, {"issue": "2", "key": "2_CR19", "doi-asserted-by": "crossref", "first-page": "257", "DOI": "10.1053/j.gastro.2011.10.032", "volume": "142", "author": "WJ Sandborn", "year": "2012", "unstructured": "Sandborn WJ, van Assche G, Reinisch W, Colombel JF, D\u2019Haens G, Wolf DC, et al. Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis. Gastroenterology. 2012;142(2):257\u201365.e1-3.", "journal-title": "Gastroenterology"}, {"issue": "5", "key": "2_CR20", "first-page": "486", "volume": "40", "author": "D Wolf", "year": "2014", "unstructured": "Wolf D, D\u2019Haens G, Sandborn WJ, Colombel JF, Van Assche G, Robinson AM, et al. Escalation to weekly dosing recaptures response in adalimumab-treated patients with moderately to severely active ulcerative colitis. Aliment Pharmacol Ther. 2014;40(5):486\u201397.", "journal-title": "Aliment Pharmacol Ther"}, {"issue": "11", "key": "2_CR21", "doi-asserted-by": "crossref", "first-page": "1771", "DOI": "10.1038/ajg.2014.242", "volume": "109", "author": "JF Colombel", "year": "2014", "unstructured": "Colombel JF, Sandborn WJ, Ghosh S, Wolf DC, Panaccione R, Feagan B, et al. Four-year maintenance treatment with adalimumab in patients with moderately to severely active ulcerative colitis: data from ULTRA 1, 2, and 3. Am J Gastroenterol. 2014;109(11):1771\u201380.", "journal-title": "Am J Gastroenterol"}, {"issue": "4", "key": "2_CR22", "doi-asserted-by": "crossref", "first-page": "964", "DOI": "10.1002/art.23383", "volume": "58", "author": "J Kay", "year": "2008", "unstructured": "Kay J, Matteson EL, Dasgupta B, Nash P, Durez P, Hall S, et al. Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: a randomized, double-blind, placebo-controlled, dose-ranging study. Arthritis Rheum. 2008;58(4):964\u201375.", "journal-title": "Arthritis Rheum"}, {"issue": "6", "key": "2_CR23", "doi-asserted-by": "crossref", "first-page": "1129", "DOI": "10.1136/ard.2009.116319", "volume": "69", "author": "E Keystone", "year": "2010", "unstructured": "Keystone E, Genovese MC, Klareskog L, Hsia EC, Hall S, Miranda PC, et al. Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD study. Ann Rheum Dis. 2010;69(6):1129\u201335.", "journal-title": "Ann Rheum Dis"}, {"issue": "8", "key": "2_CR24", "doi-asserted-by": "crossref", "first-page": "2272", "DOI": "10.1002/art.24638", "volume": "60", "author": "P Emery", "year": "2009", "unstructured": "Emery P, Fleischmann RM, Moreland LW, Hsia EC, Strusberg I, Durez P, et al. Golimumab, a human anti-tumor necrosis factor alpha monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis. Arthritis Rheum. 2009;60(8):2272\u201383.", "journal-title": "Arthritis Rheum"}, {"issue": "9685", "key": "2_CR25", "doi-asserted-by": "crossref", "first-page": "210", "DOI": "10.1016/S0140-6736(09)60506-7", "volume": "374", "author": "JS Smolen", "year": "2009", "unstructured": "Smolen JS, Kay J, Doyle MK, Landewe R, Matteson EL, Wollenhaupt J, et al. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial. Lancet. 2009;374(9685):210\u201321.", "journal-title": "Lancet"}, {"issue": "5", "key": "2_CR26", "doi-asserted-by": "crossref", "first-page": "661", "DOI": "10.1136/ard.2011.154799", "volume": "71", "author": "J Braun", "year": "2012", "unstructured": "Braun J, Deodhar A, Inman RD, van der Heijde D, Mack M, Xu S, et al. Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 104-week results of the GO-RAISE study. Ann Rheum Dis. 2012;71(5):661\u20137.", "journal-title": "Ann Rheum Dis"}, {"issue": "8", "key": "2_CR27", "doi-asserted-by": "crossref", "first-page": "2504", "DOI": "10.1002/art.34436", "volume": "64", "author": "A Kavanaugh", "year": "2012", "unstructured": "Kavanaugh A, van der Heijde D, McInnes IB, Mease P, Krueger GG, Gladman DD, et al. Golimumab in psoriatic arthritis: one-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial. Arthritis Rheum. 2012;64(8):2504\u201317.", "journal-title": "Arthritis Rheum"}, {"issue": "1", "key": "2_CR28", "doi-asserted-by": "crossref", "first-page": "85", "DOI": "10.1053/j.gastro.2013.05.048", "volume": "146", "author": "WJ Sandborn", "year": "2014", "unstructured": "Sandborn WJ, Feagan BG, Marano C, Zhang H, Strauss R, Johanns J, et al. Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis. Gastroenterology. 2014;146(1):85\u201395; quiz e14-5.", "journal-title": "Gastroenterology"}, {"issue": "1", "key": "2_CR29", "doi-asserted-by": "crossref", "first-page": "96", "DOI": "10.1053/j.gastro.2013.06.010", "volume": "146", "author": "WJ Sandborn", "year": "2014", "unstructured": "Sandborn WJ, Feagan BG, Marano C, Zhang H, Strauss R, Johanns J, et al. Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis. Gastroenterology. 2014;146(1):96\u2013109.e1.", "journal-title": "Gastroenterology"}, {"key": "2_CR30", "doi-asserted-by": "crossref", "first-page": "e168", "DOI": "10.1038/ctg.2016.24", "volume": "7", "author": "PR Gibson", "year": "2016", "unstructured": "Gibson PR, Feagan BG, Sandborn WJ, Marano C, Strauss R, Johanns J, et al. Maintenance of efficacy and continuing safety of golimumab for active ulcerative colitis: PURSUIT-SC maintenance study extension through 1 year. Clin Transl Gastroenterol. 2016;7:e168.", "journal-title": "Clin Transl Gastroenterol"}, {"issue": "3", "key": "2_CR31", "doi-asserted-by": "crossref", "first-page": "336", "DOI": "10.1136/gut.46.3.336", "volume": "46", "author": "EV Loftus Jr", "year": "2000", "unstructured": "Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut. 2000;46(3):336\u201343.", "journal-title": "Gut"}, {"issue": "1", "key": "2_CR32", "doi-asserted-by": "crossref", "first-page": "51", "DOI": "10.4292/wjgpt.v7.i1.51", "volume": "7", "author": "D Nimmons", "year": "2016", "unstructured": "Nimmons D, Limdi JK. Elderly patients and inflammatory bowel disease. World J Gastrointest Pharmacol Ther. 2016;7(1):51\u201365.", "journal-title": "World J Gastrointest Pharmacol Ther"}, {"issue": "1", "key": "2_CR33", "doi-asserted-by": "crossref", "first-page": "30", "DOI": "10.1016/j.cgh.2010.09.026", "volume": "9", "author": "M Cottone", "year": "2011", "unstructured": "Cottone M, Kohn A, Daperno M, Armuzzi A, Guidi L, D\u2019Inca R, et al. Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease. Clin Gastroenterol Hepatol. 2011;9(1):30\u20135.", "journal-title": "Clin Gastroenterol Hepatol"}, {"issue": "2", "key": "2_CR34", "doi-asserted-by": "crossref", "first-page": "309", "DOI": "10.1002/ibd.23026", "volume": "19", "author": "A Desai", "year": "2013", "unstructured": "Desai A, Zator ZA, de Silva P, Nguyen DD, Korzenik J, Yajnik V, et al. Older age is associated with higher rate of discontinuation of anti-TNF therapy in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19(2):309\u201315.", "journal-title": "Inflamm Bowel Dis"}, {"issue": "4", "key": "2_CR35", "doi-asserted-by": "crossref", "first-page": "441", "DOI": "10.1111/apt.13294", "volume": "42", "author": "T Lobaton", "year": "2015", "unstructured": "Lobaton T, Ferrante M, Rutgeerts P, Ballet V, Van Assche G, Vermeire S. Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2015;42(4):441\u201351.", "journal-title": "Aliment Pharmacol Ther"}, {"issue": "2", "key": "2_CR36", "doi-asserted-by": "crossref", "first-page": "465", "DOI": "10.1038/ajg.2008.168", "volume": "104", "author": "GR Lichtenstein", "year": "2009", "unstructured": "Lichtenstein GR, Hanauer SB, Sandborn WJ. Management of Crohn\u2019s disease in adults. Am J Gastroenterol. 2009;104(2):465\u201383; quiz 4, 84.", "journal-title": "Am J Gastroenterol"}, {"issue": "2", "key": "2_CR37", "doi-asserted-by": "crossref", "first-page": "390", "DOI": "10.1053/j.gastro.2012.05.004", "volume": "143", "author": "MD Long", "year": "2012", "unstructured": "Long MD, Martin CF, Pipkin CA, Herfarth HH, Sandler RS, Kappelman MD. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. Gastroenterology. 2012;143(2):390\u20139.e1.", "journal-title": "Gastroenterology"}, {"issue": "1", "key": "2_CR38", "doi-asserted-by": "crossref", "first-page": "24", "DOI": "10.1111/jgh.12015", "volume": "28", "author": "K Subramaniam", "year": "2013", "unstructured": "Subramaniam K, D\u2019Rozario J, Pavli P. Lymphoma and other lymphoproliferative disorders in inflammatory bowel disease: a review. J Gastroenterol Hepatol. 2013;28(1):24\u201330.", "journal-title": "J Gastroenterol Hepatol"}, {"issue": "2", "key": "2_CR39", "first-page": "204", "volume": "92", "author": "A Kornbluth", "year": "1997", "unstructured": "Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 1997;92(2):204\u201311.", "journal-title": "Am J Gastroenterol"}, {"issue": "2", "key": "2_CR40", "first-page": "71", "volume": "7", "author": "G Sylwestrzak", "year": "2014", "unstructured": "Sylwestrzak G, Liu J, Stephenson JJ, Ruggieri AP, DeVries A. Considering patient preferences when selecting anti-tumor necrosis factor therapeutic options. Am Health Drug Benefits. 2014;7(2):71\u201381.", "journal-title": "Am Health Drug Benefits"}, {"issue": "12", "key": "2_CR41", "doi-asserted-by": "crossref", "first-page": "829", "DOI": "10.7326/0003-4819-146-12-200706190-00159", "volume": "146", "author": "WJ Sandborn", "year": "2007", "unstructured": "Sandborn WJ, Rutgeerts P, Enns R, Hanauer SB, Colombel JF, Panaccione R, et al. Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial. Ann Intern Med. 2007;146(12):829\u201338.", "journal-title": "Ann Intern Med"}, {"issue": "4", "key": "2_CR42", "doi-asserted-by": "crossref", "first-page": "379", "DOI": "10.3109/00365521.2014.928901", "volume": "50", "author": "JP Gisbert", "year": "2015", "unstructured": "Gisbert JP, Chaparro M. Use of a third anti-TNF after failure of two previous anti-TNFs in patients with inflammatory bowel disease: is it worth it? Scand J Gastroenterol. 2015;50(4):379\u201386.", "journal-title": "Scand J Gastroenterol"}, {"issue": "5", "key": "2_CR43", "doi-asserted-by": "crossref", "first-page": "459", "DOI": "10.1111/j.1365-2036.2012.05214.x", "volume": "36", "author": "PS Silva de", "year": "2012", "unstructured": "de Silva PS, Nguyen DD, Sauk J, Korzenik J, Yajnik V, Ananthakrishnan AN. Long-term outcome of a third anti-TNF monoclonal antibody after the failure of two prior anti-TNFs in inflammatory bowel disease. Aliment Pharmacol Ther. 2012;36(5):459\u201366.", "journal-title": "Aliment Pharmacol Ther"}, {"issue": "1", "key": "2_CR44", "doi-asserted-by": "crossref", "first-page": "92", "DOI": "10.1111/j.1365-2036.2009.04130.x", "volume": "31", "author": "M Allez", "year": "2010", "unstructured": "Allez M, Vermeire S, Mozziconacci N, Michetti P, Laharie D, Louis E, et al. The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn\u2019s disease after failure of two other anti-TNF antibodies. Aliment Pharmacol Ther. 2010;31(1):92\u2013101.", "journal-title": "Aliment Pharmacol Ther"}, {"issue": "8", "key": "2_CR45", "doi-asserted-by": "crossref", "first-page": "2205", "DOI": "10.1007/s10620-016-4146-x", "volume": "61", "author": "JS Reich", "year": "2016", "unstructured": "Reich JS, Farraye FA, Wasan SK. Preventative care in the patient with inflammatory bowel disease: what is new? Dig Dis Sci. 2016;61(8):2205\u201316.", "journal-title": "Dig Dis Sci"}, {"issue": "6", "key": "2_CR46", "doi-asserted-by": "crossref", "first-page": "1231", "DOI": "10.1038/ajg.2009.733", "volume": "105", "author": "SK Wasan", "year": "2010", "unstructured": "Wasan SK, Baker SE, Skolnik PR, Farraye FA. A practical guide to vaccinating the inflammatory bowel disease patient. Am J Gastroenterol. 2010;105(6):1231\u20138.", "journal-title": "Am J Gastroenterol"}], "container-title": ["Treatment of Inflammatory Bowel Disease with Biologics"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-319-60276-9_2", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 11, 9]], "date-time": "2017-11-09T12:28:04Z", "timestamp": 1510230484000}, "score": 17.78936, "issued": {"date-parts": [[2017, 8, 3]]}, "ISBN": ["9783319602752", "9783319602769"], "references-count": 46, "URL": "http://dx.doi.org/10.1007/978-3-319-60276-9_2", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T21:40:59Z", "timestamp": 1575322859288}, "reference-count": 5, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1988, 12, 1]], "date-time": "1988-12-01T00:00:00Z", "timestamp": 596937600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Urol Radiol"], "published-print": {"date-parts": [[1988, 12]]}, "DOI": "10.1007/bf02926539", "type": "journal-article", "created": {"date-parts": [[2008, 11, 13]], "date-time": "2008-11-13T05:13:05Z", "timestamp": 1226553185000}, "page": "68-71", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Urothelial microvascular response to chronic renal inflammatory disease"], "prefix": "10.1007", "volume": "10", "author": [{"given": "John T.", "family": "Cuttino", "sequence": "first", "affiliation": []}, {"given": "Richard L.", "family": "Clark", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "BF02926539_CR1", "doi-asserted-by": "crossref", "first-page": "587", "DOI": "10.1148/123.3.587", "volume": "123", "author": "ZL Barbaric", "year": "1977", "unstructured": "Barbaric ZL: Pelvocalyceal wall opacification: a new radiological sign.Radiology 123:587\u2013589, 1977", "journal-title": "Radiology"}, {"key": "BF02926539_CR2", "doi-asserted-by": "crossref", "first-page": "468", "DOI": "10.1259/0007-1285-49-581-468", "volume": "49", "author": "T Sherwood", "year": "1976", "unstructured": "Sherwood T, Williams DI: A vascular ureterogram.Br J Radiol 49:468, 1976", "journal-title": "Br J Radiol"}, {"key": "BF02926539_CR3", "first-page": "281", "volume": "14", "author": "PR Koehler", "year": "1976", "unstructured": "Koehler PR, Nelson JA: Arteriographic findings in inflammatory mass lesions of the kidney.Radiol Clin North Am 14:281\u2013293, 1976", "journal-title": "Radiol Clin North Am"}, {"key": "BF02926539_CR4", "doi-asserted-by": "crossref", "first-page": "62", "DOI": "10.1097/00004424-197701000-00014", "volume": "12", "author": "RL Clark", "year": "1977", "unstructured": "Clark RL, Mandell SR, Webster WP: Microvascular changes in canine renal allograft rejection: a correlative microangiographic and histologic study.Invest Radiol 12:62\u201373, 1977", "journal-title": "Invest Radiol"}, {"key": "BF02926539_CR5", "author": "JJ Bookstein", "first-page": "11", "year": "1980", "unstructured": "Bookstein JJ, Clark RL:Renal Microvascular Disease: Angiographic-Microangiographic Correlates. Boston: Little, Brown, 1980, pp 11\u201315", "volume-title": "Renal Microvascular Disease: Angiographic-Microangiographic Correlates"}], "container-title": ["Urologic Radiology"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/BF02926539.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/BF02926539/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/BF02926539", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 22]], "date-time": "2019-05-22T22:26:17Z", "timestamp": 1558563977000}, "score": 17.78936, "issued": {"date-parts": [[1988, 12]]}, "references-count": 5, "journal-issue": {"published-print": {"date-parts": [[1988, 12]]}, "issue": "1"}, "alternative-id": ["BF02926539"], "URL": "http://dx.doi.org/10.1007/bf02926539", "relation": {"cites": []}, "ISSN": ["0171-1091"], "issn-type": [{"value": "0171-1091", "type": "print"}], "subject": ["Urology", "Radiology Nuclear Medicine and imaging"]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T01:03:17Z", "timestamp": 1575421397109}, "reference-count": 40, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2014, 2, 1]], "date-time": "2014-02-01T00:00:00Z", "timestamp": 1391212800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pathophysiology"], "published-print": {"date-parts": [[2014, 2]]}, "DOI": "10.1016/j.pathophys.2013.11.006", "type": "journal-article", "created": {"date-parts": [[2014, 1, 6]], "date-time": "2014-01-06T13:00:19Z", "timestamp": 1389013219000}, "page": "29-34", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Feeding associated neonatal necrotizing enterocolitis (Primary NEC) is an inflammatory bowel disease"], "prefix": "10.1016", "volume": "21", "author": [{"given": "David A.", "family": "Clark", "sequence": "first", "affiliation": []}, {"given": "Upender K.", "family": "Munshi", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Pathophysiology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0928468013000710?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0928468013000710?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 8, 5]], "date-time": "2019-08-05T22:11:02Z", "timestamp": 1565043062000}, "score": 17.78936, "issued": {"date-parts": [[2014, 2]]}, "references-count": 40, "journal-issue": {"published-print": {"date-parts": [[2014, 2]]}, "issue": "1"}, "alternative-id": ["S0928468013000710"], "URL": "http://dx.doi.org/10.1016/j.pathophys.2013.11.006", "ISSN": ["0928-4680"], "issn-type": [{"value": "0928-4680", "type": "print"}], "subject": ["Pathology and Forensic Medicine", "Physiology (medical)"]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}